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ABSTRACT 
 
The organocatalytic asymmetric conjugate addition of carbon nucleophiles and 
heteroatom nucleophiles to electron deficient nitroalkenes is an important tool for the 
synthesis of highly functionalized building blocks for applications in medicinal and 
synthetic organic chemistry. Although the enantioselective conjugate addition reactions 
of -nitrostyrenes are well known, the corresponding conjugate addition reactions of -
nitrostyrenes are not reported. The present study examines the organocatalytic 
asymmetric, enamine-mediated conjugate addition reaction of aldehydes or cyclic 
ketones to -nitrostyrenes that were generated in situ from the corresponding 
nitroacetates. The details of this study are described in Chapter 2 of this thesis. 
The utility of the above methodology was demonstrated by application in the 
formal total synthesis of 4-aryl indolizidine alkaloids, (+)-lasubine II and (-)-subcosine II. 
The organocatalytic Michael addition of 1,4-cyclohexanedione monoethylene ketal to an 
appropriate -nitrostyrene which were generated in situ from the corresponding 
nitroacetate gave the key -nitroketone which was used as the starting material in the 
alkaloid synthesis. The details of this study are described in Chapter 3. 
Finally, an enantiomerically enriched -nitroketone obtained from the 
organocatalytic Michael addition of 1,4-cyclohexanedione monoethylene ketal to a -
nitrostyrene has been utilized in the synthesis of a recently isolated indolizidine alkaloid, 
iv 
 
(+)-fistulopsine B, which is of interest due to its anticancer activity. Details of this 
investigation are described in Chapter 4. 
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Chapter 1 
Introduction 
1.1 Organocatalytic conjugate addition reactions 
The conjugate addition of nucleophiles to the β-position of α,β-unsaturated 
carbonyl compounds (Michael reaction) is an important method for making a carbon–
carbon bond.1  Due to the high demand for optically active compounds, much effort has 
been devoted to the development of asymmetric Michael reactions, since stereogenic 
centers  can be constructed in the course of the Michael reaction.1 Although asymmetric 
conjugate additions have, over the years, been dominated by using chiral catalysts 
containing metals, small organic molecules (organocatalysts) have been developed, over 
the past decade, as efficient catalysts for these reactions.2 
Carbon nucleophiles with active methylene groups are extensively used in direct 
Michael additions, while simple carbonyl compounds need to be activated as enol ethers 
or enamines prior to addition to a Michael acceptor (Figure 1.1). In this case, direct 
addition of unmodified carbonyl compounds to Michael acceptors would avoid unwanted 
chemical transformations and also reduce the overall synthetic effort.  
 
Figure 1.1 Direct and indirect Michael addition. 
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In this context, the concept of aminocatalysis3 has received considerable attention 
in recent years. In the presence of a secondary amine, catalytic activation of an aldehyde 
or a ketone (the Michael donor) may take place through enamine formation (a synthetic 
equivalent of to an enolate) for the addition to a Michael acceptor (Figure 1.2, path a). 
Alternatively, Michael acceptors containing a carbonyl group can be activated by the 
formation of an iminium species (Figure 1.2, path b). 
 
Figure 1.2 Activation of a Michael donor and Michael acceptor.  
 The following is a brief introduction to key developments in the areas of iminium 
ion- and enamine-mediated organocatalytic conjugate addition reactions. Since the main 
focus of the investigations described in this thesis is on enamine mediated conjugate 
addition reactions, a more detailed review is provided on this particular topic and 
iminium ion catalysis is only briefly discussed. 
1.2 Organocatalytic conjugate addition reactions via iminium catalysis 
By its very nature, iminium ion catalysis requires the use of enones or enals as 
Michael acceptors. In 2000, MacMillan reported the activation of unsaturated aldehydes 
and ketones by reversible iminium ion formation with chiral amines as a highly 
generalized strategy for conjugate addition reactions.4,5 The formation of the iminium ion 
lowers the LUMO energy of the carbonyl substrate to better match the HOMO of the 
 3 
 
nucleophile. This activation effect is similar to that associated with reactions involving 
metal-based Lewis acids (Scheme 1.1).1 
 
Scheme 1.1 
Iminium catalysis forms the basis for several conjugate addition reactions of 
various Michael donors such as malonates,7,8 nitroalkanes9,10 and thiols11 to enones as 
well as for Mukaiyama-Michael reactions of silyloxyfurans with enals.5,6 The first 
iminium-catalyzed conjugate addition (malonate 2 to enone 1) was reported by 
Yamaguchi and co-workers12 in 1991 using the lithium salt of (S)-proline 3 to obtain 
moderate to good enantioselectivities (Scheme 1.2). 
H
O
+ H3CO
O
OCH3
O NH
CO2Li H
O
H3CO2C
CO2CH3cat.
35-77% ee
1 2
3
4
 
Scheme 1.2 
In 2003, Jørgensen developed the highly enantioselective organocatalytic Michael 
addition13 of malonates such as 6 to α,β-unsaturated enones such as 5 using an 
imidazolidine catalyst 7, which was readily prepared from phenylalanine (Scheme 1.3). 
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Scheme 1.3 
The following is a summary of the enamine-mediated organocatalytic Michael 
reactions of aldehydes and ketones with a variety of Michael acceptors. 
1.3 Organocatalytic conjugate addition reactions via enamine catalysis 
 Chiral amines can catalyze the asymmetric conjugate addition of aldehydes and 
ketones to electron-deficient alkenes (Michael acceptors) such as nitroalkenes, enones, 
and vinyl sulfones by in situ formation of enamines from the starting aldehydes and 
ketones.2 The enamine catalysis relies on the reversible formation of enamines from a 
catalytic amount of primary or secondary amine. The formation of an iminium ion is the 
first step of the catalytic cycle (Figure 1.3). This results in a significant increase in α-C-H 
acidity which facilitates enamine formation.1e Nucleophilic addition of the enamine to the 
Michael acceptor ultimately generates an iminium ion, which undergoes hydrolysis under 
the reaction conditions, to regenerate the amine catalyst. 
 5 
 
 
Figure 1.3 Enamine-catalyzed Michael reaction.1e 
Although asymmetric conjugate additions have, over the years, been dominated 
by the application of chiral Lewis acids as catalysts, 14,15 more recently, organocatalysts 
have been added as efficient tools.2 For the vast majority of these reactions, chiral 
secondary amines are used as catalysts. The following is a brief summary of 
organocatalytic conjugate addition of ketones to nitroalkenes using enamine catalysis.  
1.4 Functionalized pyrrolidines as organocatalysts for the ketone-
nitroalkene conjugate addition reactions 
List et al. developed the first enamine-catalyzed asymmetric Michael reaction of 
ketone 9 to nitroalkenes 10.16 The reaction was catalyzed by (S)-proline (11) in DMSO to 
afford the desired γ-nitroketones 12 in high yields and good diastereoselectivities, but 
only low enantioselectivities (Scheme 1.4). In a related study, Enders used methanol as 
the solvent to obtain better enantio- and diastereoselectivities.17 
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O
+ Ar NO2
O
NO2
ArNH
CO2H
(15 mol%)
rt, 2 h
dr: syn/anti up to 9:1
ee = up to 47%
9 10
11
12
dr: syn/anti up to 9:1
ee = up to 76%
List (DMSO) :
Enders (MeOH) :
 
Scheme 1.4 
Since the initial report by List, several chiral pyrrolidine-based catalysts having an 
N-containing side chain or heterocycle were developed (Figure 1.4), and either the free 
amine or the corresponding salts were shown to promote the highly syn-selective addition 
of cyclic and acyclic ketones 16 to nitroalkenes 102e,g  (Scheme 1.5). Quite often the role 
of the acid co-catalyst (HX, Scheme 1.5) is to promote iminium ion formation, and 
consequently enamine formation, which results in an overall rate acceleration and 
increased conversion.  
   
Scheme 1.5 
Numerous secondary amine based catalysts18-33 have been reported for these 
reactions. A selection of catalysts reported in the early days of the reactions 
(organocatalytic ketone-nitroalkene conjugate addition) are shown in Figure 1.4. 
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Figure 1.4 Selected organocatalysts for the ketone-nitroalkene conjugate addition. 
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1.5 Chiral, functionalized primary amines as organocatalysts for the 
ketone-nitroalkene conjugate addition reaction 
1.5.1 Chiral peptides as organocatalysts for the ketone-nitroalkene 
conjugate addition reaction 
Alanine 35 and alanine-containing small oligopeptides have also shown good 
stereoselectivities in the addition of ketones 16 to nitroalkenes 1034 (Scheme 1.6). The L-
ala-L-ala dipeptide 36 is more selective than monomer 35, while the alanine derivative 37 
is a much better catalyst than 35 and 36.35 
 
Scheme 1.6 
1.52 Chiral amino-thioureas as organocatalysts for the ketone-
nitroalkene conjugate addition reaction 
In 2006, Tsogoeva, Schmatz, and co-workers utilized primary amine derived 
chiral thiourea catalysts in the Michael reaction of ketones 16 to nitroalkenes 10.36,37 
Thiourea 38, bearing a primary amine, promoted the addition of ketones to nitroalkenes 
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(Scheme 1.7) with moderate diastereoselectivities (up to 6:1 dr) but excellent 
enantioselectivities (up to 99% ee). Water plays an important role in the regeneration of 
the catalyst and enamine formation is accelerated by acidic additives.  
 
Scheme 1.7 
In 2006, Huang and Jacobsen used a similar primary amine thiourea catalyst 40 
for the conjugate addition of ketones 16 to nitroalkenes 10.38 While the reactions 
performed in polar and/or protic solvents proceeded slowly, nonpolar solvents and high 
concentrations turned out to be beneficial. Thiourea containing catalyst 40 furnished  
Michael adducts with excellent anti-selectivity (up to 20:1 dr) and enantioselectivities 
(up to 99%). A (Z)-enamine intermediate was proposed for the observed anti-
diastereoselectivity (Scheme 1.8). 
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Scheme 1.8 
 In 2007, Ma and co-workers reported a new primary amine-thiourea39 catalyst 44 
for the Michael addition of aromatic ketones 42 to nitroalkenes 43 to provide Michael 
adducts 45 with excellent enantioselectivities and moderate to good yields (Scheme 1.9). 
 
Scheme 1.9 
In 2009, the Yan group developed a simple chiral thiourea40 catalyst 47 derived 
from cyclohexane-1,2-diamine  for the Michael addition of aldehydes 46 to nitroalkenes 
10 to afford Michael adducts 48 (Scheme 1.10) with excellent enantioselectivities and 
yields. In the case of ketones, low enantioselectivities and yields were observed. The use 
of base additives is essential for good yields and excellent enantioselectivities. 
 11 
 
 
Scheme 1.10 
In 2010, Xu and co-workers, applied a primary amine-thiourea41 catalyst 49 
developed by the Tsogeva group for the conjugate addition of ketones 16 to nitroalkenes 
10 to provide Michael adducts 17 with excellent enantioselectivities and good to high 
yields (Scheme 1.11).    
 
Scheme 1.11 
In 2012, Kokotos and co-workers reported the Michael addition of aryl methyl 
ketones 50 to nitroalkenes 51 in the presence of di-tert-butyl aspirate42-derived catalyst 
52 to afford Michael adducts 53 with excellent enantioselectivities and high yields 
(Scheme 1.12).  
 12 
 
 
Scheme1.12 
In 2014, Li and co-workers developed a new primary amine-thiourea43 
organocatalyst 54 derived from chiral 1,2-diaminocyclohexane. The chiral 1,2-
diaminocyclohexane derived thiourea catalyst was able to catalyze the Michael addition 
of acetophenone derivatives 50 to -nitrostyrenes 10. The steric hindrance provided by 
the fluorenyl backbone in the catalyst allowed the formation of Michael adducts 55 with 
good enantioselectivities (Scheme 1.13).  
 
Scheme 1.13 
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Numerous other primary amine-thiourea based catalysts have been reported for 
these reactions. A selection of catalysts reported for the organocatalytic ketone-
nitroalkene conjugate addition reactions is shown in Figure 1.5. 
 
Figure 1.5 Selected organocatalysts for the ketone-nitroalkene conjugate addition. 
 
1.53 Chiral triamines as organocatalysts for ketone-nitroalkene 
conjugate addition reactions 
In 2015, Pan et al. developed the first enamine catalyzed asymmetric Michael 
reaction of -branched cyclized enones 56 to nitroalkenes 10.44 The reaction was 
catalyzed by primary amine catalyst 57 in toluene to provide the desired nitroketone 58 
with 55% yield. The enantioselectivities of the reactions are moderate (70-75%, Scheme 
1.14). 
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Scheme 1.14 
1.54 Research Objectives 
Although the enantioselective organocatalytic conjugate addition of ketones to -
nitrostyrenes are well known, the corresponding reactions of -nitrostyrenes are not 
reported. Hence the first objective of our study was to develop an organocatalyzed 
asymmetric conjugate addition of aldehydes 59 and ketones 62 to -nitrostyrenes 
(Scheme 1.17). 
 
Scheme 1.17 
The second objective was to utilize the -nitroketones 63 (Scheme 1.17) as key 
starting materials in the synthesis of selected 4-aryl quinolizine alkaloids (Scheme 1.18). 
 15 
 
Scheme 1.18 
The final objective was an application of the organocatalytic Michael addition of 
ketones to -nitrostyrenes. This project constitutes an extension of the methodology for 
indolizidine synthesis that was previously developed47 in the Pansare group. The general 
strategy, shown in Scheme 1.19, involves the organocatalytic synthesis of the -
nitroketone 67 which is then converted to the target indolizidine. In the present 
investigation, this methodology was applied in the total synthesis of an indolizidine 
alkaloid, (+)-fistulopsine B (68) that was isolated in 2016. 
O
R R'
NO2Ar O2N
Ar
O
H
N+ catalyst
64
10
67 68
R'
R
* *
H
HO
OMe
HO
OMe
(+)-Fistulopsine B
 
Scheme 1.19 
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Chapter 2 
 
 
 
 
 
 
Organocatalytic Michael Addition of Carbon Nucleophiles to in situ 
Generated -Nitrostyrenes 
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2.1 Introduction 
Organocatalytic asymmetric Michael addition reactions of symmetrical ketones and 
aldehydes to -nitroalkenes, a reaction that generates two contiguous stereocenters, have 
been extensively investigated in recent years.1 The synthetic utility of this reaction is also 
due to the nitro group, which can be utilized in numerous synthetic transformations.2c The 
use of -nitroalkenes in these reactions generates -nitroketones with 1,2-stereocenters. 
This kind of 1,2-stereoinduction is now well established and has also been extensively 
investigated in other C-C bond forming reactions such as the aldol and Mannich reactions. 
In contrast, the construction of 1,3-stereocenters in a carbon-carbon bond forming reaction 
is not very common2 (shown in Figure 2.1). Interestingly, the organocatalytic Michael 
addition of ketones or aldehydes to -nitrostyrenes would generate -nitroketones with 1,3-
stereocenters. This process, which complements the conjugate addition to -nitrostyrenes, 
is not well studied and catalytic enantioselective versions of such a reaction had not been 
reported when our studies were initiated. 
 
Figure 2.1 Asymmetric induction of adjacent 1,2 stereocenters and non-adjacent 1,3                        
stereocenters 
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This chapter describes the first enamine-mediated enantioselective organocatalytic 
Michael addition reaction of ketones and aldehydes to -nitrostyrenes. 
2.2 Objective 
The main objective of our study was to utilize cyclic ketones and aldehydes as the 
Michael donors in catalytic enantioselective conjugate addition reactions with -
nitrostyrenes as the Michael acceptors. Nitroalkenes have been of special interest as 
excellent Michael acceptors due to the strong electron-withdrawing effect of the nitro 
group. In addition, conjugate addition of carbonyl compounds to the nitroalkene offers 
synthetically useful -nitrocarbonyl derivatives for the preparation of complex synthetic 
targets.3 In addition, the nitro group itself is particularly versatile as it may be transformed 
into diverse functionalities.2c 
 
2.3 Literature Survey 
 Although no studies on the catalytic enantioselective Michael addition of 
nucleophiles to -nitrostyrenes had been reported at the time we started our investigations, 
a few reports describing the catalytic enantioselective construction of 1,3-stereocenters 
were available. The following is a brief summary of these methods. 
 In 2010, Cheng and co-workers reported the first catalytic conjugate addition 
reaction of 3-substituted oxindoles 3 to 2-chloroacrylonitriles 4 in the presence of a 
bifunctional tertiary amine thiourea catalyst4 5 to afford chiral oxindoles 6 with good yields 
and excellent diastereo- and enantioselectivity (Scheme 2.1). 
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Scheme 2.1 
 In 2012, Ellman and co-workers reported the first enantioselective catalytic 
nucleophilic addition of -substituted Meldrum’s acid1a 7 to -alkyl nitroalkenes 8 
followed by an enantioselective protonation to provide 10 with good yields and high 
enantioselectivity (up to 94%, Scheme 2.2). The catalyst of choice was an N-sulfinyl urea 
catalyst 9 which bears a chiral center at the sulfur atom. 
 
Scheme 2.2 
In 2013, Peng and co-workers reported the first organocatalytic asymmetric 
Michael addition of aldehydes1b 11 to -alkyl nitroalkenes 12 by using the (S)-proline-
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derived catalyst 13 (Scheme 2.3). The -nitro aldehydes 14 were formed with good yields 
and good diastereo- and enantioselectivity. 
 
Scheme 2.3 
In 2016, Palomo and co-workers reported the asymmetric Michael addition/-
protonation of '-hydroxy enone 15 with -substituted cyanoacetates5 16 by using a 
bifunctional Brønsted base catalyst 17 (Scheme 2.4). This methodology provided the 
acyclic carbonyl adducts 18 in good yields and high diastereo- and enantioselectivity.  
 
Scheme 2.4 
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2.4 Results and Discussion 
 We initiated studies on the Michael addition of ketone 33 to a suitable -
nitrostyrene. In anticipation of the high reactivity of the -nitrostyrene and the known 
tendency of such nitroalkenes to either polymerization6 or rearrangement,7 we chose to 
generate the required -nitrostyrene 2 in situ8 from the corresponding nitroacetate 19 (Fig. 
2.2).  
 
                                                        
Fig 2.2 -Nitrostyrene generated in situ from the corresponding nitroacetate 19. 
 The nitroacetates utilized in this study were synthesized from easily available 
starting materials by employing two different procedures. The first method relies on the 
regioselective ring opening of an epoxide with nitrite anion as the nucleophile (Scheme 
2.5). The starting epoxide 22 was synthesized from the commercially available 
veratraldehyde 20 and salt 21 following the Corey-Chaykovsky protocol (Scheme 2.5). 
Ring opening of epoxide 22 in the presence of NaNO2 and LaCl3·H2O9 provided the 
nitroalcohol 23 (40%). Acetylation of 23 in the presence of scandium triflate afforded 
nitroacetate 24 in 90% yield. 
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Scheme 2.5 
 An alternative method for the synthesis of other nitroacetates used in this study is 
shown in Scheme 2.6. This method uses benzyl bromides 25 or 26 as the starting materials. 
Displacement of the benzylic bromide with NaNO2 provided the nitro compounds 27 and 
28 from 25 and 26, respectively. A Henry reaction of the nitro compounds 27 and 28 in the 
presence of Na2CO3 and a calculated amount of 37% formalin solution afforded the 
nitroalcohols 29 and 30 in 65-70% yield. Finally, 29 and 30 were subjected to acetylation 
with acetic anhydride in the presence of scandium triflate to afford the nitroacetates 31 and 
32 in 80-90% yield. 
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Scheme 2.6 
 The Michael addition of ketone 33 to the -nitrostyrene generated in situ from 3,4-
dimethoxy phenyl nitroacetate 24 was selected as the model reaction for determining the 
optimum reaction conditions (Scheme 2.7). 
 
Scheme 2.7 
 Initially, various proline derived primary and secondary amine catalysts were 
screened for their ability to induce the elimination of acetate from 24 as well as catalyze 
the Michael addition of ketone 33 to provide nitroketone 34. The effect of various acid 
additives was also examined. DMF was used as the solvent for the screening of the acid 
additives, because previously the Pansare group, we reported the Michael addition of 
carbon nucleophiles to -nitrostyrenes,10 using DMF as the optimal solvent. The proline-
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derived diamine and triamine catalysts and the acid co-catalysts examined in this study are 
shown in Figure 2.3. 
 
Fig 2.3 Catalysts and acid co-catalysts employed in the screening of the Michael addition        
of cyclic ketones to in situ generated -nitrostyrenes. 
 In the absence of an acid co-catalyst, the yield of the Michael addition reaction as 
well as the enantiomeric excess of the products is significantly lower. The use of achiral 
acid catalysts results in an increase in yield and enantiomeric excess (as compared to the 
reaction without an acid co-catalyst) of the Michael adduct, but this increase is more 
pronounced when a chiral acid is used. The best result is obtained with the diamine catalyst 
35 and (1S)-camphorsulfonic acid 45 at ambient temperature as shown in Table 2.1. 
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Table 2.1: Catalyst and additive screening for the organocatalytic Michael addition   
of ketone to in situ generated α-nitrostyrene 
 
 (All reactions are done with 5 eq. of ketone, DMF solvent) 
Entry Catalyst Acid additive Yielda (%) 
   (36+37) 
eeb (%) 
     36              37 
1 38 41 - - - 
2 35 45 - - - 
3 35 40 12 12 nd 
4 35 46 - - - 
5 35                    47 29 51 43 
6 35 48 32 71 67 
7 35 49 47 72 58 
8 35 44 - - - 
9 35 42 39 65 59 
10 35 41 49 72 57 
11 35 43 51 67 60 
12 35 45 56 75 60 
13 39 45 41 41 nd 
14 40 45 57 12 nd 
                 aIsolated yields. bChiral HPLC analysis. ndnot determined. 
 
  Next, we screened several solvents like DMF, dichloromethane, chloroform, ethyl 
acetate and acetonitrile as shown in Table 2.2. Initially, we examined the reactions at 
ambient temperature with various solvents. In all of the reactions, the required Michael 
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addition product was obtained, but always as a mixture of diastereomers. When 
methanesulfonic acid was used as the co-catalyst, DMF, dichloromethane and chloroform 
emerged as the most promising solvents. An improved reaction rate and better 
enantioselectivity were observed when (1S)-camphorsulfonic acid was used as the co-
catalyst in DMF and acetonitrile. It appeared that DMF should be the solvent of choice for 
further optimization studies with diamine catalyst 35. We also studied the organocatalytic 
Michael addition reaction at lowered temperature with the hope of increasing the yield and 
enantioselectivity of the reaction using DMF as the solvent. Reactions with (1R)-
camphorsulfonic acid and (1S)-camphorsulfonic acid were both examined in DMF at 0 °C. 
Of these additives, (1S)-camphorsulfonic acid provided better yields and enantioselectivity 
(Table 2.2, entries 10 and 11). 
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Table 2.2: Solvent survey for the organocatalytic Michael addition reaction of 33 to   
in situ generated -nitrostyrene 
 
 
Entry Acid  Solvent Temp.  Yielda 
(%)  
eeb 
(%)  
36     37   36    37 
1 MsOH DMF rt 25 15 65 69 
2 CH2Cl2 rt 32 13 67 57 
3 CHCl3 rt - - - - 
4 EtOAc rt 25 10 55 54 
5 
1(S)-
camphorsulfonic 
acid 
DMF rt 40 16 75 60 
6 CH3CN 0 °C – 
rt 
41 17 84 51 
7 CH2Cl2 0 oC - - - - 
8  CHCl3 0 oC - - - - 
9  EtOAc 0 oC - - - - 
10 
(1R)-
camphorsulfonic 
acid 
DMF 0 oC 25 23 88 58 
11 
(1S)-
camphorsulfonic 
acid 
DMF 0 oC 51 23 92 52 
aIsolated yields. bChiral HPLC analysis. 
From this study, the diamine 35 (20 mol %) in the presence of (1S)-
camphorsulfonic acid as the co-catalyst (20 mol %) in DMF emerged as the catalytic 
system of choice.  
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Scheme 2.8 
The synthesis of nitroketone 36 constitutes the first example of the stereoselective 
Michael addition of a ketone to an in situ generated -nitrostyrene. The diastereoselectivity 
of the process is low (~1.5:1 dr), but the diastereomers can be easily separated to provide 
the major diastereomer in synthetically useful yield (51-52%) and enantiomeric excess (82-
92% ee). The enantiomeric excess of the minor diastereomers is typically low (50-55% ee). 
Treatment of pure 36 (92% ee) with catalyst 35 (20 mol %) in the presence of ketone 33 (5 
equiv) did not result in any loss of enantiomeric excess of 36 under the conditions 
employed for the Michael addition. The minor diastereomer could not be detected in this 
reaction mixture. These observations suggest that the Michael adduct 36 does not revert 
back to 33 and the nitroalkene and also that the minor diastereomer is not obtained by the 
epimerization of the major diastereomer under the reaction conditions. 
 Although the mechanistic details for the formation of 36 are not established, a 
plausible mechanism is shown in Figure 2.4. 
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Figure 2.4 Formation of major diastereomer 36 and X-ray crystal structure of nitroketone  
                   36. 
It is likely that the Michael addition of 33 with the -nitrostyrene derived from 24 
proceeds via a hydrogen-bonded11 intermediate A (Figure 2.4) in which the nitroalkene is 
delivered to the -face of the enamine derived from 33 and catalyst 35. This step establishes 
the ring stereocenter in the major diastereomer 36, and it could generate the 1,2-oxazine N-
oxide intermediate B. Similar intermediates have previously been proposed2e in 
stoichometric reactions of 4-tert-butylcyclohexanone-derived enamines with-
nitrostyrene and two of the 1,2-oxazine N-oxide intermediates were isolated and 
characterized in these studies. Subsequent opening of the oxazine produces the nitronate 
C, which is protonated stereoselectively to generate the benzylic stereocenter in 36. The 
origin of the stereoselectivity in the protonation step is not known at present. The low 
diastereoselectivity of the Michael addition may be due to the high reactivity of the -
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nitrostyrene, which enables a competing, non-hydrogen-bonded addition to the -face of 
the enamine. The absolute configuration of 36 (R,R) was established by X-ray 
crystallographic analysis.12 
Having established the optimized set of conditions for the conjugate addition 
reaction, the utility of diamine catalyst 35 was examined for Michael addition reactions of 
a variety of cyclic (6-membered) ketones to selected in situ generated -nitrostyrenes. 
These reactions proceeded efficiently with moderate enantioselectivity and 
diastereoselectivity as shown in the Table 2.3. 
Table 2.3: Results of organocatalytic Michael addition of a variety of cyclic ketones 
to in situ generated -nitrostyrenes 
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Entry
a 
Starting material 
Ketone 
Starting material 
Nitroacetate 
Product Yieldb 
(%) 
drc eed(%
) 
1 
 
 
 
 
 
24 
 
51 1.7:1 92 
2 
 
 
 
 
 
32 
 
51 1.4:1 80 
3 
 
 
 
 
 
31 
 
52 1.3:1 86 
4 
 
 
 
 
24 
 
44 1.6:1 92 
5 
 
 
 
 
32 
 
58 2.3:1 74 
6 
 
 
 
 
 
31 
 
 
30 
single 
diastere
omer 
97 
 36 
 
aAll reactions were done in DMF for 72 h at 0 oC, with 5eq. of ketone. 
bIsolated yields. cDetermined by 1H NMR of crude product. 
dChiral HPLC analysis. 
 
 
As seen from Table 2.3, a range of six-membered cyclic ketones, having various 
functionalities, could react with in situ generated -nitrostyrenes to afford the 
corresponding -nitroketone products. As mentioned before, these were obtained as a 
7 
 
 
 
 
24 
 
53 1.7:1 80 
8 
  
 
32 
 
46 1.3:1 90 
9 
 
 
 
 
31 37 1.2:1 20 
10 
 
 
 
 
24 
 
50 1.7:1 rac 
11 
 
 
 
 
32 
 
24 1:1 60 
12 
 
 
 
 
31 37 1.1:1 79 
 37 
 
mixture of diastereomers (dr = 1-1.7:1) and, with the exception of ketones 61 and 62, only 
the diastereomer which is obtained with good enantiomeric excess is shown. The 
stereochemical assignment for the nitroketones 54-64 is based on the similarity of their 1H 
NMR spectra to that for nitroketone 36, the stereochemistry of which was assigned by X-
ray crystallography. Overall, the organocatalytic Michael addition of cyclic, six-membered 
ketones with in situ generated -nitrostyrenes gave the required products with low 
diastereoselectivity but, in most instances, the enantiomeric excess of one of these 
diastereomers was good (80% to 92%). The reasons for the low enantiomeric excess of the 
ketones 61 and 62 are not known at this time. The low enantiomeric excess of 61 is 
particularly difficult to explain because ketones 59 and 60, both obtained with 
tetrahydropyran-4-one as the Michael donor, are obtained with good enantiomeric excess 
(80% and 90% ee respectively).  
As mentioned previously, a potential problem with using -nitrostyrenes is their 
facile rearrangement to the corresponding -nitrostyrenes in the presence of a base. This 
rearrangement was not observed in the vast majority of the reactions that we have 
examined. The only exception is the reaction of cyclohexanone with 4-bromophenyl 
nitroacetate 31 which gave the Michael adduct 57 (97% ee) arising from the reaction of 50 
with the -nitrostyrene obtained from the rearrangement of the -nitrostyrene obtained 
from 31 during the course of the reaction. The desired Michael adduct 65 was not obtained 
in this reaction (Scheme 2.10).  
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Scheme 2.10 
Having established the feasibility of the Michael addition of cyclic ketones to in 
situ generated -nitrostyrenes, we proceeded to examine this reaction with aldehydes as 
the Michael donors. 
Initially, we examined the reaction of cyclohexane carboxaldehyde 72 and phenyl 
nitroacetate 32 (Scheme 2.11) with various proline-derived catalysts as shown in Figure 
2.5. 
 
Scheme 2.11 
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Fig: 2.5 Catalysts employed for the screening of the Michael addition of -disubstituted  
 
               aldehydes to -nitrostyrenes 
 
 
 
Table 2.4: Catalyst screening for the organocatalytic Michael addition of aldehydes     
 
                   to in situ generated α-nitrostyrenes 
 
 
                         
 
 
     
                                   aIsolated yields. bChiral HPLC analysis. 
Entry catalyst Time  Yielda
(%) 
eeb  
(%) 
1 35 3 d - - 
2 66 2 d 45 60 
3 67 3 d 32 50 
4 40 16 h 43 70 
5 68 8 d - - 
6 69 21 h 33 racemic 
7 70 8 d 25 84 
8 71 8 d - - 
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It was immediately apparent that the optimized reaction conditions for the Michael 
addition of cyclic ketones to -nitrostyrenes do not work well for cyclohexane 
carboxaldehyde. When the diamine catalyst 35, which was the catalyst of choice in the 
ketone studies was employed, no product was observed with cyclohexane carboxaldehyde 
as the Michael donor. Only the -nitrostyrene obtained from the rearrangement of the -
nitrostyrene was observed in cyclohexane carboxaldehyde, suggesting that either enamine 
formation from the aldehyde or reaction of the enamine with the -nitrostyrene is an issue 
in these reactions. Studies with other catalysts were comparatively more fruitful. The use 
of cis 4-hydroxy-proline 66 and trans 4-hydroxy-proline 67 as catalysts gave us moderate 
yield and low enantioselectivity.  However, in the case of proline amide 68 and (S)-4-
thiazolidinecarboxylic acid 68, no reaction was observed. The use of (S)-tyrosine as the 
catalyst gave the required product in low yield (25%), but good enantiomeric excess (84% 
ee). The use of (S)-proline as the catalyst gave us promising results with 43% yield and 
70% ee as shown in Table 2.4.  
 A solvent optimization study was then conducted with (S)-proline as the catalyst 
and the results are summarized in Table 2.5. It was apparent that the reaction works well 
only with DMF and DMSO as solvents, giving the expected Michael adduct 73 with 
moderate yield and enantioselectivity. 
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Table 2.5: Solvent screening for the organocatalytic Michael addition of aldehydes 
to in situ generated α-nitrostyrenes 
 
 
 
 
 
 
 
 
                      
 
        
aIsolated yields. bChiral HPLC analysis. 
  
 In order to examine the scope of the reaction, the optimized conditions were then 
examined for the Michael addition of a variety of -substituted aldehydes to in situ 
generated -nitrostyrenes. The results are shown in Table 2.6. 
 
Entry Solvent  Time  Yielda 
 (%)  
((%)( 
 eeb 
      (%) ((   
1 EtOAc 6 d - - 
2 CH2Cl2 6 d - - 
3 Chloroform 6 d - - 
4 CH3CN 6 d - - 
5 Toluene 6 d - - 
6 DCE 6 d - - 
7 MeOH 94 h - - 
8 DMF 16 h 43 70 
9 DMSO 16 h 33 67 
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Table 2.6: Results of Organocatalytic Michael addition of a variety of -disubstituted 
aldehydes to in situ generated -nitrostyrenes 
 
Entry Nucleophiles Product Catalyst Yielda 
(%) 
eeb  
(%) 
Yieldc 
of -
nitrostyrenes 
(%) 
1 
   
38 
 
41 
 
 
35 
 
 
36 
2 
 
38 40 70 38 
3 
 
38 45 69 40 
4 
  
38 43 76 42 
5 
 
Not obtained - - - 55 
6 
 
Not obtained - - - 42 
aIsolated yields. bChiral HPLC analysis. cIsolated yields of rearranged -nitrostyrenes. 
 43 
 
The results in Table 2.6 indicate that this methodology has certain limitations. 
Firstly, rearrangement of the -nitrostyrene to -nitrostyrene during the course of the 
reaction cannot be prevented in reactions with cyclopentanecarboxaldehyde and 
cyclohexane carboxaldehyde. Secondly, a change in the cyclohexane carboxaldehyde 
structure at a site that is quite far from the aldehyde has a detrimental effect on the reaction 
as seen by the lack of reactivity of aldehyde 75 (Table 2.6, entry 5). In addition, an acyclic 
-disubstituted aldehyde also failed to react. It should be mentioned that, in order to avoid 
the formation of diastereomeric products, only -disubstituted aldehydes were examined 
in this study.  
2.5 Conclusions 
In summary, the organocatalytic Michael addition of aldehydes and cyclic ketones 
to -nitrostyrenes was achieved. The reaction works well for cyclic ketones but the 
diastereoselectivity is low. The scope of the reaction with aldehydes is limited and the 
enantioselectivities are low to moderate. Since there is no literature precedent for the 
reaction of -nitrostyrenes with aldehydes, determining the stereochemistry of the major 
enantiomer of the Michael addition products 73 and 77 to 79 is challenging. However, we 
have observed that the enantiomeric excess of 78 can be enhanced by repeated 
recrystallization,13 and are therefore optimistic that a crystal structure of the Michael adduct 
78 can be obtained to provide the required stereochemical information. 
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2.6 Experimental Section:  
General procedure for the synthesis of nitroacetates  
 
To a solution of the nitroalcohol in CH3CN at 0 oC was added acetic anhydride 
followed by Sc(OTf)3. The mixture was stirred for 30 min at 0 oC and then at ambient 
temperature for 2 h. The reaction mixture was cooled to 0 oC, water was added and the 
resulting mixture was diluted with ethyl acetate and washed with water. The organic layer 
was separated, dried (Na2SO4) and concentrated. The residue was purified by flash 
chromatography on silica gel. 
 
2-(3,4-Dimethoxyphenyl)-2-nitroethyl acetate (24): 
 
  
A mixture of 2-(3,4-dimethoxyphenyl)oxirane (4.00 g, 22.2 mmol), NaNO2 (11.9 
g, 173 mmol) and LaCl3·7H2O (10.9 g, 44.4 mmol) in THF: H2O (1:1, 160 mL) was 
vigorously stirred at ambient temperature for 12 h. The mixture was then extracted with 
ether (4 × 25 mL) and the combined extracts were dried (Na2SO4) and concentrated under 
reduced pressure. The residue was purified by flash column chromatography on silica gel 
(hexanes/EtOAc, 1:1) to provide 1.50 g (30%) of 2-(3,4-dimethoxyphenyl)-2-nitroethanol 
as a yellow foam. 
  Reaction of the above nitroalcohol (1.84 g, 8.1 mmol), acetic anhydride (1.14 mL, 
12.1 mmol) and Sc(OTf)3 (40 mg, 0.08 mmol) in CH3CN (40 mL) at 0 oC according to 
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the general procedure gave, after purification of the crude product by flash 
chromatography on silica gel (hexanes/EtOAc, 7:3), 1.70 g (81%) of 24 as a yellow solid. 
 
IR (neat): 1742, 1550, 1516, 1448, 1427, 1394, 1366, 1224, 1146, 1022 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 7.03 (dd, 1H, J = 8.3, 2.0, ArH),  6.95 (d, 1H, J = 2.0, ArH), 6.88 (d, 
1H, J = 8.3, ArH), 5.67 (dd, 1H, J = 10.7, 3.4, CHNO2), 4.95 (dd, 1H, J = 12.3, 10.7, 
CH2OCOCH3), 4.48 (dd, 1H, J = 12.3, 3.4, CH2OCOCH3), 3.90 (s, 3H, OCH3 ), 3.89 (s, 
3H, OCH3),  2.09 (s, 3H, OCOCH3); 13C NMR (75 MHz, CDCl3): C=O), 150.8 
(ArCipso), 149.5 (ArCipso), 122.9 (ArCipso), 120.7 (ArC), 111.3(ArC), 110.2 (ArC),88.6 
(CHNO2), 63.9 (CH2OCOCH3), 56.06 (OCH3),CH3), 20.6 (COCH3). MS (ESI, 
pos.): m/z 292.0 (M+Na)+; HRMS (ESI, pos.): m/z 270.1015 (270.0978 calc. for 
(C12H16NO6 (M+H)+), 292.0794 (292.0797 calc. for (C12H15NNaO6 (M+Na)+). 
2-(4-Bromophenyl)-2-nitroethyl acetate (31): 
 
  
To a solution of (4-bromophenyl)-nitromethane (1.0 g, 4.6 mmol) in THF (5 mL) 
was added aqueous formaldehyde (37% w/v, 0.14 mL, 4.6 mmol) followed by sodium 
carbonate monohydrate (631 mg, 5.1 mmol) and the mixture was stirred at ambient 
temperature for 12 h. The THF was removed under reduced pressure and the residue 
obtained was dissolved in ethyl acetate (30 mL). The solution was washed with water (5 
mL) and the organic layer was dried (Na2SO4) and concentrated under reduced pressure. 
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The residue obtained was purified by flash chromatography on silica gel (hexane/EtOAc, 
8:2) to provide 0.7 g (70%) of 2-(4-bromophenyl)-2-nitroethanol as a white solid. 
Reaction of the above nitroalcohol (600 mg, 2.4 mmol), acetic anhydride (0.34 mL, 3.7 
mmol) and Sc(OTf)3 (12 mg, 0.02 mmol) in CH3CN (10 mL) at 0 oC according to the 
general procedure gave, after purification of the crude product by flash chromatography on 
silica gel (hexanes/EtOAc, 8:2), 645 mg (92%) of 31 as a white solid. 
 
IR (neat): 1737, 1554, 1365, 1246, 1125, 1050, 1009, 927 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.57 (d, 2H, J = 8.4, ArH), 7.34 (d, 2H, J = 8.4, ArH), 5.69 (dd, 1H, J = 10.4, 
3.6, CHNO2), 4.90 (dd, 1H, J = 12.3, 10.4, CH2OCOCH3), 4.50 (dd, 1H, J = 12.3, 3.6, 
CH2OCOCH3), 2.09 (s, 3H, COCH3); 13C NMR (75 MHz, CDCl3): C=O), 132.6 
(2 × ArC), 129.5 (ArCipso), 129.3 (2 × ArC), 125.1 (ArCipso), 88.1 (CHNO2), 63.5 
(CH2OCOCH3), 20.6 (COCH3).HRMS (ESI, pos.): m/z 286.9798 (286.9793 calc. for 
(C10H1079BrNO4)+), m/z 309.9694 (309.9691 calc. for [C10H1079BrNNaO4(M+Na)+), m/z 
311.9666 (311.9670 calc. for (C10H1081BrNNaO4(M+Na)+).  
2-Nitro-2-phenylethyl acetate (32): 
 
  
To a solution of phenyl nitromethane (0.90 g, 6.6 mmol) in THF (5 mL) was added 
aqueous formaldehyde (37% w/v, 0.2 mL, 6.6 mmol) followed by sodium carbonate 
monohydrate (895 mg, 7.2 mmol) and the mixture was stirred at ambient temperature for 
12 h. The THF was removed under reduced pressure and the residue was dissolved in ethyl 
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acetate and washed with water (5 mL). The organic layer was dried (Na2SO4) and 
concentrated under reduced pressure. The residue obtained was purified by flash 
chromatography on silica gel (hexanes/EtOAc, 8:2) to provide 450 mg (45%) of 2-nitro-2-
phenyl ethanol as a white solid. 
Reaction of the above nitroalcohol (0.5 g, 3 mmol), acetic anhydride (0.42 mL, 4.5 mmol) 
and Sc(OTf)3 (15 mg, 0.03 mmol) in CH3CN (8 mL) at 0 oC according to the general 
procedure gave, after purification of the crude product by flash chromatography on silica 
gel (hexanes/EtOAc, 8:2), 565 mg (90%) of 32 as a dark orange liquid. 
 
IR (neat): 1744, 1553, 1366, 1304, 1218, 1043 cm ̶ 1; 1H NMR (500 MHz, CDCl3): δ 7.37-
7.48 (m, 5H, ArH), 5.73 (dd, 1H, J = 10.6, 3.4, CHNO2), 4.95 (dd, 1H, J = 12.3, 10.6, 
CH2OCOCH3), 4.50 (dd, 1H, J = 12.3, 3.4, CH2OCOCH3), 2.08 (s, 3H, COCH3); 13C NMR 
(75 MHz, CDCl3): C=O), rCipso), 130.60 (ArC), 129.3 (2 × ArC), 127.6 
(2 × ArC), 88.8 (CHNO2), 63.8 (CH2OCOCH3), 20.6 (COCH3); MS (ESI, pos.): m/z 232.0, 
(M+Na)+; HRMS: m/z 209.0692 (209.0688 calc. for C10H11NO4)+, 232.0579 (232.0586 
calc. for (C10H11NNaO4 (M+Na)+). 
General experimental procedure for the Michael addition of ketones to 
nitroalkenes: 
 
To a solution of the ketone, catalyst 35, and (1S)-camphorsulfonic acid in DMF was 
added the nitroacetate and the resulting solution was stirred at 0 oC for 72 h except when 
noted otherwise. Ethyl acetate (5 mL) was added and the solution was washed with water, 
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dried (Na2SO4) and concentrated. The residue was purified by flash column 
chromatography on silica gel. 
(R)-7-((R)-2-(3,4-Dimethoxyphenyl)-2-nitroethyl)-1,4-dioxaspiro[4.5]decan-8-one 
(36): 
 
To a solution of 1,4-cyclohexanedione monoethylene ketal (33, 11.6 g, 74.3 mmol), 
(S)-2-methyl-N-(pyrrolidin-2-ylmethyl)propan-1-amine catalyst 35  (505 mg, 3.0 mmol), 
and (1S)-camphorsulfonic acid (690 mg, 3.0 mmol) in DMF (46 mL) was added 3,4-
dimethoxyphenyl nitroacetate 24 (4 g, 14.8 mmol) and the resulting solution was stirred at 
0 oC for 72 h. Ethyl acetate (100 mL) was added and the solution was washed with water, 
dried (Na2SO4) and concentrated. The residue was purified by flash column 
chromatography on silica gel to provide 2.45 g (45%) 36 with 92% ee as a white solid.  
Rf = 0.25 (hexanes/EtOAc, 7:3); IR (neat): 2959, 2873, 1708, 1546, 1510, 1264, 1231, 
1150, 1137, 1027 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.03 (dd, 1H, J = 8.30, 2.1, ArH), 
6.96 (d, 1H, J = 2.1, ArH), 6.86 (d, 1H, J = 8.3, ArH), 5.63 (dd, 1H, J = 10.3, 4.4, CHNO2), 
4.03-4.01 (m, 4H, OCH2CH2O), 3.90 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 2.75-2.63 (m, 
2H, COCH, CH2CHNO2), 2.35-2.49 (m, 2H, CH2CH2CO, CH2CHNO2), 2.30 (dd, 1H, J = 
10.3, 4.1, CH2CH2CO), 2.13-1.99 (m, 2H, COCH2, COCHCH2), 1.97 (dd, 1H, J = 13.6, 
4.9, COCH2)  1.78 (t, 1H, J = 13.3, COCHCH2); 13C NMR (75 MHz, CDCl3): δ 210.4 
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(CO), 150.2 (ArCipso), 149.2 (ArCipso), 127.2 (ArCipso), 120.3 (ArC), 111.1 (ArCipso), 110.2 
(ArC), 106.8 (OCO), 89.6 (CHNO2), 64.9 (OCH2CH2O), 64.7 (OCH2CH2O), 56.0 (OCH3), 
55.9 (OCH3), 43.3 (COCH), 41.4 (CH2CHC(O)O), 38.3 (CH2CHNO2), 34.8 (CH2CO), 
34.0 (CH2CH2C(O)O); MS (ESI, neg.): 364.1 (M-H)¯; HRMS (ESI, neg.): m/z 365.1469 
(365.1475 calc. for C18H23NO7(M¯)); HPLC: Chiralpak AS-H (hexane/i-PrOH, 60/40, 
flow rate 1 mL min−1, λ= 247 nm): tmajor = 10.20 min., tminor = 12.98 min., 92% ee. 
Crystals suitable for X-ray analysis were obtained by dissolving 36 (10 mg) in 
isopropyl alcohol (0.4 mL) followed by addition of hexanes (0.6 mL) to this solution. The 
resulting clear solution was left at ambient temperature for gradual evaporation. The 
precipitated crystals were collected after 48 h, dried in vacuo and analyzed. 
(R)-7-((R)-2-Nitro-2-phenylethyl)-1,4-dioxaspiro[4.5]decan-8-one (54): 
 
To a solution of cyclohexanedione monoethylene ketal (0.37 g, 2.4mmol), (S)-2-
methyl-N-(pyrrolidin-2-ylmethyl)propan-1-amine catalyst 35 (16 mg, 0.1 mmol), and (1S)-
camphor sulfonic acid (22 mg, 0.1mmol) in DMF (2 mL) was added phenyl nitroacetate 
32 (100 mg, 0.47mmol) and the resulting solution was stirred at 0 oC for 36 h. Ethyl acetate 
(10 mL), was added and the solution was washed with water, dried over Na2SO4 and 
concentrated. The residue was purified by flash column chromatography on silica gel 
(hexanes/EtOAc, 80:20) to provide 73 mg (50%) of 54 with 80% ee as a white solid. 
IR (neat):1712, 1548, 1362, 1305, 1124, 1089, 1055 cm-1; 1H NMR (300 MHz, CDCl3): δ 
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7.50-7.42 (m, 2H, ArH), 7.43-7.36 (m, 3H, ArH), 5.70 (dd, 1H, J = 10.3, 4.3, CHNO2), 
4.06-3.96 (m, 4H, OCH2CH2O), 2.77-2.61 (m, 2H, NO2CHCH2), 2.55-2.45 (m, 1H, 
COCH), 2.45-2.25 (m, 2H, COCH2), 2.15-1.90 (3H, CH2CH2, CHCH2 (ring)), 1.77 (t, 1H, 
J = 13.0, CHCH2 (ring)); 13C NMR (75 MHz, CDCl3): δ 210.3 (CO), 134.9 (ArCipso), 129.8 
(ArCipso), 129.0 (2 x ArC), 127.4 (2 x ArC), 106.8 (OCO), 89.8 (CHNO2), 64.9 
(OCH2CH2O), 64.7 (OCH2CH2O), 43.3 (CH2C-O), 41.4 (CH2C-O), 38.3 (CH2CHNO2), 
34.8 (CH2C=O), 34.2 (CHC=O); MS (ESI, pos.): m/z 328.1 (M+Na)+; HRMS (ESI, pos.): 
m/z 328.1158 (328.1161 calc. for (C16H19NNaO5 (M+Na)+). HPLC: Chiralpak AS-H 
(hexane/i-PrOH, 90/10, flow rate 1 mL min−1, λ= 247 nm): tmajor = 10.88 min., tminor = 13.97 
min., 80% ee. 
(R)-7-((R)-(4-Bromophenyl)-2-nitroethyl)-1,4-dioxaspiro[4.5]decan-8-one (55): 
 
To a solution of cyclohexanedione monoethtylene ketal (0.40 g, 2.6 mmol), (S)-2-
methyl-N-(pyrrolidin-2-ylmethyl)propan-1-amine catalyst 35 (18 mg, 0.1 mmol), and (1S)-
camphorsulfonic acid (24 mg, 0.1 mmol) in DMF (2 mL) was added 4-bromophenyl 
nitroacetate 31 (150 mg, 0.5 mmol) and the resulting solution was stirred at 0 oC for 16 h. 
Ethyl acetate (10 mL) was added and the solution was washed with water, dried (Na2SO4) 
and concentrated. The residue was purified by flash column chromatography on silica gel 
(hexanes/EtOAc, 75:25) to provide 0.1 g (50%) of 55 with 86% ee as a white gum. 
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IR (neat): 1713, 1550, 1489, 1361, 1124, 1056 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.53 
(d, 2H, J = 8.5, ArH), 7.34 (d, 2H, J = 8.5, ArH), 5.66 (dd, 1H, J = 10.2, 4.2, CHNO2), 
4.08-3.96 (m, 4H, OCH2CH2O), 2.75-2.62 (m, 2H, NO2CHCH2), 2.45-2.25 (m, 3H, 
COCH2,COCH), 2.15-1.95 (m, 3H, CH2CH2, CHCH2 (ring)), 1.77 (t, 1H, J = 13.0, CHCH2 
(ring)); 13C NMR (75 MHz, CDCl3): δ 210.3 (CO), 133.8 (ArCipso), 132.3 (2 x ArC), 129.1 
(2 x ArC), 124.1 (ArCipso), 106.8 (OCO), 89.1 (CHNO2), 64.9 (OCH2CH2O), 64.7 
(OCH2CH2O), 43.2 (CH2C-O), 41.6 (CH2C-O), 38.3 (CH2CHNO2), 34.8 (CH2C=O), 34.2 
(CHC=O); HRMS (ESI, pos.): m/z 383.0363 (383.0638 calc. for C16H18BrNO5 (M+)), 
384.0433 (384.0477 calc. for C16H19BrNO5 (M+H)+), 406.0255 (406.0266 calc. for 
(C16H1879BrNNaO5 (M+Na)+), 408.0237 (408.0245 calc. for (C16H1881BrNNaO5 (M+Na)+). 
HPLC: Chiralpak AS-H (hexane/i-PrOH, 90/10, flow rate 1 mL min−1, λ= 247 nm): tmajor 
= 13.16 min., tminor = 22.39 min., 86% ee. 
(S)-2-((R)-2-(3,4-Dimethoxyphenyl)-2-nitroethyl)cyclohexanone (56): 
 
Reaction of  cyclohexanone (96 µL, 0.92 mmol) and (1S)-Camphorsulfonic acid 
(9.0 mg, 0.037 mmol) in the presence of (S)-2-methyl-N-(pyrrolidin-2-ylmethyl)propan-1-
amine catalyst 35 (6.0 mg, 0.037 mmol) was added nitroacetate (50 mg, 0.18 mmol) 
according to the general procedure  gave, after the purification of the crude product by flash 
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column chromatography on silica gel (85/15 hexanes/ethyl acetate), 25 mg (44%) of 56 as 
a white foam. 
IR (neat): 2935, 2853, 1703, 1547, 1514, 1364, 809, 564 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 7.03 (dd, 1H, J = 8.3, 2.0, ArH), 6.97 (d, 1H, J = 2.0,  ArH), 6.85 (d, 1H, J = 8.3, ArH), 
5.63 (dd, 1H, J = 10.2, 4.4, ArH), 3.91 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 2.50-2.42 (m, 
2H, CH2CHNO2), 2.37-2.25 (m, 3H, CH2(CO), CH(CO)), 2.20-2.08 (m, 2H, CH2), 1.91-
1.88 (m, 1H, CH2), 1.75-1.57(m, 2H, CH2), 1.51-1.43 (m, 1H, CH2); 13C NMR (75 MHz, 
CDCl3): 211.8 (CO), 150.2 (ArCipso), 149.2 (ArCipso), 127.3 (ArCipso), 120.4 (ArC), 111.0 
(ArC), 110.2 (ArC), 89.8 (CHNO2), 56.0 (OCH3), 55.9 (OCH3), 47.3 (CHNO2), 42.3 
(CH2CO), 34.9 (CH2), 34.4 (CH2CHNO2), 28.1 (CH2), 25.2 (CH2); HRMS (APPI, pos.): 
m/z 308.1469 (308.1500 calc. for (C16H22NO5 (M+H)+); HPLC: Chiralpak AD-H 
(hexane/i-PrOH, 70/30, flow rate 1 mL min−1, λ= 254 nm): t major = 17.19 min., t minor = 
15.07 min., 92% ee. 
(S)-2-((R)-2-Nitro-2-phenylethyl)cyclohexanone (57): 
 
Reaction of cyclohexanone (0.12 mL, 1.2 mmol) and (1S)-Camphorsulfonic acid 
(11 mg, 0.047 mmol) in the presence of (S)-2-methyl-N-(pyrrolidin-2-ylmethyl)propan-1-
amine catalyst 35 (8.0 mg, 0.047 mmol) was added nitroacetate (50 mg, 0.23 mmol) 
according to the general procedure  gave, after the purification of the crude product by flash 
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column chromatography on silica gel (98/2 hexanes/ethyl acetate), 34 mg (58%) of 57 as a 
yellow gum. 
IR (neat): 2937, 2859, 1704, 1545, 1448, 1364, 1296, 1070, 710, 689 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.49-7.39 (m, 5H, ArH), 5.72 (dd, 1H, J = 10.2, 4.3, CHNO2), 2.49-2.28 
(m, 5H, CH2CO, CH2CHNO2, CH(CO), CH2), 2.19-2.07 (m, 2H, CH2CH, CH2CH), 1.91-
1.87 (m, 1H, CH2CH), 1.72-1.56 (m, 2H, CH2), 1.50-1.37 (m, 1H, CH2);13C NMR (75 
MHz, CDCl3): 211.8 (CO), 134.9 (ArCipso), 129.8 (ArC), 129.0 (2 x ArC), 127.5 (2 x ArC), 
90.0 (CHNO2), 47.4 (CHCH2), 42.3 (CH2CO), 35.0 (CH2CHNO2), 34.5 (CH2), 28.1 (CH2), 
25.3 (CH2); HRMS (APPI, pos.): m/z 248.1278 (248.1300 calc. for (C14H18NO3 (M+H)+); 
HPLC: Chiralpak AD-H (hexane/i-PrOH, 90/10, flow rate 1 mL min−1, λ= 254 nm): t major 
= 9.11 min., t minor = 7.85 min., 74% ee. 
(R)-Tetrahydro-3-((R)-2-(3,4-dimethoxyphenyl)-2-nitroethyl)pyran-4-one (59): 
O
O
NO2
OMe
OMe
H H
 
Reaction of tetrahydropyran-4-one (85 µL, 0.92 mmol) and (1S)-Camphorsulfonic acid 
(9.0 mg, 0.037 mmol) in the presence of (S)-2-methyl-N-(pyrrolidin-2-ylmethyl)propan-1-
amine catalyst 35 (7.0 mg, 0.037 mmol) and 3,4-dimethoxyphenyl nitroacetate 24 (50 mg, 
0.18 mmol) according to the general procedure  gave, after the purification of the crude 
product by flash column chromatography on silica gel (75/25 hexanes/ethyl acetate), 30 
mg (53%) of 59 as a yellow solid. 
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M. P. = 125-132 ֩ C. 
IR (neat): 2969, 2936, 2845, 1707, 1601, 1552, 1514, 1461, 1441, 1367, 1267, 1146, 1019, 
763 cm-1;  1H NMR (300 MHz, CDCl3): δ 7.03 (dd, 1H, J = 8.3, 2.0, ArH), 6.95 (d, 1H, J 
= 2.0, ArH), 6.86 (d, 1H, J = 8.3, ArH), 5.63 (dd, 1H, J = 10.1, 4.7, CHNO2), 4.31-4.22 
(m, 2H, OCH2), 3.91 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 3.72-3.63 (ddd, 1H, OCH2), 3.37 
(t, 1H, J = 10.8, OCH2), 2.73-2.52 (m, 2H, COCHCH2, COCH2CH2), 2.48-2.38 (m, 2H, 
COCHCH2), 2.27-2.18 (m, 1H, COCH2CH2); 13C NMR (75 MHz, CDCl3): 207.0 (CO), 
150.3 (ArCipso), 149.3 (ArCipso), 126.7 (ArCipso), 120.4 (ArC), 111.1 (ArC), 110.0 (ArC), 
89.2 (CHNO2), 72.6 (OCH2CH), 68.8 (OCH2CH2), 56.0 (OCH3), 55.9 (OCH3), 48.1 
(OCH2CH), 42.7 (COCH2), 29.7 (COCHCH2); HRMS (APPI, pos.): m/z 310.1281 
(310.1300 calc. for C15H20NO6 [M+H]+); HPLC: Chiralpak AD-H (hexane/i-PrOH, 90/10, 
flow rate 1 mL min−1, λ= 254 nm): t major = 42.31 min., t minor = 36.85 min., 80% ee. 
(R)-Tetrahydro-3-((R)-2-nitro-2-phenylethyl)pyran-4-one (60): 
 
Reaction of tetrahydropyran-4-one (0.11 mL, 1.19 mmol) and (1S)-Camphorsulfonic acid 
(11 mg, 0.047 mmol) in the presence of (S)-2-methyl-N-(pyrrolidin-2-ylmethyl)propan-1-
amine catalyst 35 (8.0 mg, 0.047 mmol) and phenylnitroacetate 32 (50 mg, 0.23 mmol) 
according to the general procedure gave, after the purification of the crude product by flash 
column chromatography on silica gel (95/5 hexanes/ethyl acetate), 27 mg (46%) of 60 as a 
white solid. 
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 M. P. = 68.1-75.1 ֩ C. 
IR (neat):  2970, 2922, 2857, 1703, 1544, 1364, 1291, 1208, 1150, 1100, 1079, 1015, 964, 
714, 694, 654 cm-1;1H NMR (300 MHz, CDCl3):  δ 7.48-7.40 (m, 5H, ArH), 5.70 (dd, 1H, 
J = 10.2, 4.3, CHNO2), 4.32-4.23 (m, 2H, OCH2), 3.71-3.64 (ddd, 1H, OCH2), 3.36 (t, 1H, 
J = 10.9, OCH2), 2.71-2.59 (m, 2H, CH2(CO) ), 2.44-2.36 (m, 2H, CH2CHNO2), 2.31-2.23 
(m, 1H, CH(CO)); 13C NMR (75 MHz, CDCl3): 207.0 (CO), 134.5 (ArCipso), 130.0 (ArC), 
129.2 (2 x ArC), 127.4 (2 x ArC), 89.4 (CHNO2), 72.6 (OCH2CH), 68.8 (OCH2CH2), 48.2 
(COCHCH2), 42.8 (COCH2), 29.9 (CH2CHNO2); HRMS (APPI, pos.): m/z 272.1032 
(272.0900 calc. for C13H15NNaO4 [M+Na]+); HPLC: Chiralpak AD-H (hexane/i-PrOH, 
90/10, flow rate 1 mL min−1, λ= 254 nm): t major = 28.01 min., t minor = 12.75 min., 90% ee. 
(R)-3-((R)-2-(4-Bromophenyl)-2-nitroethyl)-tetrahydropyran-4-one (61): 
 
Reaction of  tetrahydropyran-4-one (80 µL, 0.86 mmol) and (1S)-Camphorsulfonic acid 
(8.0 mg, 0.034 mmol) in the presence of (S)-2-methyl-N-(pyrrolidin-2-ylmethyl)propan-1-
amine catalyst 35 (6.0 mg, 0.034 mmol) and 4-bromophenyl nitroacetate 31 (50 mg, 0.17 
mmol) according to the general procedure  gave, after the purification of the crude product 
by flash column chromatography on silica gel (80/20 hexanes/ethyl acetate), 21 mg (37%) 
of 61 as a white solid. 
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M. P. = 88.6-92 ֩ C. 
IR (neat): 2966, 2922, 2854, 1712, 1549, 1489, 1410, 1365, 1225, 1150, 1101, 1011, 970, 
824, 749 cm-1;1H NMR (300 MHz, CDCl3): δ 7.55 (d, 2H, J = 8.5, ArH), 7.34 (d, 2H, J = 
8.5, ArH), 5.68 (dd, 1H, CHNO2), 4.30-4.21 (m, 2H, OCH2), 3.66 (ddd, 1H, OCH2), 3.35 
(t, 1H, J = 10.9, OCH2), 2.80-2.50 (m, 2H, COCHCH2, COCH2CH2), 2.44-2.22(m, 2H, 
COCHCH2), 2.26-2.17 (m, 1H, COCH2CH2); 13C NMR (75 MHz, CDCl3): 207 (CO), 
133.4 (ArCipso), 132.4 (2 x ArC), 129.1 (2 x ArC), 124.4 (ArC), 88.7 (CHNO2), 72.6 
(OCH2CH), 68.8 (OCH2CH2), 48.1 (CHCH2), 42.8 (COCH2), 29.8 (CH2CHNO2); HRMS 
(APPI, neg.): m/z 326.0022 (326.0000 calc. for C13H13 79BrNO4 [M-H]-), 328.0004 
(328.0000 calc. for C13H1381BrNO4 [M-H]-);HPLC: Chiralpak AD-H (hexane/i-PrOH, 
70/30, flow rate 1 mL min−1, λ= 254 nm): t major = 34.26 min., t minor = 12.82 min., 20% ee. 
(S)-Tetrahydro-3-((R)-2-(3,4-dimethoxyphenyl)-2-nitroethyl)thiopyran-4-one (62): 
 
Reaction of tetrahydrothiopyran-4-one (0.1 g, 0.92 mmol) and (1S)-Camphorsulfonic acid 
(9.0 mg, 0.036 mmol) in the presence of (S)-2-methyl-N-(pyrrolidin-2-ylmethyl)propan-1-
amine catalyst 35 (7.0 mg, 0.036 mmol) and 3,4-dimethoxy phenyl nitroacetate 24 (50 mg, 
0.18 mmol) according to the general procedure gave, after the purification of the crude 
product by flash column chromatography on silica gel (80/20 hexanes/ethyl acetate), 30 
mg (50%) of 62 as a yellow gum. 
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IR (neat): 2958, 2919, 2837, 1704, 1601, 1550, 1514, 1427, 1359, 1240, 1142, 1114, 1020, 
852, 808, 764, 700 cm-1;1H NMR (300 MHz, CDCl3): (major diastereomer):  δ 7.02 (dd, 
1H, J = 8.3, 2.1, ArH), 6.95 (d, 1H, J = 2.1, ArH), 6.86 (d, 1H, J = 8.3, ArH), 5.59 (dd, 1H, 
J = 10.2, 4.6, CHNO2), 3.91 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 3.00-2.93 (m, 3H, SCH2, 
COCH2), 2.77-2.72 (m, 3H, SCH2, COCH2), 2.45-2.35 (m, 1H, CH2CHNO2); 13C NMR 
(75 MHz, CDCl3): (major diastereomer): 208.9 (CO), 150.3 (ArCipso), 149.5 (ArC), 126.8 
(ArC), 120.5 (ArC), 111.0 s(ArC), 110.1 (ArC), 89.3 (CHNO2), 56.1 (OCH3), 55.9 (OCH3), 
49.9 (COCHCH2), 44.6 (COCH2), 36.5 (CH2), 34.2 (CH2), 31.2 (CH2CHNO2); (minor 
diastereomer): 208.7 (CO), 150.4 (ArCipso), 149.5 (ArCipso), 126.1 (ArCipso), 120.5 (ArC), 
111.2 (ArC), 110.3 (ArC), 87.8 (CHNO2), 56.1 (OCH3), 49.6 (COCHCH2), 44.4 (COCH2), 
36.2 (CH2), 33.7 (CH2), 30.1 (CH2); HRMS (APPI, neg.): m/z 329.0911 (329.0900 calc. 
for C15H18NO5S [M-H]¯); HPLC: Chiralpak AD-H (hexane/i-PrOH, 90/10, flow rate 1 mL 
min−1, λ= 254 nm): t major = 38.80 min., t minor = 42.55 min., racemic. 
(S)-Tetrahydro-3-((R)-2-nitro-2-phenylethyl)-thiopyran-4-one (63): 
 
Reaction of tetrahydrothiopyran-4-one (140 mg, 0.047 mmol) and (1S)-Camphorsulfonic 
acid (11 mg, 0.047 mmol) in the presence of (S)-2-methyl-N-(pyrrolidin-2-
ylmethyl)propan-1-amine catalyst 35 (8.0 mg, 0.047 mmol) and phenyl nitroacetate 32 (50 
mg, 0.23 mmol) according to the general procedure  gave, after the purification of the crude 
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product by flash column chromatography on silica gel (95/5 hexanes/ethyl acetate), 15 mg 
(24%) of 63 as a white solid. 
M. P. = 120-121.8 ֩ C. 
IR (neat): 2986, 2902, 1701, 1541, 1417, 1294, 1110, 1089, 1013, 774, 717, 673 cm-1; 
1H NMR (300 MHz, CDCl3):  δ 7.47-7.41 (m, 5H, ArH), 5.62 (dd, 1H, J = 10.1, 4.4, 
CHNO2), 2.98-2.95 (m, 3H, SCH2, COCH2), 2.77-2.72 (m, 4H, SCH2, COCH2, 
COCH2CHCH2), 2.56-2.38 (m, 1H, CH2CHNO2); 13C NMR (75 MHz, CDCl3): 208.8 
(CO), 134.5 (ArCipso), 129.9 (ArC), 129.1 (2 x ArC), 127.4 (2 x ArC), 89.5 (CHNO2), 49.9 
(COCHCH2), 44.6 (COCH2), 36.6 (CH2), 34.4 (CH2), 31.2 (CH2CHNO2); HRMS (APPI, 
neg.): m/z 264.0696 (264.0700 calc. for C13H14NO3S [M-H]-); HPLC: Chiralpak AD-H 
(hexane/i-PrOH, 80/20, flow rate 1 mL min−1, λ= 254 nm): t major = 32.51 min., t minor = 
12.57 min., 90% ee. 
(S)-3-((R)-2-(4-Bromophenyl)-2-nitroethyl)-tetrahydrothiopyran-4-one (64): 
 
Reaction of tetrahydrothiopyran-4-one (100 mg, 8.65 mmol) and (1S)-Camphorsulfonic 
acid (8 mg, 0.34 mmol) in the presence of (S)-2-methyl-N-(pyrrolidin-2-ylmethyl)propan-
1-amine catalyst 35 (6.0 mg, 0.34 mmol) and 4-bromophenyl nitroacetate 31 (50 mg, 1.7 
mmol) according to the general procedure gave, after the purification of the crude product 
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by flash column chromatography on silica gel (95/5 hexanes/ethyl acetate), 16 mg (24%) 
of 64 as a white solid. 
M. P. = 100-105 ֩ C. 
IR (neat): 2961, 2921, 2852, 1707, 1544, 1486, 1414, 1358, 1288, 1226, 1113, 1072, 1010, 
967, 904, 858, 820, 744, 572 cm-1; 1H NMR (300 MHz, CDCl3):  δ 7.54 (d, 1H, J = 8.5, 
ArH), 7.34 (d, 1H, J = 8.5, ArH), 5.58 (dd, 1H, J = 10.1, 4.4, CHNO2), 3.00-2.95 (m, 3H, 
SCH2, COCH2), 2.78-2.72 (m, 4H, SCH2, COCH2, COCH2CHCH2), 2.52-2.34 (m, 1H, 
CH2CHNO2); 13C NMR (75 MHz, CDCl3): 208.8 (CO), 133.5 (ArCipso), 132.4 (2 x ArC), 
129.1 (2 x ArC), 124.3 (ArC), 88.9 (CHNO2), 49.9 (COCHCH2), 44.7 (COCH2), 36.6 
(CH2), 34.4 (CH2), 31.2 (CH2CHNO2); HRMS (ESI, neg.): m/z 341.9824 (341.9800 calc. 
for C13H1379BrNO3S [M-H]-); 343.9797 (343.9800 calc. for C13H1381BrNO3S [M-H]-); 
HPLC: Chiralpak AS-H (hexane/i-PrOH, 90/10, flow rate 1 mL min−1, λ= 254 nm): t major 
= 19.62 min., t minor = 15.42 min., 79% ee. 
General experimental procedure for the Michael addition of aldehydes to 
nitroalkenes: 
 
To a solution of the aldehyde and catalyst 40 in DMF was added the nitroacetate 
and the resulting solution was stirred at ambient temperature for 72 h. After completion of 
the reaction (TLC), ethyl acetate (5 mL) was added and the resulting solution was washed 
with water (5 mL), dried (Na2SO4) and concentrated. The residue was purified by flash 
column chromatography on silica gel. 
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1-(2-Nitro-2-phenylethyl)cyclohexanecarbaldehyde (73): 
 
Reaction of cyclohexane carboxaldehyde 72 (0.14 mL, 1.2 mmol) and phenyl 
nitroacetate 32 (50 mg, 0.24 mmol) in the presence of (S)-proline catalyst 40 (4.0 µL, 0.047 
mmol) according to the general procedure gave, after the purification of the crude product 
by flash column chromatography on silica gel (95/5 hexanes/ethyl acetate), 27 mg (43%) 
of 73 as a white gum. 
IR (neat): 2932, 2856, 1720, 1552, 1453, 1363, 719, 696 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 9.32 (s, 1H, CHO), 7.47-7.36 (m, 5H, ArH), 5.48 (dd, 1H, J =  8.0, 5.0, CH2NO2), 2.89 
(dd, 1H, J = 15.3, 8.0, CH2CHNO2), 2.21 (dd, 1H, J = 15.3, 5.0, CH2CHNO2), 1.96-1.84 
(m, 2H, CH2), 1.57-1.51 (m, 2H, CH2), 1.38-1.26 (m, 6H, CH2); 13C NMR(75 MHz, 
CDCl3): 204.7 (CHO), 135.3 (ArCipso), 130.0 (ArC), 129.2 (2 x ArC), 127.6 (2 x ArC), 
87.3 (CHNO2), 49.0 (CHO-(C)-CH2), 39.8 (CH2CHNO2), 31.4 (CH2), 30.2 (CH2), 
25.3(CH2), 22.1 (CH2), 21.2 (CH2); HRMS (APPI, pos.): m/z 262.1434 (262.1400 calc. for 
C15H20NO3[M+H]+), 284.1444 (284.1300 calc. for C15H19NNaO3 [M+Na]+); HPLC: 
Chiralpak AS-H (hexane/i-PrOH, 98/2, flow rate 1 mL min−1, λ= 254 nm): t major = 28.96 
min., t minor = 27.70 min., 76% ee. 
 
 
 61 
 
1-(2-Nitro-2-phenylethyl)cyclopentanecarbaldehyde (77): 
 
Reaction of cyclopentane carboxaldehyde 79 (0.13 mL, 1.19 mmol), phenyl 
nitroacetate (50 mg, 0.23 mmol) and (S)-proline catalyst 40 (5.5 mg, 0.047 mmol) 
according to the general procedure gave, after the purification of the crude product by flash 
column chromatography on silica gel (98/2 hexanes/ethyl acetate), 31 mg (52%) of 82 as a 
yellow solid. 
M. P. = 86.4-89 ֩ C. 
IR (neat): 2962, 2879, 1689, 1546, 1454, 1365, 1281, 1225, 940, 911, 717, 692, 504 cm-
1;1H NMR (300 MHz, CDCl3): δ 9.29 (s, 1H, CHO), 7.46-7.38 (m, 5H, ArH), 5.49 (dd, 1H, 
J = 7.5, 5.6, CHNO2), 2.86 (dd, 1H, J = 15.0, 7.5, CH2CHNO2), 2.46 (dd, 1H, J = 15.0, 
5.6, CH2CHNO2), 2.05-1.86 (m, 2H, CH2), 1.74-1.48 (m, 5H, CH2), 1.42-1.33 (m, 1H, 
CH2); 13C NMR (75 MHz, CDCl3): 182.3 (CHO), 135.2 (ArCipso), 129.8 (ArC), 128.9 (2 x 
ArC), 127.8 (2 x ArC), 89.4 (CHNO2), 52.6 (CHO-(C)-CH2), 41.9 (CH2CHNO2), 37.4 
(CH2), 35.1 (CH2), 24.7 (CH2),  24.4 (CH2). HRMS (APPI, neg.): m/z 246.1137 (246.113 
calc. for C14H16NO3 [M-H]-); HPLC: Chiralpak AD-H (hexane/i-PrOH, 90/10, flow rate 1 
mL min−1, λ= 254 nm): t major = 7.90 min., t minor = 8.56 min., 35% ee. 
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1-(2-(3,4-Dimethoxyphenyl)-2-nitroethyl)cyclohexanecarbaldehyde (78): 
 
CHO NO2
MeO
OMe
*
 
Reaction of cyclohexane carboxaldehyde 72 (0.11 mL, 0.92 mmol) and 3,4-
dimethoxyphenyl nitroacetate 24 (50 mg, 0.18 mmol) in the presence of (S)-proline catalyst 
40 (3.0 µL, 0.037 mmol) according to the general procedure gave, after the purification of 
the crude product by flash column chromatography on silica gel (1:1 hexane/ethyl acetate), 
25 mg (41%) of 83 as a white solid. 
M. P. = 77.6-83 ֩ C. 
IR (neat): 2934, 2854, 1721, 1594, 1551, 1517, 1453, 1365, 1266, 1145, 1025 cm-1; 
1H NMR (300 MHz, CDCl3): δ 9.31 (s, 1H, CHO), 6.98 (dd, 1H, J = 8.3, 2.1, ArH), 6.92 
(d, 1H, J = 2.1, ArH), 6.83 (d, 1H, J = 8.3, ArH), 5.41 (dd, 1H, J = 7.7, 5.5, CHNO2), 3.90 
(s, 3H, OCH3), 3.88 (s, 3H, OCH3), 2.78 (dd, 1H, J = 15.2, 7.7, CH2CHNO2), 2.24 (dd, 1H, 
J = 15.2, 5.5, CH2CHNO2), 1.96-1.84 (m, 1H, CH2), 1.60-1.50 (m, 3H, CH2), 1.41-1.26 
(m, 5H, CH2). 13C NMR(75 MHz, CDCl3): 204.7 (CHO), 150.4 (ArCipso), 149.4 (ArCipso), 
127.5 (ArCipso), 120.7 (ArC), 111.1 (ArC), 110.3 (ArC), 87.1(CHNO2), 56.1(OCH3), 
55.9(OCH3), 48.9 (CHO-(C)-CH2), 39.8 (CH2CHNO2), 31.5 (CH2), 30.3 (CH2), 25.3 
(CH2), 22.1 (CH2), 20.0 (CH2); HRMS (APPI, pos.): m/z 322.1638 (322.1654 calc. for 
C17H23NO5[M+H]+). HPLC: Chiralpak AS-H (hexane/i-PrOH, 70/30, flow rate 1 mL 
min−1, λ= 254 nm): t major = 16.68 min., t minor = 18.34 min., 83% ee. 
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1-(2-(4-Bromophenyl)-2-nitroethyl) cyclohexanecarbaldehyde (79): 
 
Reaction of cyclohexane carboxaldehyde 72 (0.11 mL, 0.92 mmol) and 4-
bromophenyl nitroacetate 31 (50 mg, 0.18 mmol) in the presence of (S)-proline catalyst 40 
(3.0 µL, 0.037 mmol) according to the general procedure gave, after the purification of the 
crude product by flash column chromatography on silica gel (98/2 hexanes/ethyl acetate), 
23 mg (40%) of 84 as a yellow gum. 
IR (neat): 2930, 2845, 1720, 1553, 1489, 1451, 1363, 1073, 1011, 825, 744 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 9.34 (s, 1H, CHO), 7.52 (d, 2H, J = 8.5, ArH), 7.31 (d, 2H, J = 8.5, 
ArH), 5.44 (dd, 1H, J = 7.9, 4.9, CH2NO2), 2.82 (dd, 1H, J = 15.3, 7.9, CH2NO2), 2.16 (dd, 
1H, J = 15.3, 4.9, CH2NO2), 1.92-1.82 (m, 2H, CH2), 1.59-1.53 (m, 2H, CH2), 1.41-1.20 
(m, 6H, CH2); 13C NMR (75 MHz, CDCl3): 204.7 (CHO), 134.2 (ArCipso), 132.4 (2 x ArC), 
129.2 (2 x ArC), 124.4 (ArCipso), 86.7 (CHNO2), 49.0 (CHO-(C)-CH2), 39.5 (CH2NO2), 
31.4 (CH2), 30.2 (CH2), 25.3 (CH2), 22.0 (CH2), 21.9 (CH2), 21.9 (CH2); HRMS (ESI, 
neg.): m/z 338.0411 (338.0400 calc. for C15H1779BrNO3 [M-H]-), 340.0392 (340.0400 calc. 
for C15H1781BrNO3 [M-H]-); HPLC: Chiralpak AS-H (hexane/i-PrOH, 70/30, flow rate 1 
mL min−1, λ= 254 nm): tmajor = 22.11 min., tminor = 13.24 min., 69% ee. 
 
 
 64 
 
2.7 References: 
1) For reviews, see: a) Dalko, P. L.; Moisan, L. Angew. Chem. Int. Ed. 2004, 43, 5138- 
 
    5175. b) Seayad, J.; List, B. Org. Biomol. Chem. 2005, 719-724. 
 
2) Only three reports of enantioselective organocatalytic Michael additions to -alkyl 
 
     nitroalkenes are available a) Kimmel, K. L.; Weaver, J. D.; Lee, M.; Ellman, J. A. 
 
     J. Am. Chem. Soc. 2012, 134, 9058-9061; b) B. Zheng, H. Wang, Y. Han, C. Liu, Y. 
 
     Peng, Chem. Commun. 2013, 49, 4561-4563; c) Han, Y.; Zheng, B.; Peng, Y. Adv. 
 
     Synth. Catal. 2015, 357, 1136.  For Stoichiometric reactions of preformed - 
 
     nitrostyrene with achiral enamines, see: (d) Bradamante, P.; Pitacco, G.; Risaliti, A.; 
 
     Valentin, E. Tetrahedron Lett. 1982, 23, 2683. (e) Benedetti, F.; Drioli, S.; Nitti, P.; 
 
     Pitacco, G.; Valentin, E. ARKIVOC 2001, (v), 140. For classical examples of 
 
     multistep approaches to ,-substituted carbonyl patterns en route to erythromycins, 
 
     see: a) E. J. Corey, P. B. Hopkins, S. K. Sung-eun, Y. Krishnan, P. Nambiar, J. R. 
 
     Falck, J. Am. Chem. Soc. 1979, 101, 7131-7134; b) R. B. Woodwar, E.  Logusch,  
 
     K. P. Nambiar, K. Sakan, D. E. Ward, B. W. Au-Yueng, P. Balram, L. J. Browne,  
 
      P.  J. Card, C. H. Chen, J. Am. Chem. Soc. 1981, 103, 3215-3217; c) G. Stork, D. R.  
 
      Rychnovsky, J. Am. Chem. Soc. 1987, 109, 1565-1567; d) J. Mulzer, Angew.  
 
      Chem.  Int. Ed. Engl. 1991, 30, 1452-1454; Angew. Chem. 1991, 103, 1484-1486. e)  
 
      R. Sturmer, K. Ritter, R. W. Hofmann, Angew. Chem. Int. Ed. Engl. 1993, 32,  
 
      101-103; Angew. Chem. 1993, 105, 112-114. For a synthesis of a racemic ,- 
 
      substituted carbonyl pattern with all carbon quaternary/tertiary non adjacent  
 
      stereocenters, see: J.-H. Fan, W.-T. Wei, M.-B. Zhou, R.-J. Song, J.-H. Li, Angew.  
 
 65 
 
 
 
     Chem. Int. Ed. 2014, 53, 6650-6654; Angew. Chem. 2014, 126, 6768-6772. 
 
3) (a) Perlmutter, P. Conjugate Addition Reactions in Organic Synthesis, Pergamon,  
 
     Oxford, 1992. (b) Krause, N.; Hoffmann-Roder, A. Synthesis 2001, 171. (c) Berner,  
 
     0. M.; Tedeschi, L.; Enders, D. Eur. J. Org. Chem. 2002, 1877. (d) Sibi, M. P.;  
 
     Manyem, S. Tetrahedron 2000, 56, 8033. (e) Christoffers, J.; Baro, A. Angew. Chem.  
 
     2003, 115, 1726; Angew. Chem., Int.  Ed. 2003, 42, 1688. 
 
4) Li, X.; Luo, S.; Cheng, J. –P. Chem. Eur. J. 2010, 16, 14290. 
 
5) Iriarte, I. ; Vera, S.; Badiola, E.; Mielgo, A.; Oiarbide, M.; Garcia, J. M.; Odriozola, J.  
 
    M.; Palomo, C.; Chem. Eur. J. 2016, 22, 13690. 
     
6) Kunetsky, R. A.; Dilman, A. D.; Struchkova, M. I.; Tartakovsky, V. A.; Ioff, S. L.  
 
     Tetrahedron Lett. 2005, 46, 5203. 
 
7)  (S)-Proline and (1R,2R)-1,2-diphenylethylenediamine provided 35 in low yield and  
 
      low ee. (1R,2S)-Ephedrine was not effective as a catalyst. 
 
8) For application in the conjugate additions of thiols, see: Baricordi, N.; Benetti, S.;  
 
 Bertolasi, V.; De Risi, C.; Pollini, G. P.; Zamberlan, F.; Zanirato, V. Tetrahedron 2012,  
 
  68, 208. 
 
9) Borah, J. C.; Gogoi, S.; Boruwa, J.; Barua, N. C. Synth. Commun. 2005, 35, 873-878. 
 
10) Pansare, S. V.; Pandya, K. J. Am. Chem. Soc. 2006, 128, 9624.  
 
11) For a theoretical study of the role of hydrogen bonding in the Michael addition of  
  
       enamines to nitroalkenes, see: Arno, M.; Zaragoza, R. J.; Domingo, L. R.  
 
       Tetrahedron Asymmetry 2007, 18, 157. 
 
12) The crystallographic data has been deposited with the Cambridge Crystallographic  
 
 66 
 
 
       Data Centre, reference no. CCDC 1423549. 
 
13) Ritesh A. Annadate, unpublished results from the Pansare group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 67 
 
 
 
 
 
 
 
 
 
2.8 Selected 1H NMR, 13C NMR Spectra and Chiral HPLC 
Chromatograms. 
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2.9 X-Ray Crystallographic Data for -Nitroketone 36 
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Experimental 
A colorless rod-shaped specimen of C18H23NO7, approximate dimensions 0.220 mm x 0.246 mm x 0.448 
mm, was used for the X-ray crystallographic analysis. X-ray data were measured using rotating anode-
generated Cu radiation (λ = 1.34 Å) and a Bruker 6K SMART CCD detector, at room temperature. Unit cell 
parameters were initially established from reflections in the first 100 frames in three orientations.  
The integration of the data using a hexagonal unit cell yielded a total of 21010 reflections to a maximum θ 
angle of 70.06° (0.82 Å resolution), of which 3170 were independent (average redundancy 6.628, 
completeness = 99.0%, Rint = 3.95%, Rsig = 2.18%) and 3097 (97.70%) were greater than 2σ(F2). The final 
cell constants of a = 10.20930(10) Å, b = 10.20930(10) Å, c = 30.4222(3) Å, volume = 2746.08(6) Å3, are 
based upon the refinement of the XYZ-centroids of reflections above 20 σ(I). The calculated minimum and 
maximum transmission coefficients (based on crystal size) are 0.7529 and 0.8772.  
 
The structure was solved and refined using the Bruker SHELXTL Software Package (v.2014/6), using the 
space group P 65, with Z = 6 for the formula unit, C18H23NO7. The final anisotropic full-matrix least-squares 
refinement on F2 with 281 variables converged at R1 = 3.14%, for the observed data and wR2 = 9.29% for 
all data. The goodness-of-fit was 1.075. The largest peak in the final difference electron density synthesis 
was 0.120 e-/Å3 and the largest hole was -0.115 e-/Å3 with an RMS deviation of 0.026 e-/Å3. On the basis of 
the final model, the calculated density was 1.326 g/cm3 and F(000), 1164 e-. 
 
Table 1.  Crystal data and structure refinement for nitroketone 36 
Identification code  P65 
Empirical formula  C18 H23 N O7 
Formula weight  365.37 
Temperature  295(2) K 
Wavelength  1.54178 Å 
Crystal system  Hexagonal 
Space group  P65 
Unit cell dimensions a = 10.20930(10) Å = 90°. 
 b = 10.20930(10) Å = 90°. 
 c = 30.4222(3) Å  = 120°. 
Volume 2746.08(6) Å3 
Z 6 
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Density (calculated) 1.326 g/cm3 
Absorption coefficient 0.860 mm-1 
F(000) 1164 
Crystal size 0.448 x 0.246 x 0.220 mm3 
Theta range for data collection 5.002 to 70.063°. 
Index ranges -11<=h<=12, -12<=k<=12, -35<=l<=32 
Reflections collected 21010 
Independent reflections 3170 [R(int) = 0.0395] 
Completeness to theta = 67.679° 99.1 %  
Absorption correction Numerical 
Max. and min. transmission 0.8772 and 0.7529 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3170 / 1 / 281 
Goodness-of-fit on F2 1.075 
Final R indices [I>2sigma(I)] R1 = 0.0314, wR2 = 0.0911 
R indices (all data) R1 = 0.0321, wR2 = 0.0929 
Absolute structure parameter 0.11(9) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.120 and -0.115 e.Å-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for P65.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O(11) -2491(2) 4824(2) 1166(1) 64(1) 
O(12) 5110(2) 9304(3) 1827(1) 68(1) 
O(14) 6998(2) 8816(2) 1404(1) 58(1) 
O(17) 1323(3) 9835(2) 743(1) 90(1) 
O(18) 2796(4) 10193(2) 214(1) 93(1) 
N(16) 1935(2) 9399(2) 494(1) 49(1) 
C(1") 3025(2) 7935(2) 779(1) 41(1) 
C(1') 119(2) 6800(2) 746(1) 43(1) 
C(2") 3349(2) 8486(3) 1210(1) 45(1) 
C(2') 1663(2) 7786(2) 539(1) 41(1) 
C(5) -1411(3) 2825(3) 200(1) 52(1) 
O(1) -1766(16) 2390(20) -241(7) 58(2) 
C(2) -798(11) 1784(10) -383(3) 71(2) 
C(3) -342(8) 1346(8) 50(2) 71(1) 
O(4) -534(18) 2260(20) 383(6) 61(2) 
C(5A) -1411(3) 2825(3) 200(1) 52(1) 
O(1A) -1460(30) 2460(50) -267(14) 58(2) 
C(2A) -1240(20) 1238(18) -283(6) 71(2) 
C(3A) 244(16) 2115(15) -36(4) 71(1) 
O(4A) -230(40) 2440(40) 319(12) 61(2) 
C(3") 4673(3) 8762(3) 1413(1) 47(1) 
C(4") 5704(2) 8471(2) 1182(1) 45(1) 
C(5") 5349(3) 7877(3) 765(1) 50(1) 
C(6") 4018(3) 7619(3) 563(1) 47(1) 
C(6) -644(3) 4535(3) 240(1) 47(1) 
C(7) -426(3) 5109(2) 714(1) 44(1) 
C(8) -1922(3) 4227(3) 962(1) 53(1) 
C(9) -2680(5) 2532(3) 924(1) 80(1) 
C(10) -2903(4) 2051(3) 443(1) 71(1) 
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C(13) 4150(4) 9661(5) 2072(1) 78(1) 
C(15) 8073(3) 8581(4) 1174(1) 71(1) 
 
 
Table 3.   Bond lengths [Å] and angles [°] for  P65. 
_____________________________________________________  
O(11)-C(8)  1.204(3) 
O(12)-C(3")  1.358(3) 
O(12)-C(13)  1.417(4) 
O(14)-C(4")  1.363(3) 
O(14)-C(15)  1.419(3) 
O(17)-N(16)  1.199(3) 
O(18)-N(16)  1.202(3) 
N(16)-C(2')  1.533(3) 
C(1")-C(6")  1.376(3) 
C(1")-C(2")  1.399(3) 
C(1")-C(2')  1.510(3) 
C(1')-C(2')  1.520(3) 
C(1')-C(7)  1.530(3) 
C(1')-H(1'B)  0.98(3) 
C(1')-H(1'A)  1.03(3) 
C(2")-C(3")  1.381(3) 
C(2")-H(2")  0.93(3) 
C(2')-H(2'A)  0.99(3) 
C(5)-O(4)  1.40(2) 
C(5)-O(1)  1.40(2) 
C(5)-C(10)  1.513(4) 
C(5)-C(6)  1.520(3) 
O(1)-C(2)  1.469(17) 
C(2)-C(3)  1.536(11) 
C(2)-H(2A)  0.9700 
C(2)-H(2B)  0.9700 
C(3)-O(4)  1.456(19) 
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C(3)-H(3A)  0.9700 
C(3)-H(3B)  0.9700 
C(5A)-O(1A)  1.46(4) 
C(5A)-O(4A)  1.49(4) 
C(5A)-C(10)  1.513(4) 
C(5A)-C(6)  1.520(3) 
O(1A)-C(2A)  1.37(4) 
C(2A)-C(3A)  1.52(2) 
C(2A)-H(2AA)  0.9700 
C(2A)-H(2AB)  0.9700 
C(3A)-O(4A)  1.29(4) 
C(3A)-H(3AA)  0.9700 
C(3A)-H(3AB)  0.9700 
C(3")-C(4")  1.415(3) 
C(4")-C(5")  1.376(4) 
C(5")-C(6")  1.392(4) 
C(5")-H(5")  0.99(3) 
C(6")-H(6")  1.04(4) 
C(6)-C(7)  1.531(3) 
C(6)-H(6B)  0.99(3) 
C(6)-H(6A)  0.98(3) 
C(7)-C(8)  1.528(3) 
C(7)-H(7A)  0.98(3) 
C(8)-C(9)  1.506(4) 
C(9)-C(10)  1.522(5) 
C(9)-H(9B)  0.90(5) 
C(9)-H(9A)  1.02(5) 
C(10)-H(10B)  0.9700 
C(10)-H(10A)  0.9700 
C(13)-H(13C)  0.9600 
C(13)-H(13B)  0.9600 
C(13)-H(13A)  0.9600 
C(15)-H(15C)  0.9600 
C(15)-H(15B)  0.9600 
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C(15)-H(15A)  0.9600 
 
C(3")-O(12)-C(13) 117.7(2) 
C(4")-O(14)-C(15) 116.4(2) 
O(17)-N(16)-O(18) 122.5(2) 
O(17)-N(16)-C(2') 119.7(2) 
O(18)-N(16)-C(2') 117.7(2) 
C(6")-C(1")-C(2") 119.3(2) 
C(6")-C(1")-C(2') 119.6(2) 
C(2")-C(1")-C(2') 121.0(2) 
C(2')-C(1')-C(7) 113.09(18) 
C(2')-C(1')-H(1'B) 106.2(17) 
C(7)-C(1')-H(1'B) 108.2(17) 
C(2')-C(1')-H(1'A) 107.9(16) 
C(7)-C(1')-H(1'A) 112.5(16) 
H(1'B)-C(1')-H(1'A) 109(2) 
C(3")-C(2")-C(1") 120.8(2) 
C(3")-C(2")-H(2") 119(2) 
C(1")-C(2")-H(2") 120(2) 
C(1")-C(2')-C(1') 117.64(19) 
C(1")-C(2')-N(16) 105.74(17) 
C(1')-C(2')-N(16) 108.54(18) 
C(1")-C(2')-H(2'A) 107.8(17) 
C(1')-C(2')-H(2'A) 113.6(16) 
N(16)-C(2')-H(2'A) 102.2(18) 
O(4)-C(5)-O(1) 111.6(11) 
O(4)-C(5)-C(10) 105.9(6) 
O(1)-C(5)-C(10) 105.6(6) 
O(4)-C(5)-C(6) 111.9(8) 
O(1)-C(5)-C(6) 110.1(9) 
C(10)-C(5)-C(6) 111.5(2) 
C(5)-O(1)-C(2) 107.1(12) 
O(1)-C(2)-C(3) 103.6(11) 
O(1)-C(2)-H(2A) 111.0 
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C(3)-C(2)-H(2A) 111.0 
O(1)-C(2)-H(2B) 111.0 
C(3)-C(2)-H(2B) 111.0 
H(2A)-C(2)-H(2B) 109.0 
O(4)-C(3)-C(2) 104.7(9) 
O(4)-C(3)-H(3A) 110.8 
C(2)-C(3)-H(3A) 110.8 
O(4)-C(3)-H(3B) 110.8 
C(2)-C(3)-H(3B) 110.8 
H(3A)-C(3)-H(3B) 108.9 
C(5)-O(4)-C(3) 107.8(14) 
O(1A)-C(5A)-O(4A) 95.4(19) 
O(1A)-C(5A)-C(10) 116.5(12) 
O(4A)-C(5A)-C(10) 118.8(12) 
O(1A)-C(5A)-C(6) 107.7(17) 
O(4A)-C(5A)-C(6) 105.3(14) 
C(10)-C(5A)-C(6) 111.5(2) 
C(2A)-O(1A)-C(5A) 106(3) 
O(1A)-C(2A)-C(3A) 90.8(19) 
O(1A)-C(2A)-H(2AA) 113.5 
C(3A)-C(2A)-H(2AA) 113.5 
O(1A)-C(2A)-H(2AB) 113.5 
C(3A)-C(2A)-H(2AB) 113.5 
H(2AA)-C(2A)-H(2AB) 110.8 
O(4A)-C(3A)-C(2A) 100(2) 
O(4A)-C(3A)-H(3AA) 111.7 
C(2A)-C(3A)-H(3AA) 111.7 
O(4A)-C(3A)-H(3AB) 111.7 
C(2A)-C(3A)-H(3AB) 111.7 
H(3AA)-C(3A)-H(3AB) 109.5 
C(3A)-O(4A)-C(5A) 109(3) 
O(12)-C(3")-C(2") 125.9(2) 
O(12)-C(3")-C(4") 114.8(2) 
C(2")-C(3")-C(4") 119.3(2) 
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O(14)-C(4")-C(5") 125.3(2) 
O(14)-C(4")-C(3") 115.3(2) 
C(5")-C(4")-C(3") 119.4(2) 
C(4")-C(5")-C(6") 120.5(2) 
C(4")-C(5")-H(5") 121.2(19) 
C(6")-C(5")-H(5") 118.3(19) 
C(1")-C(6")-C(5") 120.6(2) 
C(1")-C(6")-H(6") 120.0(17) 
C(5")-C(6")-H(6") 119.4(17) 
C(5A)-C(6)-C(7) 114.0(2) 
C(5)-C(6)-C(7) 114.0(2) 
C(5A)-C(6)-H(6B) 108.8(18) 
C(5)-C(6)-H(6B) 108.8(18) 
C(7)-C(6)-H(6B) 109.1(19) 
C(5A)-C(6)-H(6A) 106.2(18) 
C(5)-C(6)-H(6A) 106.2(18) 
C(7)-C(6)-H(6A) 108.4(19) 
H(6B)-C(6)-H(6A) 110(3) 
C(8)-C(7)-C(1') 109.03(19) 
C(8)-C(7)-C(6) 109.18(19) 
C(1')-C(7)-C(6) 113.2(2) 
C(8)-C(7)-H(7A) 104.8(19) 
C(1')-C(7)-H(7A) 111.0(18) 
C(6)-C(7)-H(7A) 109.3(18) 
O(11)-C(8)-C(9) 121.4(3) 
O(11)-C(8)-C(7) 123.3(2) 
C(9)-C(8)-C(7) 115.3(2) 
C(8)-C(9)-C(10) 110.6(3) 
C(8)-C(9)-H(9B) 106(3) 
C(10)-C(9)-H(9B) 117(3) 
C(8)-C(9)-H(9A) 103(3) 
C(10)-C(9)-H(9A) 107(3) 
H(9B)-C(9)-H(9A) 112(4) 
C(5A)-C(10)-C(9) 110.6(3) 
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C(5)-C(10)-C(9) 110.6(3) 
C(5)-C(10)-H(10B) 109.5 
C(9)-C(10)-H(10B) 109.5 
C(5)-C(10)-H(10A) 109.5 
C(9)-C(10)-H(10A) 109.5 
H(10B)-C(10)-H(10A) 108.1 
O(12)-C(13)-H(13C) 109.5 
O(12)-C(13)-H(13B) 109.5 
H(13C)-C(13)-H(13B) 109.5 
O(12)-C(13)-H(13A) 109.5 
H(13C)-C(13)-H(13A) 109.5 
H(13B)-C(13)-H(13A) 109.5 
O(14)-C(15)-H(15C) 109.5 
O(14)-C(15)-H(15B) 109.5 
H(15C)-C(15)-H(15B) 109.5 
O(14)-C(15)-H(15A) 109.5 
H(15C)-C(15)-H(15A) 109.5 
H(15B)-C(15)-H(15A) 109.5 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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 Table 4.   Anisotropic displacement parameters (Å2x 103) for P65.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(11) 64(1)  60(1) 56(1)  -5(1) 17(1)  22(1) 
O(12) 52(1)  100(2) 53(1)  -22(1) -10(1)  39(1) 
O(14) 43(1)  67(1) 68(1)  3(1) -1(1)  30(1) 
O(17) 97(2)  57(1) 130(2)  10(1) 39(2)  48(1) 
O(18) 130(2)  49(1) 75(2)  18(1) 31(2)  26(1) 
N(16) 51(1)  41(1) 52(1)  1(1) -6(1)  20(1) 
C(1") 42(1)  36(1) 43(1)  2(1) 3(1)  18(1) 
C(1') 43(1)  41(1) 45(1)  -4(1) 2(1)  21(1) 
C(2") 40(1)  48(1) 47(1)  -4(1) 3(1)  22(1) 
C(2') 46(1)  38(1) 40(1)  -2(1) 0(1)  20(1) 
C(5) 67(1)  48(1) 48(1)  -8(1) -10(1)  34(1) 
O(1) 71(6)  71(2) 52(3)  -19(2) -18(5)  49(5) 
C(2) 106(6)  83(6) 48(4)  -8(3) -2(3)  65(5) 
C(3) 99(4)  67(3) 72(3)  -7(3) -11(3)  61(3) 
O(4) 87(7)  70(5) 49(6)  -10(3) -14(4)  56(5) 
C(5A) 67(1)  48(1) 48(1)  -8(1) -10(1)  34(1) 
O(1A) 71(6)  71(2) 52(3)  -19(2) -18(5)  49(5) 
C(2A) 106(6)  83(6) 48(4)  -8(3) -2(3)  65(5) 
C(3A) 99(4)  67(3) 72(3)  -7(3) -11(3)  61(3) 
O(4A) 87(7)  70(5) 49(6)  -10(3) -14(4)  56(5) 
C(3") 43(1)  50(1) 45(1)  -1(1) 2(1)  22(1) 
C(4") 38(1)  41(1) 55(2)  9(1) 5(1)  20(1) 
C(5") 49(1)  50(1) 57(2)  5(1) 11(1)  30(1) 
C(6") 53(1)  47(1) 42(1)  -1(1) 6(1)  25(1) 
C(6) 55(1)  44(1) 43(1)  0(1) 2(1)  25(1) 
C(7) 47(1)  41(1) 43(1)  -2(1) -2(1)  22(1) 
C(8) 61(1)  48(1) 42(1)  -2(1) 3(1)  21(1) 
C(9) 94(2)  47(2) 76(2)  11(1) 30(2)  19(2) 
C(10) 72(2)  40(1) 83(2)  -10(1) 3(2)  15(1) 
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C(13) 61(2)  113(3) 61(2)  -36(2) -9(1)  43(2) 
C(15) 48(1)  87(2) 91(2)  6(2) 4(1)  43(1) 
______________________________________________________________________________  
 
 
 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for P65. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1'B) -590(40) 7000(30) 583(10) 52 
H(1'A) 170(30) 7150(30) 1066(10) 52 
H(2") 2660(30) 8660(30) 1364(11) 54 
H(2'A) 1730(30) 7520(30) 229(11) 50 
H(2A) 84 2544 -539 86 
H(2B) -1350 909 -571 86 
H(3A) -989 277 111 85 
H(3B) 700 1572 39 85 
H(2AA) -1123 959 -579 86 
H(2AB) -2000 365 -123 86 
H(3AA) 699 1497 23 85 
H(3AB) 958 3018 -194 85 
H(5") 6040(40) 7650(40) 598(11) 59 
H(6") 3790(30) 7220(30) 241(12) 56 
H(6B) 350(40) 4990(40) 93(11) 57 
H(6A) -1300(40) 4830(30) 88(11) 57 
H(7A) 270(40) 4860(30) 865(10) 52 
H(9B) -3510(50) 2150(50) 1093(17) 96 
H(9A) -1880(50) 2310(50) 1046(17) 96 
H(10B) -3338 963 425 85 
H(10A) -3602 2311 307 85 
H(13C) 4583 10030 2357 118 
H(13B) 4039 10425 1921 118 
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H(13A) 3176 8771 2106 118 
H(15C) 8934 8858 1359 107 
H(15B) 7624 7534 1094 107 
H(15A) 8389 9192 913 107 
________________________________________________________________________________  
 
 
 Table 6.  Torsion angles [°] for P65. 
________________________________________________________________  
C(6")-C(1")-C(2")-C(3") 2.2(3) 
C(2')-C(1")-C(2")-C(3") -173.6(2) 
C(6")-C(1")-C(2')-C(1') 126.3(2) 
C(2")-C(1")-C(2')-C(1') -57.9(3) 
C(6")-C(1")-C(2')-N(16) -112.3(2) 
C(2")-C(1")-C(2')-N(16) 63.4(3) 
C(7)-C(1')-C(2')-C(1") -72.9(3) 
C(7)-C(1')-C(2')-N(16) 167.2(2) 
O(17)-N(16)-C(2')-C(1") -100.1(3) 
O(18)-N(16)-C(2')-C(1") 78.0(3) 
O(17)-N(16)-C(2')-C(1') 27.0(3) 
O(18)-N(16)-C(2')-C(1') -154.9(3) 
O(4)-C(5)-O(1)-C(2) -12.8(16) 
C(10)-C(5)-O(1)-C(2) -127.4(10) 
C(6)-C(5)-O(1)-C(2) 112.1(12) 
C(5)-O(1)-C(2)-C(3) 21.4(15) 
O(1)-C(2)-C(3)-O(4) -22.5(13) 
O(1)-C(5)-O(4)-C(3) -2.3(14) 
C(10)-C(5)-O(4)-C(3) 112.1(8) 
C(6)-C(5)-O(4)-C(3) -126.1(9) 
C(2)-C(3)-O(4)-C(5) 15.6(11) 
O(4A)-C(5A)-O(1A)-C(2A) 36(2) 
C(10)-C(5A)-O(1A)-C(2A) -90.1(18) 
C(6)-C(5A)-O(1A)-C(2A) 143.8(17) 
C(5A)-O(1A)-C(2A)-C(3A) -56.7(19) 
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O(1A)-C(2A)-C(3A)-O(4A) 59(3) 
C(2A)-C(3A)-O(4A)-C(5A) -39(2) 
O(1A)-C(5A)-O(4A)-C(3A) 5(3) 
C(10)-C(5A)-O(4A)-C(3A) 129.5(17) 
C(6)-C(5A)-O(4A)-C(3A) -105(2) 
C(13)-O(12)-C(3")-C(2") -1.8(4) 
C(13)-O(12)-C(3")-C(4") 178.2(3) 
C(1")-C(2")-C(3")-O(12) 179.5(2) 
C(1")-C(2")-C(3")-C(4") -0.4(3) 
C(15)-O(14)-C(4")-C(5") 2.2(3) 
C(15)-O(14)-C(4")-C(3") -178.0(2) 
O(12)-C(3")-C(4")-O(14) -1.7(3) 
C(2")-C(3")-C(4")-O(14) 178.2(2) 
O(12)-C(3")-C(4")-C(5") 178.1(2) 
C(2")-C(3")-C(4")-C(5") -2.0(3) 
O(14)-C(4")-C(5")-C(6") -177.6(2) 
C(3")-C(4")-C(5")-C(6") 2.7(3) 
C(2")-C(1")-C(6")-C(5") -1.5(3) 
C(2')-C(1")-C(6")-C(5") 174.3(2) 
C(4")-C(5")-C(6")-C(1") -0.9(3) 
O(1A)-C(5A)-C(6)-C(7) -176.7(11) 
O(4A)-C(5A)-C(6)-C(7) -75.8(13) 
C(10)-C(5A)-C(6)-C(7) 54.3(3) 
O(4)-C(5)-C(6)-C(7) -64.1(7) 
O(1)-C(5)-C(6)-C(7) 171.2(5) 
C(10)-C(5)-C(6)-C(7) 54.3(3) 
C(2')-C(1')-C(7)-C(8) 175.6(2) 
C(2')-C(1')-C(7)-C(6) -62.7(3) 
C(5A)-C(6)-C(7)-C(8) -49.4(3) 
C(5)-C(6)-C(7)-C(8) -49.4(3) 
C(5A)-C(6)-C(7)-C(1') -171.1(2) 
C(5)-C(6)-C(7)-C(1') -171.1(2) 
C(1')-C(7)-C(8)-O(11) -3.9(4) 
C(6)-C(7)-C(8)-O(11) -128.0(3) 
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C(1')-C(7)-C(8)-C(9) 174.4(3) 
C(6)-C(7)-C(8)-C(9) 50.3(3) 
O(11)-C(8)-C(9)-C(10) 123.8(3) 
C(7)-C(8)-C(9)-C(10) -54.6(4) 
O(1A)-C(5A)-C(10)-C(9) 179.6(18) 
O(4A)-C(5A)-C(10)-C(9) 66.5(18) 
C(6)-C(5A)-C(10)-C(9) -56.2(3) 
O(4)-C(5)-C(10)-C(9) 65.8(9) 
O(1)-C(5)-C(10)-C(9) -175.8(9) 
C(6)-C(5)-C(10)-C(9) -56.2(3) 
C(8)-C(9)-C(10)-C(5A) 55.9(4) 
C(8)-C(9)-C(10)-C(5) 55.9(4) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Chapter 3 
 
 
 
 
 
 
 
Formal Synthesis of (+)-Lasubine II and (−)-Subcosine II via 
Organocatalytic Michael Addition of a Ketone to an -Nitrostyrene 
 
 
 
A portion of this work has been published in Organic Letters:  
Moorthy, N. V. G.; Dyapa, R.; Pansare, S. V.; Org. Lett. 2015, 17, 5312. 
Mr. N. V. G. Moorthy has carried out all of the experimental work described in this 
publication and in this Chapter. Dr. R. Dyapa conducted the initial experiments on the 
optimization of the organocatalytic Michael addition reaction for the synthesis of the 
starting -nitroketone for the synthesis of Lasubine II. 
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3.1 Introduction 
 
 The principal objective of the work described in this chapter was to explore the 
possibility of utilizing the organocatalytic asymmetric Michael addition reaction of in situ 
generated -nitrostyrenes (Chapter 2 of this thesis) as a key reaction in a target oriented 
synthetic investigation. To this effect, we decided to explore the use of the product -
nitroketones obtained from ketone/-nitrostyrene Michael addition reactions in the 
synthesis of selected alkaloids that contain the quinolizidine framework. The 4-
arylquinolizidine motif was chosen as the synthetic target for this purpose. 
The 4-arylquinolizidine motif is found in several lythraceae alkaloids of which (−)-
lasubine I (1) and (−)-lasubine II (2) are prominent examples (Figure 3.1).1 From a 
structural perspective, the lasubine framework is incorporated in other members of the 
lythraceous alkaloids such as subcosines I (4) and II1(5) and the macrocyclic lactones (+)-
lythrine2(3) and (+)-vertine2(4). Hence, a synthetic strategy for the lasubines also provides 
a potential route to the macrocyclic members of the lythraceae family. 
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Figure 3.1: Selected alkaloids having a 4-arylquinozilidine motif. 
Several enantioselective syntheses of lasubine II have therefore been investigated,3 
and only three enantioselective syntheses of subcosine II are documented.3 The following 
section provides a summary of the enantioselective syntheses of lasubine II that have been 
reported since 2010. 
3.2 Synthetic routes to lasubine II reported since 2000  
In 2003, Aube and co-workers reported the enantioselective formal synthesis of 
(−)-lasubine II.3j Enol ether 9 was synthesized from the TIPS protected 4-(S)-(-)-hydroxy-
2-cyclopentenone 7 using Karstedt’s catalyst 8 (Scheme 3.1).  Next, enol ether 9 was 
subjected to a Mukaiyama aldol reaction with aldehyde 10 followed by dehydration to 
provide the enone 11. Debenzylation and catalytic hydrogenation of 11 with 10% Pd/C in 
ethanol afforded the alcohol 12 as a single stereoisomer. 
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Scheme 3.1 
 Azide 13 was prepared from the alcohol 12 by using a modified Mitsunobu 
reaction. Subsequent treatment of azide 13 with TiCl4 provided the lactams 14 and 15 
(Scheme 3.2) via a Schmidt rearrangement. 
 
Scheme 3.2 
Lactam 14 was subjected to a Grignard reaction, with the reagent derived from 4-
bromoveratrole (15), in the presence of anhydrous CeCl3. The resulting alkoxide was 
directly treated with NaBH3CN in the presence of acetic acid to provide the quinolizidine 
16 as a single diastereomer in 85% yield. Presumably, the hemiaminal that is formed after 
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protonating the alkoxide with acetic acid, generates an iminium ion which is 
stereoselectively reduced by NaBH3CN. Removal of the TIPS protecting group with TBAF 
in THF afforded (−)-2-epi-lasubine II (17) in 87% yield (Scheme 3.3). The conversion of 
17 to (−)-lasubine II (1) by a Mitsunobu inversion of the secondary alcohol is known.3k  
 
Scheme 3.3 
In 2005, Back and co-workers reported the total synthesis of (−)-lasubine II by the 
conjugate addition and intramolecular acylation of an amino ester with an acetylenic 
sulfone (Scheme 3.4).3h Conjugate addition of aminoester (S)-18 to acetylenic sulfone 19 
was effectively carried out in refluxing  methanol for 4 h. The resultant adduct 20 was 
cyclized by deprotonation of the vinyl sulfone with LDA to afford enaminone 21. 
Treatment of the enaminone 21 with NaBH4 resulted in the reduction of the enamine and 
the ketone to provide an inseparable mixture of diastereomers of the secondary alcohol. 
Swern oxidation of this mixture followed by desulfonylation with Li/NH3 (liq.) provided 
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the easily separable ketones 22 and 23 in 58% and 8% overall yields respectively (Scheme 
3.4). Finally, the stereoselective reduction of ketone 22 with L-selectride afforded (−)-
lasubine II (1). 
 
Scheme 3.4 
Davis and co-workers reported the highly stereoselective synthesis of (−)-lasubine 
II from a suitably functionalized -amino--hydroxyketone.3l Condensation of 
sulfonamide 24 with aldehyde 25 provided the corresponding sulfinimine 26 in 95% yield. 
Treatment of 26 with the enolate of methyl acetate (27) provided the-ketoester 28. This 
was subjected to a highly diastereoselective reduction with zinc borohydride, followed by 
reaction with the lithium salt of N,O-dimethylhydroxylamine to afford the Weinreb amide 
29 (Scheme 3.5). Reaction of 29 with the Grignard reagent 30, cleavage of the sulfonamide 
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under acidic conditions (4 M HCl) and neutralization with conc. NH4OH gave the cyclic 
imine 31. 
Scheme 3.5 
The crude imine 31 was not isolated, but was reduced with LiAlH4/MeONa to give 
the cis-hydroxypiperidine 32. Removal of the benzyl group by hydrogenolysis gave a 90% 
yield of alcohol 33. Finally, activation of the alcohol in 33 as the tosylate (TsCl/pyridine) 
proceeded with concomitant cyclization to provide (−)-lasubine II (1) (Scheme 3.6) in 71% 
yield. 
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Scheme 3.6 
In 2009, Rutjes and co-workers reported the enantioselective synthesis of both 
enantiomers of lasubine II3e by a proline-catalyzed asymmetric Mannich reaction. The R-
aminoketone 37 was obtained from veratraldehyde 34 and p-anisidine 35 by a proline 
catalyzed asymmetric Mannich reaction. Deprotection of N-PMP amine 37 under H5IO6 
acidic conditions followed by treatment with HCl provided the amine salt 38. 
 
Scheme 3.7 
The conversion of ketone 38 to imine 40 was achieved by the treatment of ketone 
38 with cinnamaldehyde (39) in the presence of Et3N in dichloroethane. The imine 40 was 
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then cyclized in the presence of camphorsulfonic acid to provide the piperidine 41, 
presumably via an intramolecular Mannich reaction (Scheme 3.8). Acylation of 41 with 
vinyl acetic acid followed by a ring closing metathesis in the presence of the Grubbs 
second-generation catalyst provided the unsaturated lactam 44. 
 
Scheme 3.8 
Hydrogenation of the unsaturated lactam 44 provided the ketolactam 45. Reduction 
of 45 with LAH provided the (+)-2-epi-lasubine II (46). A Mitsunobu reaction of 46 
provided (+)-lasubine II 47 (Scheme 3.9). 
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Scheme 3.9 
Chattopadhyay and co-workers reported the enantiodivergent synthesis of both 
enantiomers of lasubine II.3a The nitrone 49 was obtained from the syn amine 48 on 
treatment with hydrogen peroxide-sodium tungstate reagent.  The nitrone was subjected to 
intramolecular cycloaddition in toluene to provide 50. Next, the diol functionality in 50 
was liberated by acid hydrolysis of the ketal to provide 51. Oxidative cleavage of diol 51 
provided the aldehyde 52. A three-carbon Wittig homologation of 52 provided the cis 
olefin 54. 
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Scheme 3.10 
 Hydrogenation of 54 provided 55, which upon reduction with Zn/AcOH afforded 
4-hydroxy piperidine 56 (Scheme 3.11) by cleavage of the N-O bond. Protection of the 
alcohol in 56 as a TBS ether gave 57. Debenzylation of 57 (H2, Pd(OH)2) provided the 
alcohol 58, which underwent cyclization under Mitsunobu conditions to provide the 
quinolizidine 59. 
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Scheme 3.11 
Finally, removal of the TBS protecting group in 59 to give 60, and subsequent 
Mitsunobu reaction3k of 60 afforded (−)-lasubine II (1, Scheme 3.12).  
 
Scheme 3.12 
In 2016, Prasad and co-workers reported the total synthesis of (+)-lasubine II (47) 
starting from N-sulfinylimine 61.4 Treatment of 61 with  silyl enol ether 62 afforded  
product 63 in 63% yield with 85:15 diastereomeric ratio. Removal of the sulfinyl group in 
the major diastereomer 63 followed by treatment with DBU furnished cis and trans-
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quinolizidines 64 and 65, in 41% and 35% yield respectively, involving an in situ tandem 
Michael addition/displacement of bromine. Reduction of the ketone in 64 with LAH 
furnished 2-epi-lasubine II (46), which on Mitsunobu inversion provided (+)-lasubine II 
(47) in 81% yield (Scheme 3.13).  
 
Scheme 3.13 
In addition to the enantioselective syntheses described above, syntheses of racemic 
lasubine II were also reported since 2010. In 2012, Yang and co-workers reported the 
racemic total synthesis of lasubine II.5 This synthesis starts with aldehyde 66 which on 
treatment with piperidine perchlorate 67 provided iminium salt 68. Next, the iminium salt 
68 was subjected to a Grignard reaction with 69 to afford tertiary benzylic amine 70. 
Cyclization of 70 to 71 was effected by treatment with m-CPBA followed by Ph3PAuNTf2 
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(Scheme 3.14). Finally, the reduction of ketone 71 with L-Selectride provided (±)-lasubine 
II (72) in 66% yield along with the diastereomeric (±)-2-epi-lasubine I (72a) in 14% yield. 
 
Scheme 3.14 
In 2016, William and co-workers reported the five-step racemic total synthesis of 
lasubine II.6 Deprotonation of 2-picoline 73 (Scheme 3.3) with LDA followed by acylation 
with 75 afforded 76. Next, 76 was subjected to silver (I) catalyzed cyclization to provide 
77. Hydrogenation of 77 afforded quinolizidine 78, which was then subjected to the Swern 
oxidation to afford ketone 79 (Scheme 3.15). Finally, 79 was reduced with L-selectride to 
provide (±)-lasubine II 72 in 36% overall yield. 
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Scheme 3.15 
3.3 Results and Discussion 
In developing a synthetic route to the quinolizidine framework in lasubine II 
(Figure 3.2), we noted that the relative stereochemistry of the secondary alcohol and the 
benzylic stereocenter could be established regardless of the stereochemistry in a bicylic 
precursor, as either of these stereocenters can be inverted at a later stage if necessary.7 The 
retrosynthetic strategy for the synthesis of (+)-lasubine II and (−)-subcosine II is provided 
in Figure 3.2. 
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Figure 3.2    Retrosynthesis of (+)-lasubine II and (−)-subcosine II. 
The required quinolizidine framework could be obtained by cyclization of a 
trisubstituted piperidine A.  Construction of A was planned from a diastereomerically pure 
acyclic precursor B by homologation of the alcohol, deprotection of the acetal, and 
piperidine ring formation by intramolecular reductive amination. We anticipated that 1,3-
induction during the formation of the piperidine ring8 would assist in setting the new 
stereocenter in the product (diequatorial disposition of Ar and side chain in A). Compound 
B derives from the nitrolactone C by reductive ring opening of the lactone. The nitrolactone 
ultimately leads to the -aryl--nitroketone D as the key starting material. From a 
methodology development perspective, -aryl--nitroketones like D are appealing starting 
materials for 2,6-disubstituted 3-hydroxypiperidines such as B, many of which have 
interesting biological profiles and are also valuable synthetic intermediates.9 We therefore 
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chose to address the stereoselective synthesis of the -nitroketone D by employing the 
organocatalytic Michael addition of a monoprotected cyclohexanedione to an -
nitrostyrene as the pivotal step. 
 The organocatalytic Michael addition of ketone 80 with nitroacetate 81 in presence 
of the proline-derived diamine catalyst 82 provided the nitroketone 83 (Scheme 3.16). The 
details of this synthesis are discussed in Chapter 2 of this thesis. 
 
Scheme 3.16 
The diastereoselectivity of the process is low (~1.5:1 dr), but the diastereomers can 
be easily separated to provide the major diastereomer in synthetically useful yield (51-
52%) and enantiomeric excess (82-92% er).10 Employing the optimized reaction 
conditions, gram quantities of 83 could be synthesized routinely. The absolute 
configuration of 83 (R,R) was established by X-ray crystallographic analysis as shown in 
Chapter 2 (page 33) of this thesis. 
With 83 in hand, the synthesis of the lasubine was initiated. Treatment of 83 with 
mCPBA provided the Baeyer-Villiger oxidation product 84, which was reduced to the 
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nitrodiol 85. In order to prevent potentially competing reactions involving the primary 
alcohol in 85 (hemiacetal formation and its reduction to a tetrahydrofuran11 in subsequent 
transformations), it was converted to the primary acetate 86 prior to the hydrolysis of 
acetal. This provided -nitroketone 87 (Scheme 3.17) which was examined as a precursor 
to the functionalized piperidine ring in lasubine.  
 
Scheme 3.17 
Initial studies with 87 were focused on converting nitroketone 87 to cyclic nitrone 
88 (Scheme 3.18), which could potentially be reduced stereoselectively to establish the 
third stereocenter in the piperidine ring. However, only a trace amount of nitrone 88 could 
be detected in the complex mixture of products obtained from the attempted reduction of 
87 (Zn/aq, NH4Cl). It is plausible that 88 is unstable and it undergoes unwanted side 
reactions such as dehydration and/or isomerization12 to the conjugated nitrone. 
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Scheme 3.18 
In an alternative approach, and having diol 85 in hand, the ketal in 85 was 
hydrolyzed (3M HCl/dioxane 1:1) to give ketodiol 89. Reductive cyclization of 89 by 
treatment with Zn/aq. NH4Cl afforded spiropiperidine 90. Notably, the anticipated nitrone, 
corresponding to 88, was not detected in this reaction. Presumably, cyclization of the 
pendant primary alcohol onto the nitrone directly leads to 90. The stereochemistry of the 
spiro ring junction in 90 was not determined in this study. Reduction of 90 with 
NaBH4/MeOH provided amino alcohol 91.  
 
Scheme 3.19 
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Treatment of 91 with trifluoroacetic anhydride provided the tris-trifluoroacetyl 
derivative 92. Selective hydrolysis of the trifluoroacetyl esters in 92 afforded 
trifluoroacetamide 93. Unfortunately, attempted homologation of 93 by conversion to the 
mesylate and subsequent treatment with NaCN afforded a complex mixture of undesired 
products (Scheme 3.20).  
 
Scheme 3.20 
In our continued search for a synthetic protocol that would ultimately lead to the 
required trisubstituted piperidine intermediate (A, Figure 3.2), an alternative strategy that 
involved the initial complete reduction of the nitro group in 71 to a primary amine was 
envisaged. Thus, the reduction of nitrodiol 85 with NiCl2/NaBH4 in MeOH afforded the 
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aminodiol 96 in 70% yield. Protection of the free amine in 96 with Boc anhydride provided 
the N-Boc compound 97 in 90% yield (Scheme 3.21). 
 
Scheme 3.21 
In contrast to the previously unsuccessful homologation attempt with 97, treatment 
of 97 with mesyl chloride and subsequent cyanation in the presence of NaCN smoothly 
provided the required nitrile 99 in 85% yield (overall in 2 steps Scheme 3.22). Removal of 
the acetal in 99, by treatment with iodine in acetone, provided ketone 100 in 78% yield. 
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Scheme 3.22 
 According to our synthetic plan, the next step involved deprotection of the amine 
in 100 followed by an intramolecular amination of the ketone in 100. Unfortunately, 
treatment of 100 with TFA followed by neutralization and subsequent treatment with 
NaBH3CN did not provide any of the expected piperidine 102. Small amounts of undesired 
enone 103 could be detected in the crude product from the proton NMR spectrum (Scheme 
3.23). 
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Scheme 3.23 
In another approach, the mesylation of nitrodiol 85 afforded the mesylated product 
101. However, treatment of 104 with NaCN in DMSO afforded only ketone 107, the 
product of a Nef reaction of 104 (Scheme 3.24). Furthermore, attempted conversion of 104 
to the nitrone 108 via the ketone 106 was also unsuccessful. Although deprotection of 104 
provided 106, the conversion of 106 to 108 was unsuccessful and resulted in a complex 
mixture of undesired products. 
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Scheme 3.24 
 Given the lack of success in strategies that did not involve a cyclic nitrone as the 
key intermediate, we chose to re-examine our initial synthetic attempts described in 
Scheme 3.9. Although, in previous studies, we had converted 89 to 90 (Scheme 3.9), 
repeated reduction of the nitroketone 89 with Zn/aq. NH4Cl provided an inseparable 
mixture of the piperidine 90 and the N-hydroxypiperidine 92 (Scheme 3.25). Attempts to 
convert the hydroxylamine to the amine by varying the amounts of zinc used for the 
reduction were unsuccessful. The precise reasons for the partial reduction of 89 are not 
known at present. However, the mixture of 90 and 92 could be used further. This mixture 
was first reduced with NaBH4 to provide a mixture of the trisubstituted piperidine 91 and 
the corresponding N-hydroxypiperidine 109. Subsequent reduction of this mixture with 
indium metal provided 91 as a single diastereomer. The newly formed stereocenter in 91 
was assigned the R configuration on the assumption that the 2,6-cis (diequatorial) isomer 
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would be favored8 in the reduction of the imine or nitrone that is transiently formed from 
91 and 109 (Scheme 3.25).  
 
Scheme 3.25 
The conversion of 91 into the quinolizidine framework required a homologation of 
the hydroxypropyl side chain at C6. This was achieved by transitory protection of the 
nitrogen by formylation (treatment with excess formic acetic anhydride, followed by basic 
hydrolysis of the concurrently formed formate ester) to provide 112 (Scheme 3.26) 
followed by activation of the primary alcohol as the mesylate and subsequent cyanation to 
provide 114. Simultaneous methanolysis of the nitrile as well as the formamide in 114 
provided the amino ester 115. 
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Scheme 3.26 
Reduction of the ester in 115 and cyclization of the resulting aminodiol could 
potentially provide 2-epi-lasubine II. However, the observation3a that this aminodiol, 
prepared by an unrelated approach, has poor solubility in conventional solvents suggested 
the need for an alternative strategy. Hence, the secondary alcohol in 115 was first protected 
as a TIPS ether. Subsequent reduction of the ester provided 117 (Scheme 3.27), which was 
cyclized to 119 employing a Mitsunobu-type reaction (Ph3P, di-2-methoxyethyl 
azodicarboxylate (DMEAD)13). Deprotection of 119 provided (+)-2-epi-lasubine II 46 
(Scheme 3.27). The enantiomer of 46 has previously been converted into (−)-lasubine II 
by Mitsunobu reaction of the secondary alcohol,3k and a Mitsunobu reaction of ent-7 with 
155 
 
3,4-dimethoxycinnamic acid provided (+)-subcosine II.9e Thus, the present synthesis of 46 
constitutes a formal synthesis of (+)-lasubine II 47 and (−)-subcosine II 121. 
 
Scheme 3.27 
3.4 Conclusion  
In conclusion, the first examples of organocatalytic enantioselective Michael 
additions of a ketone to in situ generated -nitrostyrenes have been developed. The 
methodology has been applied to a formal synthesis of (+)-lasubine II and (−)-subcosine 
II. We are currently investigating the scope of the Michael addition reaction and the 
application of this methodology in the stereoselective synthesis of various trisubstituted 
piperidines. 
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A comparison of the overall yields and the number of steps involved in the 
enantioselective synthesis of lasubine II reported since 2000 as shown in the Table 3.1.    
Table 3.1: Comparsion of number of steps and overall yields for the enantioselective 
syntheses of lasubine II. 
Authors Year # of steps % overall yield  
Davis et. al 2000 9 3 
Aube et. al 2002 11 21 
Back et. al 2002 6 2 
Rutjes et. al 2009 10 3 
Chattopadhyay et. al 2011 17 2 
Pansare et. al 2015 21 3 
Prasad et. al 2016 8 14 
 
As compared to other enantioselective syntheses of lasubine II, ours syntheses 
involved a longer linear sequence. However, the novelty of our synthesis is the use of 
organocatalysis as an important tool for the enantioselective synthesis of a key starting 
material. 
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 3.5 Experimental section  
 
2-(3,4-Dimethoxyphenyl)-2-nitroethyl acetate (81): 
 
 
  
 
A mixture of 2-(3,4-dimethoxyphenyl)oxirane (4.00 g, 22.2 mmol), NaNO2 (11.90 
g, 172.5 mmol) and LaCl3·7H2O (10.9 g, 44.4 mmol) in THF: H2O (1:1, 160 mL) was 
vigorously stirred at ambient temperature for 12 h. The mixture was then extracted with 
ether (4 × 25 mL) and the combined extracts were dried (Na2SO4) and concentrated under 
reduced pressure. The residue was purified by flash column chromatography on silica gel 
(hexanes/EtOAc, 1:1) to provide 1.5 g (30%) of 2-(3,4-dimethoxyphenyl)-2-nitroethanol 
as a yellow foam. 
  Reaction of the above nitroalcohol (1.84 g, 8.1 mmol), acetic anhydride (1.14 mL, 
12.1 mmol) and Sc(OTf)3 (40 mg, 0.08 mmol) in CH3CN (40 mL) at 0 oC, after purification 
of the crude product by flash chromatography on silica gel (hexanes/EtOAc, 7:3), 1.7 g 
(81%) of 81 as a yellow solid. 
Rf = 0.3 (hexanes/EtOAc, 7:3). IR (neat): 1742, 1550, 1516, 1448, 1427, 1394, 1366, 1224, 
1146, 1022cm-1; 1H NMR (300 MHz, CDCl3): δ 7.03 (dd, 1H, J = 8.3, 2.0, ArH),  6.95 (d, 
1H, J = 2.0, ArH), 6.88 (d, 1H, J = 8.3, ArH), 5.67 (dd, 1H, J = 10.7, 3.4, CHNO2), 4.95 
(dd, 1H, J = 12.3, 10.7, CH2OCOCH3), 4.48 (dd, 1H, J = 12.3, 3.4, CH2OCOCH3), 3.90 (s, 
3H, OCH3 ), 3.89 (s, 3H, OCH3),  2.09 (s, 3H, OCOCH3).13C NMR (75 MHz, CDCl3): 
C=O), 150.8 (ArCipso), 149.5 (ArCipso), 122.9 (ArCipso), 120.7 (ArC), 111.3( 
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ArC), 110.2 (ArC),88.6 (CHNO2), 63.9 (CH2OCOCH3), 56.06 (OCH3),CH3), 
20.6 (COCH3).MS (ESI, pos.): m/z 292.0 (M+Na)+ HRMS (ESI, pos.): m/z 270.1015 
(270.0978 calc. for (C12H16NO6 (M+H)+), 292.0794 (292.0797 calc. for (C12H15NNaO6 
(M+Na)+). 
(R) -7-((R)-2-(3,4-Dimethoxyphenyl)-2-nitroethyl)-1,4-dioxaspiro[4.5]decan-8-one 
(83): 
 
To a solution of 1,4-cyclohexanedione monoethylene ketal (80, 11.6 g, 74.3 mmol), 
(S)-2-methyl-N-(pyrrolidin-2-ylmethyl)propan-1-amine (82)1 (505 mg, 3.0 mmol), and 
(1S)-Camphor sulfonic acid (690 mg, 3.0 mmol) in DMF (46 mL) was added 81 (4.00 g, 
14.8 mmol) and the resulting solution was stirred at 0 oC for 72 h. Ethyl acetate (100 mL) 
was added and the solution was washed with water, dried (Na2SO4) and concentrated. The 
residue was purified by flash column chromatography on silica gel to provide 2.45 g (45%) 
83 with 92% ee as a white solid. Rf = 0.25 (hexanes/EtOAc, 7:3); [α]D20 = +18.2 (c 1, 
CH2Cl2) ; IR (neat): 2959, 2873, 1708, 1546, 1510, 1264, 1231, 1150, 1137, 1027 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 7.03 (dd, 1H, J = 8.3, 2.1, ArH), 6.96 (d, 1H, J = 2.1, ArH), 
6.86 (d, 1H, J = 8.3, ArH) 5.63 (dd, 1H, J = 10.3, 4.4, CHNO2), 4.03-4.01 (m, 4H, 
OCH2CH2O), 3.90 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 2.75-2.63 (m, 2H, COCH, 
CH2CHNO2), 2.35-2.49 (m, 2H, CH2CH2CO), 2.30 (dd, 1H, J = 10.3, 4.1, CH2CH2CO), 
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2.13-1.99 (m, 2H, COCH2, COCHCH2), 1.97 (dd, 1H, J = 13.6, 4.9, COCH2)  1.78 (t, 1H, 
J = 13.3, COCHCH2); 13C NMR (75 MHz, CDCl3): δ 210.4 (CO), 150.2 (ArCipso), 149.2 
(ArCipso), 127.2 (ArCipso), 120.3 (ArC), 111.1 (ArCipso), 110.2 (ArC), 106.8 (OCO), 89.6 
(CHNO2), 64.9 (OCH2CH2O), 64.7 (OCH2CH2O), 56.0 (OCH3), 55.9 (OCH3), 43.3 
(COCH), 41.4 (CH2CHC(O)O),38.3 (CH2CHNO2), 34.8 (CH2CO), 34.0 (CH2CH2C(O)O); 
MS (ESI, neg.): 364.1 (M-H)−; HRMS (ESI, neg.): m/z 365.1469 (365.1475 calc. for 
C18H23NO7(M−)); HPLC: Chiralpak AS-H (hexane/i-PrOH, 60/40, flow rate 1 mL min−1, 
λ= 247 nm): tmajor = 10.20 min., tminor = 12.98 min., 92% ee. 
Crystals suitable for X-ray analysis were obtained by dissolving 83 (10 mg) in isopropyl 
alcohol (0.4 mL) followed by addition of hexanes (0.6 mL) to this solution. The resulting 
clear solution was left at ambient temperature for gradual evaporation. The precipitated 
crystals were collected after 48 h, dried in vacuo and analyzed. 
(R)-7-((R)-2-(3,4-Dimethoxyphenyl)-2-nitroethyl)-1,4,8-trioxaspiro[4.6]undecan-9-
one (84): 
 
To a solution of the nitroketone 83 (2.45 g, 6.71 mmol) in anhydrous 
dichloromethane (70 mL ) at ambient temperature, was added solid sodium phosphate 
heptahydrate (2.34 g, 8.73 mmol) followed by m-chloroperoxybenzoic acid (3.59 g, 20.8 
mmol). The resulting white slurry was stirred vigorously at ambient temperature for 16 h. 
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Dichloromethane (70 mL) was added and the resulting solution was washed with saturated 
aqueous sodium bicarbonate (3 x 15 mL). The organic layer was dried (Na2SO4) and 
concentrated under reduced pressure to give a white, solid foam. Purification of the crude 
product by flash chromatography on silica gel (hexanes/EtOAc, 40:60) provided 2.35 g 
(92%) of 84 as a yellow foam. 
Rf   = 0.4 (hexanes/EtOAc, 40:60);[α]D20 = +30.0 (c 1, CH2Cl2); IR (neat): 1732, 1552, 1514, 
1252, 1238, 1153, 1098, 1024 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.03 (dd, 1H, J = 2.1, 
8.3, ArH), 6.96 (d, 1H, J = 2.1, ArH), 6.86 (d, 1H, J = 8.3, ArH), 5.77 (dd, 1H, J = 2.6, 
11.5, CHNO2), 4.54-4.47 (m, 1H, CH-O), 4.05-3.95 (m, 4H, OCH2CH2O), 3.90 (s, 3H, 
OCH3), 3.89 (s, 3H, OCH3), 2.87-2.74 (m, 2H, CH2C(O)O), 2.63-2.56 (ddd, 1H, J = 2.0, 
6.4, 8.4), 2.27-2.17 (ddd, 1H, J = 2.7, 10.8, 13.5), 2.05-1.80 (m, 4H). 13C NMR (75 MHz, 
CDCl3): δ174.0 (CO), 150.4 (ArC), 149.3 (ArC), 126.6 (ArC), 120.3 (ArC), 111.2 (OCO), 
110.4 (ArC), 107.3 (ArC), 86.9 (CHNO2), 71.7 (CH-O-C(O)), 65.2 (OCH2CH2O), 64.7 
(OCH2CH2O), 56.04 (OCH3), 55.98 (OCH3), 44.9 (COCH), 40.3 (CH2CHC(O)O), 32.7 
(CH2CHNO2), 29.2 (CH2CH2C(O)O); MS (APCI, neg.): 380.0 (M–1)−; HRMS (EI, pos.): 
m/z 381.1423 (381.1424 calc. for C18H23NO8 (M+)). 
(2R,4R)-4-(3,4-Dimethoxyphenyl)-1-(2-(3-hydroxypropyl)-1,3-dioxolan-2-yl)-4-
nitrobutan-2-ol (85): 
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To a solution of the lactone 84 (2.35 g, 6.16 mmol) in THF (60 mL) at 0 °C (ice/salt 
bath), was added lithium borohydride (188 mg, 8.63 mmol). The mixture was stirred at 0 
°C for 30 min. and then at ambient temperature for 3 h. It was then cooled to 0 °C and 2 
mL of cold water was added to give a mixture containing a white precipitate. The THF was 
removed under reduced pressure and the residue was dissolved in ethyl acetate (60 mL) 
and the aqueous layer was separated. The organic layer was dried (Na2SO4) and 
concentrated to provide 1.91 g (81%) of the nitroketal 85 as a pale yellow gum. This 
material was pure by 1H NMR and was used in the step without purification. An analytical 
sample was obtained by flash chromatography on silica gel (EtOAc). 
Rf  = 0.25 (EtOAc); [α]D20 = –21.7 (c 1, CHCl3); IR (neat): 3498 (br), 1547, 1517, 1422, 
1365, 1264, 1247, 1142, 1056, 1024, 949 cm-1; 1H NMR (300 MHz, CDCl3): δ7.04 (dd, 
1H, J = 8.3, 2.1, ArH), 6.98 (d, 1H, J = 2.1, ArH), 6.86 (d, 1H, J = 8.3, ArH), 5.84 (dd, 1H, 
J =11.3, 2.9, CHNO2), 4.01 (br s, 4H, OCH2CH2O), 3.90 (br s, 4H, OCH3, CHOH), 3.88 
(s, 3H, OCH3), 3.74 (br s, 1H, ), 3.64 (br t, 2H, CH2OH), 2.70-2.65 (ddd, 1H, J = 14.5, 
11.3, 2.0), 1.93-1.72 (m, 7H), 1.70-1.55 (m, 2H). 13C NMR (75 MHz, CDCl3): δ150.1 
(ArC), 149.2 (ArC), 127.6 (ArC), 120.3 (ArC), 111.6 (OCO), 111.1 (ArC), 110.4 (ArC), 
87.3 (CHNO2), 64.9 (OCH2CH2O), 64.7 (OCH2CH2O), 64.3 (CHOH), 62.7 (CH2OH), 
56.01 (OCH3), 56.00 (OCH3), 42.9 (CH2), 41.5 (CH2), 33.7 (CH2), 27.0 (CH2). MS (ESI, 
neg.): 384.1 (M–1)− ; HRMS (EI, pos.): m/z 385.1730 (385.1737 calc. for C18H27NO8 (M+)). 
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(6R, 8R)-8-(3,4-Dimethoxyphenyl)-6-hydroxy-8-nitro-4-oxooctyl acetate (87): 
 
A solution of the diol 85 (100 mg, 0.26 mmol) in dry dichloromethane (3 mL) was 
cooled to  –78 oC and acetyl chloride (22 µL, 0.3 mmol) and collidine (69 µL, 0.5 mmol) 
were added. The solution was stirred at –78 oC for 2 h and then at ambient temperature for 
2 h. Dichloromethane (3 mL) was added and the resulting solution was washed with aq. 
HCl (0.5 M, 5 mL). The organic layer was dried (Na2SO4) and concentrated to provide 78 
mg (70%) of the acetate 86 as a pale yellow gum. This was used in the next step without 
purification. 
To a solution of the above ketal (60 mg, 0.14 mmol) in acetone (0.5 mL) was added 
iodine (1.7 mg, 14 mmol) and the solution was stirred at ambient temperature for 30 min. 
The acetone was removed under reduced pressure and the residue was diluted with 
dichloromethane (5 mL). The resulting solution was washed successively with aqueous 
Na2S2O3 (5% w/v, 2 mL) and brine (2 mL). The organic layer was dried (Na2SO4) and 
concentrated under reduced pressure to provide 44 mg (82%) of the nitro ketone 87 as a 
yellow solid. This material was pure by 1H NMR and was directly used in the next step. 
Rf   = 0.3 (hexanes/EtOAc, 60:40); IR (neat): 3509 (br), 1710, 1548, 1516, 1462, 1421, 
1364, 1238, 1145, 1106, 1024 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.03 (dd, 1H, J = 8.3, 
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2.2, ArH), 6.96 (d, 1H, J = 2.2, ArH), 6.85 (d, 1H, J = 8.3, ArH), 5.83 (dd, 1H, J = 11.3, 
2.8, CHNO2), 4.08 (t, 2H, J = 6.3, CH2OCOCH3), 4.11-4.14 (m, 1H, CHOH), 3.90 (s, 3H, 
OCH3), 3.88 (s, 3H, OCH3), 3.41 (brs, 1H, CHOH), 2.65-2.73 (m, 2H, NO2CHCH2), 2.46-
2.63 (m, 4H, CH2C(O)CH2), 2.04 (s, 3H, COCH3), 1.88-1.98 (m, 2H, CH2CH2OCOCH3). 
13C NMR (75 MHz, CDCl3): δ 210.0 (C=O), 171.1 (OC(O)CH3), 150.2 (ArC), 149.2 (ArC), 
127.3 (ArC),120.3 (ArC),111.1 (ArC), 110.4 (ArC), 87.2 (CHNO2), 64.2 (CHOH), 63.4 
(CH2OCOCH3), 56.03 (OCH3), 55.97 (OCH3), 48.8 (CH2CO), 40.2 (COCH2), 39.7 
(NO2CHCH2), 22.5 (CH2CH2CO), 20.9 (OCOCH3); MS (ESI, pos.): m/z 406.1 (M+Na)+ 
HRMS (EI, pos.): m/z 383.1583 (383.1580 calc. for (C18H25NO8)+), 406.1474 (406.1478 
calc. for (C18H25NNaO8 (M+Na)+). 
(6R,8R)-8-(3,4-Dimethoxyphenyl)-1,6-dihydroxy-8-nitrooctan-4-one (89): 
 
A solution of the ketal 85 (1.91 g, 4.96 mmol) in a mixture of 3M aqueous HCl and 
dioxane (1:1, 24 mL) was stirred at 0 ºC for 30 min. and then at ambient temperature for 1 
h. The solution was neutralized with saturated aqueous sodium bicarbonate and the mixture 
was extracted with dichloromethane (3 x 10 mL). The combined organic layers were dried 
(Na2SO4) and concentrated under reduced pressure to give a yellow gum. Purification of 
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the crude product by flash chromatography on silica gel (hexanes/EtOAc, 20:80) provided 
1.33 g (78%) of 89 as a white foam. 
Rf  = 0.25 (hexanes/EtOAc, 20:80); [α]D20= +6.5 (c 1, CHCl3); IR (neat): 3519 (br), 1706, 
1550, 1512, 1461, 1419, 1364, 1261, 1146, 1020 cm-1;1H NMR (300 MHz, CDCl3): δ 7.04 
(dd, 1H, J = 8.3, 2.1, ArH), 6.98 (d, 1H, J = 2.1, ArH), 6.86 (d, 1H, J = 8.3, ArH), 5.77 (dd, 
1H, J = 11.3, 2.7, CHNO2), 4.09-4.00 (m, 1H,), 3.90 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 
4.00-3.75 (m (overlaps with OCH3 singlets), 2H), 3.66 (m, 2H), 3.56 (s, 1H), 2.75-2.52 (m, 
6H), 2.05-1.90 (m, 2H), 1.90-1.75 (m, 4H). 13C NMR (75 MHz, CDCl3): 150.2 (ArC), 
149.2 (ArC), 127.4 (ArC), 120.3 (ArC), 111.1 (ArC), 110.4 (ArC), 87.3 (CHNO2), 64.3 
(CHOH), 62.0 (CH2OH), 56.03 (OCH3), 56.00 (OCH3), 49.1, 40.3, 40.2, 26.2. MS (ESI, 
neg.): 340.1 (M-1)−; HRMS (EI, pos.): m/z 341.1472 (341.1475 calc. for C16H23NO7 (M+)). 
(2R, 4S, 6R)-2-(3,4-Dimethoxyphenyl)-6-(3-hydroxypropyl)piperidin-4-ol (91): 
 
To the solution of nitroketone 89 (1.33 g, 3.9 mmol) in THF (25 mL) was added a 
solution of NH4Cl (208 mg, 3.9 mmol) in water (3.6 mL) followed by activated Zn powder 
(2.53 g, 39.0 mmol). The mixture was stirred vigorously at ambient temperature under 
nitrogen for 3 h. The mixture was then filtered through a pad of celite, the residue was 
washed with THF, and the combined filtrates were concentrated under reduced pressure to 
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provide 1.04 g of 90 piperidine as a pale yellow foam. This was used in the next step 
without purification. 
To a solution of 90 (1.04 g) in MeOH (18 mL) at 0 ºC was added sodium 
borohydride (0.53 g, 14.2 mmol). The mixture was stirred at 0ºC for 30 min. and then at 
ambient temperature for 2 h. Aqueous HCl (2 M, 15 mL) was added and the mixture was 
concentrated under reduced pressure to remove MeOH. The resulting aqueous mixture was 
basified (pH~ 10) with solid NaOH and then extracted with ethyl acetate (25 x 3 mL). The 
combined extracts were dried (Na2SO4) and concentrated to provide 0.89 g of piperidine 
91 as a white gum.  
IR (neat): 3342 (br), 2936, 2840, 1517, 1453, 1421, 1263, 1163, 1143, 1026 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 6.93-6.81 (m, 3H, ArH), 3.89 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 
3.90-3.80 (m (overlaps with OCH3 singlets), 1H, CHOH), 3.69 (dd, 1H, J =11.7, 2.4, 
ArCH), 3.60-3.55 (m, 2H, CH2OH), 2.90-2.80 (m, 1H, CH2CHNH), 2.25-2.15 (m, 1H, 
NCH), 2.05-1.96 (m, 2H, CH2CHOH), 2.15-1.95 (br, 1H, NH), 1.70-1.60 (m, 5H, 
CH2CH2OH), 1.52 (m, 1H, J = 11.6, CH2CH2CH2OH), 1.35 (m, 1H, J = 11.6, 
CH2CH2CH2OH).13C NMR (75 MHz, CDCl3): 149.0 (ArCipso), 148.3 (ArCipso), 
135.6(ArCipso), 118.6 (ArC), 111.1 (ArC), 110.1 (ArC), 69.3 (CHOH), 62.7 (CH2OH), 59.1 
(ArCH), 55.9 (2 x OCH3), 54.8 (CHNH), 42.8, (ArCHCH2), 40.7 (CH2CHOH), 35.1 
(CH2CH2OH), 29.4 (CH2(CH2)2OH). MS (APCI, pos.): 296.2 (M+1)+; HRMS (EI, pos.): 
m/z 295.1774 (295.1784 calc. for C16H25NO4 (M+)). 
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3-((2R,4S,6R)-6-(3,4-Dimethoxyphenyl)-4-(2,2,2-trifluoroacetoxy)-1-(2,2,2- 
trifluoroacetyl)piperidin-2-yl)propyl 2,2,2-trifluoroacetate (92): 
 
To an ice cold solution of amino alcohol 91 (90 mg, 0.30 mmol) in dichloromethane (2 ml) 
containing pyridine (86 µL, 1.06 mmol) and 4-(dimethylamino)pyridine  (2 mg, 0.01 
mmol) was added trifluoroacetic anhydride (0.15 mL, 1.06 mmol). The solution was stirred 
at ambient temperature for 12 h, water was added and the solution was extracted with 
dichloromethane and the combined extracts were dried (Na2SO4), and concentrated in 
vacuum to provide 0.136 g (80%) of 92 as a brown gum. This crude material was taken for 
the next step without further purification. 
IR (neat): 2964, 2927, 2845, 1783, 1679, 1517, 1456, 1353, 1137, 1023 cm-1. 
1-((2R, 4S, 6R)-2-(3,4-Dimethoxyphenyl)-4-hydroxy-6-(3-hydroxypropyl)piperidin-1-
yl)-2, 2, 2-trifluoroethanone (93): 
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The residue 92 (136 mg, 0.23 mmol) was dissolved in THF (7 mL), K2CO3 (71 mg, 0.51 
mmol) was added and the mixture was stirred at the ambient temperature for 24 h. Water 
was added and the mixture was extracted with dichloromethane (5 mL) and the combined 
extracts were dried (Na2SO4) and concentrated in vacuum. The crude 93 was obtained as a 
brown gum. 
 IR (neat): 3398, 2924, 2853, 1677, 1518, 1456, 1418, 1256, 1200, 1142, 1026 cm-1. 
3-((2R,4S,6R)-6-(3,4-Dimethoxyphenyl)-4-hydroxy-1-(2,2,2 trifluoroacetyl)piperidin-
2-yl)propyl methanesulfonate (94): 
 
To a stirred solution of 93 (70 mg, 0.178 mmol) in dichloromethane (2 mL), at -78 
oC, was added DIPEA (31µL) followed by methanesulfonyl chloride (14 µL, 0.178 mmol) 
in dichloromethane (2 mL) over 15 min at -78 oC. The reaction mixture was warm up to 
ambient temperature. Cold water (3 mL) was added and the organic layer was separated, 
washed with water (5 mL), brine (5 mL), dried (Na2SO4) and concentrated to provide 65 
mg (77%) as a brown gum of the crude mesylate 94 as a yellow gum. This crude material 
was immediately used in the next step. 
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(2R, 4R)-4-Amino-4-(3, 4-dimethoxyphenyl)-1-(2-(3-hydroxypropyl)-1, 3-dioxolan-2- 
yl)butan-2-ol (96): 
 
 To a solution of 85 (550 mg, 1.42 mmol) methanol was added NiCl2 (370 mg, 2.85 mmol) 
at -20 °C followed by NaBH4 (540 mg, 14.2 mmol) in portions over the period of 1h. The 
reaction mixture was stirred at -20 °C for 1 h and at ambient temperature for 2 h. Then the 
reaction mixture was concentrated to remove methanol and 3 M NaOH (10 ml) was added 
to the residue followed by ether (15 ml). The resulting suspension was filtered and the 
organic layer was separated, washed with brine and dried (Na2SO4). It was then 
concentrated under vacuum, provided 96 of 70% as a yellow gum and the crude was used 
in the next step without further purification. 
IR (neat): 3500, 2930, 2365, 2329, 1672, 1594, 1305, 1260, 1143, 1094, 905, 833, 730 cm-
1;1H NMR (300 MHz, CDCl3): δ 6.89-6.83 (m, 3H, ArH), 4.21 (br s, CHOH), 4.11-3.94 
(m, 5H, CHNH2, OCH2CH2O), 3.89 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 3.63 (t, 2H, J = 
6.1, CH2OH), 1.82-1.60 (m, 8H, CH2CH2CH2OH, CH2CH2OH, CH2CHOH, 
CH2C(OCH2CH2O)). MS (ESI, pos.): m/z 356.2 (356.44 calc. for C18H30NO6 [M+H]+). 
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tert-Butyl (1R,3R)-1-(3, 4-dimethoxyphenyl)-3-hydroxy-4-(2-(3-hydroxypropyl)-1,3- 
dioxolan-2-yl)butylcarbamate (97): 
 
 
To a solution of 96 (0.350g, 0.98 mmol) in dichloromethane (12 mL), Et3N (0.13ml, 0.98 
mmol) followed by boc anhydride (230 mg, 1.08 mmol) was added in an ice bath. The 
reaction was warmed up to ambient temperature and allowed to stir for 12 h in ambient 
temperature. The reaction mixture was diluted with dichloromethane and washed with 
water. The organic layer was separated and dried (Na2SO4). It was then concentrated 
through vacuum to provide 400 mg of 97 (90%) as a yellow gum. This material was taken 
further without purification. 
IR (neat): 3450, 2980, 2926, 2365, 2328, 1808, 1763, 1689, 1513, 1459, 1367, 1314, 1119, 
1066 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.86-6.80 (m, 3H, ArH), 4.00-3.93 (m, 4H, 
OCH2CH2O), 3.87 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.87-3.86 (br s, CHOH), 3.62 (m, 
2H, CH2OH), 1.93-1.57 (m, 8H, CH2CH2CH2OH, CH2CH2OH, CH2CHOH, 
CH2C(OCH2CH2O)) 1.47-1.36 (m, 9H, (CH3)3C). 
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3-(2-((2R,4R)-4-(tert-Butoxycarbonylamino)-4-(3, 4-dimethoxyphenyl)-2- 
hydroxybutyl)-1, 3-dioxolan-2-yl)propyl methanesulfonate (98): 
 
To a stirred solution of 97 (75 mg, 0.16 mmol) in dichloromethane (2 mL), at -78 
oC, was added collidine (44 µL) followed by methanesulfonyl chloride (13.0 µL, 0.164 
mmol) in dichloromethane (10 mL) over 15 min at -78 oC. The reaction mixture was warm 
up to ambient temperature. Cold water (3 mL) was added and the organic layer was 
separated, washed with water (5 mL), brine (5 mL), dried (Na2SO4) and concentrated to 
provide 80 mg as a brown gum of the crude mesylate 98 as a yellow gum. This was 
immediately used in the next step. 
 
1H NMR (300 MHz, CDCl3): δ 6.87-6.78 (m, 3H, ArH), 5.60-5.57 (br s, NH, rotamer), 
4.85 (br s, CHNH, rotamer), 4.22 (t, 2H, J = 6.0, CH2CH2OH), 3.99-3.94 (m, 4H, 
OCH2CH2O), 3.88 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.87 (br s, CHOH), 3.00 (s, 3H, 
OSO2CH3),1.93-1.62 (m, 8H, CH2CH2CH2OH,CH2CH2OH, CH2CHOH, 
CH2C(OCH2CH2O)), 1.49-1.33 (br m, 9H, (CH3)3C). 
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tert-Butyl (1R,3R)-4-(2-(3-cyanopropyl)-1,3-dioxolan-2-yl)-1-(3,4-dimethoxyphenyl)- 
3-hydroxybutylcarbamate (99): 
NH OH
OMe
MeO
O O
CN
O
O
 
To a solution of the mesylate 98 (80 mg, 0.15 mmol) in anhydrous DMSO (2 mL) at 
ambient temperature was added NaCN (15 mg, 0.3 mmol). The mixture was stirred at 
ambient temperature for 15 h. Ethyl acetate was added to the reaction mixture and the 
solution was washed with water (5 mL), brine (3 mL) and then dried (Na2SO4). It was then 
concentrated to provide 59 mg (85%) of 99 as a dark red gum. 
1H NMR (300 MHz, CDCl3): δ 6.84-6.82 (m, 3H, ArH), 5.54 (br s, 1H, NH), 4.84 (br s, 
1H, CHNH), 3.98-3.96 (m, 4H, OCH2CH2O), 3.87 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 
3.88-3.86 (br s, CHOH), 2.36 (t, 2H, CH2CN), 1.92-1.62 (m, 8H, CH2CH2OH, CH2CHOH, 
CH2C(OCH2CH2O)) 1.49-1.34 (br m, 9H, (CH3)3C). 
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tert-Butyl(1R,3R)-8-cyano-1-(3,4-dimethoxyphenyl)-3-hydroxy-5-oxooctylcarbamate  
(100): 
 
 
To a solution of 99 (34 mg, 0.07 mmol) in acetone (0.5 mL) was added iodine (1.0 mg, 
0.007 mmol) and the solution was stirred at ambient temperature for 2 h. The acetone was 
removed under reduced pressure and the residue was diluted with dichloromethane (5 mL). 
The resulting solution was washed successively with aqueous Na2S2O3 (5% w/v, 2 mL) and 
brine (2 mL). The organic layer was dried (Na2SO4) and concentrated under reduced 
pressure to provide 27 mg (90%) of 100 as a brown gum. This material was pure by 1H 
NMR and was directly used in the next step. 
IR (neat): 2973, 2364, 2328, 2254, 1699, 1599, 1508, 1257, 1169, 907, 728 cm-1. 
 
(6R,8R)-8-(3,4-Dimethoxyphenyl)-6-hydroxy-8-nitro-4-oxooctylmethanesulfonate  
(106): 
NO2 OH
OMe
MeO
OMs
O  
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To a stirred solution of 85 (50 mg, 0.129 mmol) in dichloromethane (1 mL), at -78 oC, was 
added collidine (35µL) followed by methanesulfonyl chloride (10µL, 0.164 mmol) in 
dichloromethane (1 mL) over 15 min at -78 oC. The reaction mixture was warmed up to 
ambient temperature. Cold water (3 mL) was added and the organic layer was separated, 
washed with water (3 mL), brine (3 mL), dried (Na2SO4) and concentrated to provide 40 
mg (67%) of the crude mesylate 104 as a yellow gum. This was immediately used in the 
next step 
To a solution of 104 (145 mg, 0.31 mmol) in acetone (2 mL) was added iodine (4.0 mg, 
0.014 mmol) and the solution was stirred at ambient temperature for 2 h. The acetone was 
removed under reduced pressure and the residue was diluted with dichloromethane (5 mL). 
The resulting solution was washed successively with aqueous Na2S2O3 (5% w/v, 2 mL) and 
brine (2 mL). The organic layer was dried (Na2SO4) and concentrated under reduced 
pressure to provide 100 mg (77%) of the 106 as a yellow liquid. This material was pure by 
1H NMR and was directly used in the next step. 
1H NMR (300 MHz, CDCl3): δ 7.02 (dd, 1H, J = 8.3, 2.2, ArH), 6.97 (d, 1H, J = 2.1, ArH), 
6.85 (d, 1H, J = 8.3, ArH), 5.83 (dd, 1H, CHNO2), 4.27 (t, 2H, J = 6.1, CH2OMs), 4.14-
4.06 (m, 1H), 3.91 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 3.01 (s, 3H, OSO2CH3), 2.74-2.55 
(m, 4H, CH2CHOH, CH2COCH2), 2.09-1.93 (m, 4H, CH2CH2CH2OMs, CH2CH2OMs). 
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(R)-3-(2-(4-(3,4-Dimethoxyphenyl)-2-hydroxy-4-oxobutyl)-1,3-dioxolan-2-yl)propyl 
methanesulfonate (107): 
 
To a solution of mesylate 104 (13 mg, 0.02 mmol) in DMSO (0.25 mL) was added sodium 
cyanide (3 mg, 0.05 mmol) at ambient temperature. The reaction mixture was stirred at 
ambient temperature for one hour. Then the reaction mixture was washed with 0.5 mL of 
water and extracted with (2 x 3 mL) of ethyl acetate. The organic layer was separated and 
dried (Na2SO4). It was then concentrated under reduced pressure and the crude 107 was 
obtained as a yellow gum. 
1H NMR (300 MHz, CDCl3): δ 7.62 (d, 1H, J = 8.4, ArH), 7.56 (s, 1H, ArH), 6.92 (d, 
1H, J = 8.4, ArH), 4.30 (t, 2H, J = 6.0, CH2OMs), 4.05-4.01 (m, 4H, OCH2CH2O), 3.98 
(s, 3H, OCH3), 3.96 (s, 3H, OCH3), 3.66 (s, 1H, CHOH), 3.22 (dd, 1H, J = 16.8, 6.2, 
COCH2), 3.07 (dd, 1H, J = 16.8, 6.2, COCH2),  3.04 (s, 3H, OSO2CH3), 1.99-1.88 (m, 
6H, CH2(C)CH2, CH2CH2CH2OMs, CH2CH2CH2OMs). 
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(2R,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-(3-hydroxypropyl)piperidin-4-ol (91): 
 
To the solution of nitroketone 89 (1.33 g, 3.9 mmol) in THF (25 mL) was added a 
solution of NH4Cl (208 mg, 3.9 mmol) in water (3.6 mL) followed by activated Zn powder 
(2.53 g, 39.0 mmol). The mixture was stirred vigorously at ambient temperature under 
nitrogen for 3 h. The mixture was then filtered through a pad of celite, the residue was 
washed with THF, and the combined filtrates were concentrated under reduced pressure to 
provide 1.04 g of an inseparable mixture of 90 (piperidine) and 92 (N-hydroxy piperidine) 
as a pale yellow foam. This was used in the next step without purification. 
To a solution of 90+92 (1.04 g) in MeOH (18 mL) at 0 ºC was added sodium 
borohydride (530 mg, 14.2 mmol). The mixture was stirred at 0ºC for 30 min. and then at 
ambient temperature for 2 h. Aqueous HCl (2 M, 15 mL) was added and the mixture was 
concentrated under reduced pressure to remove MeOH. The resulting aqueous mixture was 
basified (pH~10) with solid NaOH and then extracted with ethyl acetate (3 x 25 mL). The 
combined extracts were dried (Na2SO4) and concentrated to provide 0.89 g of a mixture of 
91 and the corresponding N-hydroxy piperidine 109 as a white gum. This was dissolved in 
a mixture of EtOH (15 mL) and saturated aqueous NH4Cl (7 mL). Indium powder (0.65 g, 
5.7 mmol) was added and mixture was heated at 85 oC for 4h. The mixture was then cooled, 
filtered through a pad of celite, and concentrated. Saturated aqueous Na2CO3 (5 x 3 mL) 
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was added to the residue and the mixture was extracted with ethyl acetate (2 x 15 mL). The 
combined extracts were dried over (Na2SO4) and concentrated to provide 0.81 g (70%) of 
the amine 91 as a colorless gum. This was pure by 1H NMR and was used in the next step 
without purification. 
Rf  = 0.25 (CH2Cl2/MeOH, 95:5); [α]D20 = +12.4 (c 1, CHCl3); IR (neat): 3342 (br), 2936, 
2840, 1517, 1453, 1421, 1263, 1163, 1143, 1026 cm-1; 1H NMR (300 MHz, CDCl3): δ 
6.93-6.81 (m, 3H, ArH), 3.89 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.90-3.80 (m (overlaps 
with OCH3 singlets), 1H, CHOH), 3.69 (dd, 1H, J =11.7, 2.4, ArCH), 3.60-3.55 (m, 2H), 
2.90-2.80 (m, 1H), 2.25-2.15 (m, 1H), 2.05-1.96 (m, 2H), 2.15-1.95 (br, 1H, NH), 1.70-
1.60 (m, 5H, CH2CH2OH), 1.52 (m, 1H, J = 11.6, CH2CH2CH2OH), 1.35 (m, 1H, J = 11.6, 
CH2CH2CH2OH);13C NMR (75 MHz, CDCl3): 149.0 (ArCipso), 148.3 (ArCipso), 
135.6(ArCipso), 118.6 (ArC), 111.1 (ArC), 110.1 (ArC), 69.3 (CHOH), 62.7 (CH2OH), 59.1 
(ArCH), 55.9 (2 x OCH3), 54.8 (CHNH), 42.8, (ArCHCH2), 40.7 (CH2CHOH), 35.1 
(CH2CH2OH), 29.4 (CH2(CH2)2OH). MS (APCI, pos.): 296.2 (M+1)+; HRMS (EI, pos.): 
m/z 295.1774 (295.1784 calc. for C16H25NO4(M+)). 
(2R,4S,6R)-2-(3,4-Dimethoxyphenyl)-4-hydroxy-6-(3-hydroxypropyl)piperidine-1-
carbaldehyde (112): 
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To a cooled (0 oC) solution of the amino diol 91 (0.76 g, 2.6 mmol) in 
dichloromethane (18 mL) was added acetic formic anhydride (0.46 mL, 5.1 mmol). The 
solution was stirred at ambient temperature for 15 min. and then concentrated under 
reduced pressure to provide 0.88 g of the formamido diformate derivative of 110 as a 
yellow gum. This was dissolved in THF (15 mL), 1M NaOH (15 mL) was added and the 
mixture was stirred at ambient temperature for 2 h. The THF was removed under reduced 
pressure, the residue was dissolved in dichloromethane (30 mL) and the solution was 
washed with water (2 ×5 mL), dried (Na2SO4) and concentrated. The residue was purified 
by flash column chromatography on silica gel (CH2Cl2/MeOH, 95:5) to provide 745 mg 
(92%) of 112 as a colorless gum. 
Rf  = 0.30 (CH2Cl2/MeOH, 95:5); [α]D20 = +42.0 (c 1, CHCl3); IR (neat): 3379 (br), 2937, 
2872, 1642, 1515, 1462, 1418, 1254, 1142, 1063, 1023, 911 cm-1; 1H NMR (500 MHz, 
CDCl3): δ 8.16 (br s, 1H, CHO), 7.20-6.75 (br m, 3H, ArH), 4.75-4.60 (br, 0.5H), 4.35-
4.30 (br, 0.5H), 4.17-4.08 (m, 1H), 3.87 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.70-3.40 (br, 
2H), 2.45-2.15 (br, 4H), 2.05-1.96 (m, 2H), 1.95-1.80 (br, 1H), 1.75-1.65 (m, 1H), 1.65-
1.25 (br, 3H). 13C NMR (75 MHz, CDCl3): 164.0-163.0 (br), 149.0-147.5 (br), 134.0-
133.0 (br), 119.2, 112.0-110.0 (br), 64.7, 61.9 (br), 56.7-56.0 (br), 55.96, 55.92, 49.8 (br), 
37.3 (br), 35.4 (br), 34.2-33.0 (br), 32.8 (br), 29.3 (br). MS (CI, pos.): 324.2 (M+1)+; 
HRMS (APPI, pos.): m/z 323.1737 (323.1733 calc. for C17H25NO5 (M+)). 
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4-((2R,4S,6R)-6-(3,4-Dimethoxyphenyl)-1-formyl-4-hydroxypiperidin-2-
yl)butanenitrile (114): 
 
To a stirred solution of 112 (745 mg, 2.30 mmol) in dichloromethane (15 mL), at 0 
oC, was added DIPEA (0.4 mL) followed by methanesulfonyl chloride (0.18 mL, 2.30 
mmol) in dichloromethane (10 mL) over 15 min. Stirring was continued at 0 oC  for 3 h. 
Cold water (7 mL) was added and the organic layer was separated, washed with water (3 x 
15 mL), brine (1 x 15 mL), dried (Na2SO4) and concentrated to provide 0.76 g of the crude 
mesylate 113 as a yellow gum. This was immediately used in the next step. 
To a solution of the mesylate 113 (0.76 g, 1.9 mmol) in anhydrous DMSO (15 mL) at 
ambient temperature was added NaCN (0.93 g, 18.9 mmol). The mixture was stirred at 
ambient temperature for 15 h. Ethyl acetate was added to the reaction mixture and the 
solution was washed with water (3 x 30 mL), brine (30 mL) and then dried (Na2SO4) and 
concentrated. The residue was purified by flash chromatography on silica gel (EtOAc) to 
provide 349 mg (55%) of 114 as a colourless gum. 
Rf  = 0.20 (EtOAc); [α]D20 = +8.0 (c 0.7, CHCl3); IR (neat): 3407 (br), 2938 (br), 2247, 
1643, 1515, 1459, 1419, 1256, 1143, 1077, 1024, 916 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 8.20 (br s, 1H, CHO), 7.25-6.75 (br m, 3H, ArH), 4.80-4.70 (br, 0.5H), 4.30-4.25 (br, 
0.5H), 4.22-4.18 (m, 1H), 3.88 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 2.50-1.75 (br, 7H), 
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1.75-1.50 (br, 5H). 13C NMR (75 MHz, CDCl3):  164.1 (br), 163.2 (br), 149.9-147.5 (br), 
133.4 (br), 120.0-119.5 (br), 119.3, 64.9, 56.01, 55.96, 48.7 (br), 36.8-36.3 (br), 36.1-
35.7(br), 35.7-35.4 (br), 35.4-35.0 (br), 33.0-32.0 (br), 22.59, 16.8. MS (APCI, pos.): 333.2 
(M+1)+; HRMS (APPI, pos.): m/z 332.1733 (332.1736 calc. for C18H24N2O4(M+)). 
Methyl-4-((2R,4S,6R)-6-(3,4-dimethoxyphenyl)-4-hydroxypiperidin-2-yl)butanoate 
(115): 
 
A solution of nitrile 114 (0.349 g, 1.0 mmol) in methanolic HCl (3 M, 14 mL) was 
heated to reflux for 72 h. The methanol was removed under reduced pressure and the 
residue was neutralized with saturated aqueous sodium bicarbonate (2 × 10 mL). The 
resulting mixture was extracted with ethyl acetate (2 x 15 mL). The combined organic 
layers were dried (Na2SO4) and concentrated. The residue was purified by flash 
chromatography on silica gel (CH2Cl2/MeOH, 95:5) to provide 285 mg (80%) of 115 as a 
colorless gum. In repeated preparations, the crude product was of sufficient purity to be 
directly used in the next step. 
Rf  = 0.25 (CH2Cl2/MeOH, 95:5); [α]D20 = + 29.8 (c 0.5, CHCl3); IR (neat): 3377 (br), 2929, 
2847, 1733, 1515, 1452, 1368, 1308, 1259, 1157, 1029 cm-1;1H NMR (500 MHz, CDCl3): 
δ 6.94 (d, 1H, J = 2.0, ArH), 6.89 (dd, 1H, J = 8.2, 2.0, ArH), 6.82 (d, 1H, J = 8.2, ArH), 
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3.90 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 3.82-3.75 (m, 1H, CHOH), 3.66 (s, 3H, CO2CH3), 
3.61 (dd, 1H, J = 11.5, 2.4, ArCH), 2.74-2.71 (m, 1H, CHNH), 2.33 (t, 2H, J = 7.4, 
CH2CO2CH3), 2.11-2.08 (m, 1H), 2.05-2.02 (m, 1H), 1.75-1.65 (m, 2H), 1.55-1.70 (br, 
NH), 1.54-1.48 (m, 2H, CH2CH2COOMe), 1.46 (q (overlaps with m), 1H, J = 11.3, 
CH2CH2CH2COOMe), 1.15 (q, 1H, J = 11.3, CH2CH2CH2COOMe). 13C NMR (125 MHz, 
CDCl3): 173.9 (CO), 149.0 (ArCipso), 148.3 (ArCipso), 136.6 (ArCipso), 118.8 (ArC), 111.0 
(ArC), 110.0 (ArC), 69.7 (CHOH), 59.4 (ArCH), 55.95 (OCH3), 55.93 (OCH3), 55.0 
(CO2CH3), 51.6 (NCH), 43.7 (CHCH2), 41.3 (CHCH2), 36.1 (NCHCH2CH2), 34.0 
(NCHCH2CH2), 21.4 (CH2CO2CH3). MS (APCI, pos.): 338.2 (M+1)+; HRMS (APPI, 
pos.): m/z 337.1881 (337.1889 calc. for C18H27NO5(M+)). 
4-((2R,4S,6R)-6-(3,4-Dimethoxyphenyl)-4-((triisopropylsilyl)oxy)piperidin-2-
yl)butan-1-ol (117): 
 
To a solution of the aminoester 115 (285 mg, 0.84 mmol) in dichloromethane (12 
mL) at   0 oC was added DIPEA (0.15 mL, 0.85 mmol) followed by TIPSOTf (0.25 mL, 
0.93 mmol) and the mixture was stirred at ambient temperature for 4 h. Dichloromethane 
(15 mL) was added and the solution was washed with water (10 mL). The organic layer 
was dried (Na2SO4) and concentrated to provide 375 mg of the crude TIPS ether of 116. 
This was used immediately in the next step without purification. 
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To a solution of the TIPS ether 116 (375 mg, 0.76 mmol) in dry THF (6 mL) at 0 
ºC was added LiBH4 (33 mg, 1.5 mmol) and the mixture was stirred at ambient temperature 
for 12 h. Aqueous HCl (0.1 M, 6 mL) was added, the mixture was stirred for 15 mins. and 
then neutralized with aqueous NaOH (6 M). The resulting mixture was extracted with ethyl 
acetate (2 x 15) and the combined extracts were dried (Na2SO4) and concentrated to provide 
0.25 g (71%) of 117 as an oil. This was pure by 1H NMR and was used in the next step 
without purification. 
Rf  = 0.25 (CH2Cl2/MeOH, 95:5); [α]D20 = +5.0 (c 1, CHCl3); IR (neat): 3318 (br), 2939, 
2864, 1516, 1463, 1379, 1264, 1231, 1140, 1108, 1065, 1029, 996 cm-1;1H NMR (300 
MHz, CDCl3): δ 6.98 (br s, 1H, ArH), 6.89 (dd, 1H, J = 8.2, 1.9,ArH), 6.81 (d, 1H, J = 8.2, 
ArH), 3.91 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.80-3.87 (m, 1H, CHOH), 3.64-3.52 (m, 
3H), 2.75-2.50 (m, 1H), 2.10-1.90 (m, 1H), 1.87-1.35 (m, 12H, ArH), 1.30-1.20 (m, 1H), 
1.06 (br s, 18H, CH(CH3)2). 13C NMR (75 MHz, CDCl3):  149.0 (2 x ArCipso), 148.4 
(ArCipso), 119.2 (ArC), 111.0 (ArC), 110.4 (ArC), 70.00, 70.02 (CHOSi), 62.6 (CH2OH), 
59.8 (ArCH), 56.01 (OCH3), 55.96 (OCH3), 55.5 (CHNH), 43.8 (SiOCHCH2), 41.9 
(SiOCHCH2), 36.2 (CH2CH2CH2CH2OH, or CH2CH2CH2CH2OH), 
32.5(CH2CH2CH2CH2OH, or CH2CH2CH2CH2OH), 22.2(CH2CH2CH2CH2OH), 18.13 
(CH(CH3)2), 12.4 (CH(CH3)2). MS (APCI, pos.): m/z 466.3 (M+1)+; HRMS (APPI, pos.): 
m/z 465.3263 (465.3274 calc. for C26H47NO4Si(M+)). 
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(2S,4R,9aR)-4-(3,4-Dimethoxyphenyl)-2-(triisopropylsilyloxy)octahydro-1H-
quinolizine (119)3j: 
 
To a solution of the aminoalcohol 117 (250 mg, 0.53 mmol) in dry THF (5 mL), at 
–5 oC under nitrogen, was added Ph3P (282 mg, 1.07 mmol) followed by DMEAD (252 
mg, 1.07 mmol). The mixture was stirred at ambient temperature for 3 h and concentrated. 
The residue was dissolved in ethyl acetate (5 mL) and the solution was washed with water 
(7 mL). The organic layer was separated, dried (Na2SO4) and concentrated. The residue 
was purified by flash chromatography on silica gel (hexanes/EtOAc, 80:20) to give 166 
mg (70%) of 119 as a colorless gum. 
Rf   = 0.25 (hexanes/EtOAc, 80:20); [α]D23= +53.3 (c 0.3, CHCl3, lit.1 [α]D23= – 48.6 (c 0.15, 
CHCl3) for the enantiomer); IR (neat): 2936, 2864, 1510, 1463, 1382, 1263, 1230, 1110, 
1070, 1031, 910, 882, 815 cm-1;1H NMR (500 MHz, CDCl3): δ 7.10-6.75 (br m, 3H, ArH), 
3.89 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.81-3.75 (m, 1H), 2.85 (dd, 1H, J =11.8, 2.7), 
2.68-2.63 (apparent br d, 1H, J = 11.5), 1.97-1.82 (m, 3H), 1.71-1.55 (m, 6H), 1.55-1.35 
(m, 5H), 1.27-1.19 (m,1H), 1.04 (br s, 18H, CH(CH3)2). Spectrum matches Aube’s. 
Integration listing in aliphatic region does not match Aube’s, but his listing also does not 
match his actual spectrum.13C NMR (75 MHz, CDCl3):  147.9 (ArC), 137.3 (ArC), 120.0-
119.0 (br, ArC), 111.0-110.0 (br, ArC), 69.1, 68.4, 61.1 (ArCH), 56.0(OCH3), 55.9 
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(OCH3), 53.1 (CHNH), 45.8, 43.7, 33.8, 26.2, 24.7, 18.1 (CH(CH3)2), 12.4 (CH(CH3)2). 
Agrees with Aube, also looks like Aube’s spectrum which also has broad peaks, but lists 4 
peaks that are not seen in the actual spectrum. MS (APCI, pos.): 448.3 (M+1)+. HRMS 
(APPI, pos.): m/z 447.3169 (447.3169 calc. for C26H45NO3Si(M+)). 
(2S,4R,9aR)-4-(3,4-Dimethoxyphenyl)octahydro-1H-quinolizin-2-ol(2-epi-lasubine 
II, 46): 
 
To the solution of 119 (162 mg, 0.36 mmol) in anhydrous THF (5 mL), at 0 oC, was 
added a solution of tetrabutylammonium fluoride in THF (0.36 mL of a 1.0 M solution, 
0.36 mmol). The mixture was stirred at ambient temperature for 3 h and then concentrated. 
The residue was purified by flash chromatography on silica gel (CH2Cl2/MeOH, 95:5) to 
provide 85 mg (81%) of 46 as clear colorless oil. 
Rf  = 0.25 (CH2Cl2/MeOH, 95:5)[α]D20 = +47.9 (c 0.6, CHCl3, lit.3b [α]D20 = +43.4 (c 1.0, 
CHCl3));IR (neat): 3363 (br), 2929, 2852, 2790, 1512, 1454, 1382, 1363, 1263, 1230, 1137, 
1059, 1030 cm-1;1H NMR (500 MHz, CDCl3): δ 7.10-6.75 (br m, 3H), 3.89 (s, 3H), 3.86 
(s, 3H), 3.75 (m, 1H), 2.92 (br d, 1H, J = 11.0), 2.70 (br d, 1H, J = 11.0), 2.05-1.90 (brm, 
3H), 1.75-1.35 (br m, 9H), 1.25 (m, 1H); agrees well with Ma3k, Rovis.3b 13C NMR (75 
MHz, CDCl3):  147.9(ArCipso), 136.4 (ArCipso), 120.0-119.4 (br, 2 x ArC), 111.0 110.5 
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(br, 2 x ArC), 68.5, 68.2, 61.0 (ArCH), 55.99 (OCH3), 55.86 (OCH3), 52.9 (CHNH), 45.2, 
42.8 (OCHCH2), 33.6, 26.0, 24.6. agrees well with Rutjes, Chattopadhyay. MS (APCI, 
pos.): 292.1 (M+1)+; HRMS (APPI, pos.): m/z 291.1842 (291.1834 calc. for 
C17H25NO3(M+)). 
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3.7 Selected 1H NMR and 13C NMR Spectra 
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Chapter 4 
 
 
 
 
 
 
Synthesis of Fistulopsine B: Application of an Organocatalytic Michael 
Addition Reaction 
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4.1 Introduction 
 The indolizidine motif is a prominent structural unit in numerous alkaloids1 and 
also constitutes a major class of glycosidase inhibitors.2 In addition, several indolizidines 
have an interesting biological profile which includes antibacterial, antiviral, antitumor and 
antidiabetic properties.3 Aryl-substituted indolizidines are also of interest; either as 
bioactive natural products4 or as peptidomimetics.5 Accordingly, the synthesis of 
arylindolizidines continues to be intensely investigated and general synthetic strategies 
toward aryl-fused6 or aryl-substituted indolizidines7 as well as other functionalized8 
indolizidines have been reported.9 Recently, two arylindolizidine alkaloids (−)-fistulopsine 
A (1, Figure 4.1) and (+)-fistulopsine B (2), which are structurally similar to the 
arylindolizidine alkaloid (+)-septicine (3), were isolated from the bark and the leaves of 
Ficus fistulosa.10 Fistulopsine A and B have potent in vitro antiproliferative activity against 
breast (MCF7) and colon (HCT 116) carcinoma cell lines.11 
 
Figure 4.1: Structures of (-)-fistulopsine A, (+)-fistulopsine B and (+)-septicine. 
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4.2 Objective 
Our interest in indolizidines stems from our studies on the organocatalytic synthesis 
of -nitroketones from cyclic ketones and 2-nitrovinylarenes via an enamine-based Michael 
addition reaction as shown in Scheme 4.1.12 This Michael addition reaction has been 
extensively studied and the development of new catalysts for the process continues at a 
remarkable pace.13  
 
Scheme 4.1   
Undoubtedly, the full potential of organocatalytic ketone-nitroalkene will be 
realized only when the -nitroketone products are utilized in target-oriented synthesis, but 
this has been relatively unexplored.14 We therefore chose to examine the application of a 
suitably functionalized -nitroketone 6 (Scheme 4.2) in the synthesis of (+)-fistulopsine B. 
At the time of writing this thesis, the synthesis of (+)-fistulopsine B had not been reported. 
 
Scheme 4.2 
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4.3 Results and Discussion 
 The strategy for the synthesis of fistulopsine B follows our previously reported 
synthesis of the diarylindolizidine alkaloids (+)-ipalbidine and (+)-antofine.15 A 
retrosynthetic analysis is provided in Figure 4.2. 
 
Figure 4.2 Retrosynthetic analysis for fistulopsine B. 
According to our synthetic plan, fistulopsine B (the target alkaloid A) could be 
obtained from the ketone B by conversion to an enol triflate and cross-coupling with an 
aryl partner. Compound B could be constructed from the trisubstituted piperidine C by the 
cyclization of a suitable side chain, followed by oxidation of the alcohol. Compound C 
could be obtained from a diastereomerically pure acyclic precursor D by reductive 
cyclization involving the nitro group and the ketone. Compound D derives from lactone E 
by reductive ring opening followed by methanolysis and deprotection of the ketal.  Finally, 
lactone E derives from a Baeyer-Villiger oxidation of the -nitroketone F which, in turn, 
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could be obtained from the organocatalytic Michael addition of a monoprotected 1,4-
cyclohexanedione G to a -nitrostyrene H (Figure 4.2). 
Our studies thus began with the synthesis of an appropriate -nitroketone starting 
material for fistulopsine B. Accordingly, the organocatalytic Michael addition of 
cyclohexane-1,4-dione monoethylene ketal (7) and 4-hydroxy-3-methoxy-β-nitrostyrene16 
(8), employing the triamine catalyzed protocol13 developed in the Pansare group, provided  
nitroketone 9 in good yield and stereoselectivity (er = 91/9, dr > 19/1).  
 
Scheme 4.3 
Somewhat unexpectedly, the Baeyer-Villiger oxidation of nitroketone 9 was 
unsuccessful (Scheme 4.4). Instead, complete decomposition of 9 was observed and the 
anticipated lactone 10 could not be detected in the crude reaction mixture. Although the 
precise reasons for the decomposition of 9 are not known, it is possible that the phenol 
functionality in 9 is incompatible with the peracid used in the reaction. Some support for 
this hypothesis was provided by the observation that conversion of 9 to the corresponding 
acetate 11 (53%), by reaction with acetic anhydride in the presence of Sc(OTf)3 in 
acetonitrile, was beneficial. Thus, the Baeyer-Villiger oxidation of 11 provided the lactone 
212 
 
12 in good yield (81%). Methanolysis of 12 resulted in lactone ring opening to provide the 
nitroester 13 (78%). Subsequent hydrolysis of the ketal and concomitant deacetylation in 
13 generated the highly functionalized octanoate 14 (Scheme 4.4, 55% over two steps) that 
has all the required carbon atoms for the indolizidine framework of fistulopsine B. 
 
Scheme 4.4 
With the functionalized octanoate 14 in hand, its conversion to the key trisubstituted 
piperidine intermediate B (see retrosynthetic Figure 4.2) was investigated next. Toward 
this goal, and as in our previous studies,16 we attempted a reductive cyclization involving 
the nitro group and the ketone in 14. Unfortunately, the attempted reduction of nitroketone 
14 with zinc in aqueous ammonium chloride resulted in decomposition of 14 and the 
expected nitrone 15 was not obtained (Scheme 4.5).  
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Scheme 4.5 
Since the only difference between 14 and some of our previously, successfully, 
studied substrates for the reductive cyclization in the presence of the free phenolic 
functionality, it was reasonable to assume that an O-protected version of 14 would be more 
suitable for our purposes. Also, as the O-acetyl derivative 13 was deacetylated during 
hydrolysis of ketal, and since the phenyl acetate functionality was considered to be 
generally unsuitable, due to its reactivity, for subsequent transformations, we decided to 
employ a more robust protecting group for the phenol. Accordingly, the nitrostyrene 16 (4-
benzyloxy-3-methoxy-β-nitrostyrene,17 Scheme 4.6), in which the problematic phenolic 
functionality is protected as a benzyl ether, was chosen as the starting material for our 
modified synthetic approach.  
 As expected, the organocatalytic Michael addition of 7 to 16 employing our 
triamine catalyzed protocol,13 provided nitroketone 17 in good yield and stereoselectivity 
(er = 94/6, dr> 19/1, Scheme 4.6). Baeyer-Villiger oxidation of 17 provided lactone 18 in 
excellent yield (95%). Methanolysis of 18 and subsequent hydrolysis of the ketal generated 
the highly functionalized octanoate 20 (Scheme 4.6, 90% over two steps) that has all the 
required carbon atoms for the indolizidine framework. Gratifyingly, reductive cyclization 
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of nitroketone 20, with zinc in aq. ammonium chloride, was successful and provided  
nitrone 21 in 60% yield (Scheme 4.6).  
 
Scheme 4.6 
In the next crucial, and stereochemistry defining step, nitrone 21 was anticipated to 
undergo a stereoselective reduction due to its 1,3 disposition with the secondary alcohol 
stereocenter. Thus, treatment of 21 with Me4NBH(OAc)3 provided hydroxyl amine 22 
(80%) as a single diastereomer, presumably via a hydroxyl-directed reduction18 (Scheme 
4.7). At this stage, 22 was assigned the shown stereochemistry which was assumed to 
derive from an intramolecular hydroxyl-directed reduction of 21. Notably, this reduction 
sets a stereocenter that would be ultimately retained in the target fistulopsine B. 
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Scheme 4.7 
With the key piperidine 22 in hand, its conversion to the indolizidine framework 
was examined next. Reduction of the N-O bond in 22 was achieved with indium metal to 
provide a mixture of the amino ester 23 and the corresponding indolizidine 24 resulting 
from cyclization of the amino ester. This product mixture was treated with DIPEA in 
refluxing THF to complete the lactamization and provide 24 (Scheme 4.8). 
 
Scheme 4.8 
Oxidation of 24 (Dess-Martin periodinane) provided ketolactam 25 (80%). 
Conversion of 25 to enol triflate 26 followed by a Suzuki-Miyaura coupling19 of 26 with 
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4-hydroxy-3-methoxyphenylboronic acid pinacolate20 27 furnished lactam 28. 
Debenzylation of 28 with H2, 10% Pd/C provided lactam 29 which is an amido analogue 
of fistulopsine B. Unfortunately, attempted reduction of amide 29 led to a complex mixture 
of products which did not contain any of the desired product Fistulopsine B (Scheme 4.9). 
 
Scheme 4.9 
In an alternative approach, amide 28 was first reduced to O-benzyl Fistulopsine B 
(30) in 40% yield. Debenzylation of 30 with Raney Nickel21 in ethanol provided the target 
molecule, (+)-fistulopsine B, 2, in 45% yield. Spectroscopic data for the synthetic sample 
is in agreement with reported12 data for (+)-fistulopsine B isolated from the natural source. 
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Scheme 4.10 
 The fistulopsine B obtained from this synthesis has a small amount of an impurity 
that is seen only in the 13C NMR (peak at  29.7, see Section 4.7). This impurity could not 
be easily removed. Since the amount of fistulopsine available to us was the limiting factor, 
the synthesis is currently being repeated to obtain fistulopsine B in amounts that are 
sufficient for a more rigorous purification. It may be noted that similar difficulties have 
been encountered during the synthesis of other, highly polar, tertiary amine-containing 
alkaloids.22  
4.4 Conclusion 
In conclusion, an organocatalytic Michael addition based, first enantioselective 
total synthesis of the recently isolated indolizidine alkaloid (+)-Fistulopsine B was 
accomplished (13 steps, 1% overall yield). This approach has potential applications in the 
synthesis of analogs of Fistulopsine B by changing the aryl cross-coupling partner. 
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4.5 Experimental section 
(S)-7-((R)-1-(4-(Hydroxy)-3-methoxyphenyl)-2-nitroethyl)-1,4-dioxaspiro[4.5]decan- 
8-one (9): 
 
To a solution of 1,4-cyclohexanedione monoethylene ketal (2.00 g, 12.8 mmol), N1,N1- 
dimethyl-N2-(((S)-pyrrolidin-2-yl)methyl)ethane-1,2-diamine (88.0 mg, 0.512 mmol) and 
p-toluene sulfonic acid monohydrate (97 mg, 0.512 mmol) was added a solution of 4-
hydroxy-3-methoxy-β-nitrostyrene 8 (0.500 mg, 2.56 mmol) in DMF (5 mL) and the 
resulting solution was stirred at ambient temperature for 5 d. Ethyl acetate (25 mL) was 
added and the solution washed with water, dried (Na2SO4) and concentrated under reduced 
pressure. The residue was purified by flash column chromatography on silica gel (55/45 
hexanes/EtOAc) to provide 0.720 g (80%) of nitroketone 9 as a white foam with 91% ee. 
1H NMR (300 MHz, CDCl3): δ 6.86 (d, 1H, J = 8.6, ArH), 6.66-6.63 (m, 2H, ArH), 5.63 
(s, 1H, OH), 4.91 (dd, 1H, J = 12.3, 4.7, CH2NO2), 4.56 (dd, 1H, J = 12.3, 9.8, CH2NO2), 
3.98-3.86 (m, 4H, OCH2CH2O), 3.86 (s, 3H, OCH3), 3.74 (dt, 1H, J = 9.8, 4.7, ArCH), 
3.06-2.96 (m, 1H, COCH), 2.75-2.64 (m, 1H, COCH2), 2.49-2.41 (m, 1H, COCH2), 2.05-
1.94 (m, 2H, CHCH2), 1.76-1.69 (m, 1H, CH2CH2), 1.55 (t, 1H, J = 13.1, CH2CH2); 13C 
NMR (75 MHz, CDCl3): δ 210.5 (CO), 146.7 (ArCipso), 145.1 (ArCipso), 129.0 (ArCipso), 
120.4 (ArCH), 114.9 (ArCH), 111.2 (ArCH), 107.1 (OCO), 79.1 (CH2NO2), 64.8 
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(OCH2CH2O), 64.6 (OCH2CH2O), 55.9 (OCH3), 48.3 (COCH), 43.2 (CHCH2NO2), 39.3 
(COCH2), 38.7 (CH2), 35.1 (CH2); HRMS (APPI): m/z 351.1326 (351.1318 calc. for 
C17H21NO7 [M]+), 352.1392 (352.1396 calc. for C17H22NO7 [M+H]+). HPLC (Chiralpak 
AS-H, hexanes/2-propanol: 60/40, flow rate 1.0 mL/min, 254 nm): tminor = 10.61 min, tmajor 
= 14.30 min, ee = 91 %, dr = 20:1 (average value from multiple reactions). 
(S)-7-((R)-1-(4-(Acetoxy)-3-methoxyphenyl)-2-nitroethyl)-1, 4-dioxaspiro [4.5]  
decan-8-one (11): 
O
OH
O
O2N
AcO OMe
 
To the solution of nitroketone 9 (100 mg, 0.280 mmol) in CH3CN at 0 °C was added acetic 
anhydride (40.0 L, 0.42 mmol) followed by Sc(OTf)3 (1.4 mg, 0.0028 mmol). The 
mixture was stirred for 30 min at 0 °C and then at ambient temperature for 2 h. The reaction 
mixture was cooled to 0 °C, water was added followed by ethyl acetate (15 mL). The 
resulting mixture was washed with water (10 mL). The organic layer was separated, dried 
(Na2SO4) and concentrated under reduced pressure. The residue was purified by flash 
column chromatography on silica gel (60/40 hexanes/Ethyl acetate) to provide 72 mg 
(65%) of acetate 11 as yellow foam. 
1H NMR (300 MHz, CDCl3): δ 6.99 (d, 1H, J = 8.1, ArH), 6.78 (d, 1H, J = 1.9, ArH), 6.73 
(dd, 1H, J = 8.1, 2.0, ArH), 4.90 (dd, 1H, J = 12.7, 4.8, CH2NO2), 4.62 (dd, 1H, J = 12.7, 
9.6, CH2NO2), 3.99-3.86 (m, 4H, OCH2CH2O), 3.81 (s, 3H, OCH3), 3.81-3.79 (m, 1H, 
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CH2CH2), 3.10-3.01 (m, 1H, ArCH), 2.75-2.64 (dt, 1H, J = 13.3, 6.6, COCH), 2.48-2.42 
(m, 1H, COCH2), 2.30 (s, 3H, OCOCH3), 2.05-1.94 (m, 2H, COCH, CH2), 1.78-1.71 (m, 
1H, CHCH2), 1.59 (t, 1H, J = 13.1, CH2CH2). 
(S)-7-((R)-1-(4-(Acetoxy)-3-methoxyphenyl)-2-nitroethyl)-1,4,8-
trioxaspiro[4.6]undecan-9-one (12): 
 
To a solution of acetate 11 (50.0 mg, 0.12 mmol) in anhydrous dichloromethane (3 mL) at 
ambient temperature was added solid sodium phosphate (44.0 mg, 0.16 mmol) followed 
by m-chloroperbenzoic acid (~77%, 68.0 mg, 0.39 mmol). The resulting white slurry was 
stirred vigorously at ambient temperature for 16 h. Dichloromethane (3 mL) was added 
and the mixture was washed with aq. NaHCO3 (2 x 5 mL). The organic layer was dried 
(Na2SO4) and concentrated under reduced pressure. The residue was purified by flash 
column chromatography on silica gel (1:1 hexanes/EtOAc) to provide 42.0 mg (81%) of 
12 as a yellow foam. 
1H NMR (300 MHz, CDCl3): δ 7.02 (dd, 1H, J = 7.4, 1.0, ArCH), 6.84-6.81 (m, 2H, ArCH), 
4.95 (dd, 1H, J = 13.0, 4.7, CH2NO2), 4.76 (dd, 1H, J = 13.0, 9.1, CH2NO2), 4.80-4.72 (m, 
1H, (CO)OCH), 3.89-3.79 (m, 3H, OCH2CH2O), 3.84 (s, 3H, OCH3), 3.68-3.54 (m, 2H, 
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ArCH, OCH2CH2O), 2.88-2.78 (m, 1H, CH2CO), 2.66-2.58 (m, 1H, CH2CO), 2.30 (s, 3H, 
OCH3), 1.94-1.90 (m, 2H, COCH2(C)CH2, 1.87-1.85 (m, 2H, CH2(C)CH2). 
Methyl 3-(2-((2S, 3R)-3-(4-(acetoxy)-3-methoxyphenyl)-2-hydroxy-4-nitrobutyl)-1,3-
dioxolan-2-yl)propanoate (13): 
 
A solution of the lactone 12 (42 mg, 0.10 mmol) in methanol (1 mL) was cooled to 0 °C 
and potassium carbonate (28 mg, 0.20 mmol) was added. The mixture was stirred at 
ambient temperature for 2 h. The mixture was cooled to 0 °C, neutralized with aq. HCl (0.5 
M) and the solution was extracted with dichloromethane (2 × 5 mL). The combined organic 
layers were dried (Na2SO4) and concentrated to provide 35 mg, (78%) of nitroketal 13 as 
a light brown gum. This material was pure by 1H NMR and was directly used further. 
1H NMR (300 MHz, CDCl3): δ 6.86 (d, 1H, J = 7.9, ArCH), 6.69-6.65 (m, 2H, ArCH), 
5.65 (br s, 1H, OH), 5.03 (dd, 1H, J = 12.6, 5.2, CH2NO2), 4.58 (dd, 1H, J = 12.6, 9.6, 
CH2NO2), 3.99 -3.96 (m, 4H, OCH2CH2O), 3.89-3.86 (s, 1H, CHOH),m 3.86 (s, 3H, 
OCH3), 3.64 (s, 3H, CO2CH3), 3.39-3.33 (m, 1H, ArCH), 2.27-2.17 (m, 1H, COCH2), 2.17 
(s, 3H, C(O)CH3), 2.07-1.97 (m, 2H, CH2(C)CH2), 1.88-1.81 (m, 1H, CH2(C)CH2), 1.66-
1.64 (m, 2H, CH2(C)CH2).  
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(6S, 7R)-Methyl 7-(4-(hydroxy)-3-methoxyphenyl)-6-hydroxy-8-nitro-4- 
oxooctanoate (14): 
O2N
OH
O
O
OH
OMe
O  
To a solution of nitroketal 13 (35 mg, 0.070 mmol) in methanol (0.5 mL) was added 6 M 
HCl (0.4 mL) and the solution was stirred at the ambient temperature for 24 h. The 
methanol was removed under reduced pressure and the aqueous layer was extracted with 
dichloromethane (2 x 5 mL). The combined organic layers were dried (Na2SO4) and 
concentrated under reduced pressure to provide 20 mg, (71%) of  nitroketone 14 as a brown 
gum. The material was pure by 1H NMR and was directly used in the next step. 
1H NMR (300 MHz, CDCl3): δ 6.87 (d, 1H, ArCH), 6.70-6.65 (m, 2H, ArCH), 5.59 (s, 1H, 
OH), 5.08 (dd, 1H, J = 12.8, 5.1, CH2NO2), 4.63 (dd, 1H, J = 12.8, 9.7, CH2NO2), 4.25-
4.15 (m, 1H, ArCH), 3.90 (s, 3H, ArOCH3), 3.67 (s, 3H, CO2CH3), 3.58 (br d, 1H, CHOH), 
3.48-3.41 (m, 1H, CHOH), 2.65-2.56 (m, 4H, CH2COCH2), 2.50-2.48 (m, 2H, 
CH2CO2CH3); 
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(S)-7-((R)-1-(4-(Benzyloxy)-3-methoxyphenyl)-2-nitroethyl)-1,4- 
dioxaspiro[4.5]decan-8-one (17): 
 
To a solution of 1,4-cyclohexanedione monoethylene ketal (16.4 g, 105 mmol), 
N1,N1- dimethyl-N2-(((S)-pyrrolidin-2-yl)methyl)ethane-1,2-diamine (720 mg, 4.2 mmol) 
and p-toluene sulfonic acid monohydrate (800 mg, 4.2 mmol) was added a solution of 4-
benzyloxy-3-methoxy-β-nitrostyrene 16 (6.0 g, 21 mmol) in DMF (60 mL) and the 
resulting solution was stirred at ambient temperature for 5 d. Ethyl acetate (200 mL) was 
added and the resulting solution washed with water, dried (Na2SO4) and concentrated under 
reduced pressure. The residue obtained was purified by flash column chromatography on 
silica gel (70/30 hexanes/EtOAc) to provide 8.3 g (89%) of 17 as a white foam with 95% 
ee.  
IR (neat): 2925, 1709, 1548, 1510, 1257, 1232, 1139, 1117, 1011, 948 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.45-7.29 (m, 5H, ArH), δ 6.82 (d, 1H, J = 8.2, ArH), 6.68 (d, 1H, J = 2.1, 
ArH), 6.64 (d, 2H, J = 8.2, 2.1, ArH), 5.11 (s, 2H, OCH2Ph), 4.90 (dd, 1H, J = 12.4, 4.7, 
CH2NO2), 4.60 (dd, 1H, J = 12.4, 9.8, CH2NO2), 4.00-3.83 (m, 4H, OCH2CH2O), 3.86 (s, 
3H, OCH3), 3.79-3.7 (dt, 1H, J = 13.4, 6.6, ArCH), 3.07-2.93 (m, 1H, COCH), 2.76-2.62 
(dt, 1H, J = 13.8, 6.6, COCH2), 2.50-2.39 (m, 1H, COCH2), 2.09-1.86 (m, 2H, CHCH2), 
1.74-1.64 (m, 1H, CH2CH2), 1.54 (t, 1H, J = 13.0, CH2CH2); 13C NMR (75 MHz, CDCl3): 
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δ 210.5 (CO), 149.8 (ArCipso), 147.8 (ArCipso), 137.0 (ArCipso), 130.2 (ArCipso), 128.6 (2 x 
ArC), 127.9 (ArC), 127.4 (2 x ArC), 120.2 (ArC), 114.2 (ArC), 112.0 (ArC), 107.1 (OCO), 
79.0 (CH2NO2), 71.1 (CH2OPh), 64.8 (OCH2CH2O), 64.6 (OCH2CH2O), 56.1 (OCH3), 
48.3 (COCH), 43.1 (CHCH2NO2), 39.3 (COCH2), 38.7 (CH2), 35.1 (CH2); HRMS (APPI, 
pos.) m/z 441.1801 (441.1788 calc. for C24H27NO7 [M]+); HPLC (Chiralpak AS-H, 
hexanes/2-propanol, 90/10, flow rate 1.0 mL/min, 254 nm): tminor = 12.55 min, tmajor = 17.54 
min, ee = 95%, dr = 20:1 (average value from multiple reactions). 
(S)-7-((R)-1-(4-(Benzyloxy)-3-methoxyphenyl)-2-nitroethyl)-1,4,8- 
trioxaspiro[4.6]undecan-9-one (18): 
 
To a solution of nitroketone 17 (3.0 g, 6.8 mmol) in anhydrous dichloromethane 
(50 mL) at ambient temperature was added solid sodium phosphate (2.36 g, 8.80 mmol) 
followed by m-chloroperoxybenzoic acid (~77%, 3.63 g, 21 mmol). The resulting white 
slurry was stirred vigorously for 16 h at ambient temperature. Dichloromethane (100 mL) 
was added and the mixture was washed with aq. NaHCO3 (2 x 60 mL). The organic layer 
was dried (Na2SO4) and concentrated. The residue obtained was purified by flash column 
chromatography on silica gel (60/40 EtOAc/hexanes) to provide 2.9 g (93%) of 18 as a 
yellow foam. 
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IR (neat): 2936, 2887, 1734, 1551, 1513, 1378, 1327, 1260, 1232, 1144, 1099, 1028 cm-1; 
1H NMR (300 MHz, CDCl3) : δ 7.44-7.31 (m, 5H, ArH), 6.85 (d, 1H, J = 8.2, ArH), 6.73 
(d, 1H, J = 2.1, ArH), 6.70 (dd, 1H, J = 8.2, 2.1, ArH),  5.13 (s, 2H, OCH2Ph), 4.93 (dd, 
1H, J = 12.7, 4.7, CH2NO2), 4.72 (dd, 1H, J = 12.7, 9.3, CH2NO2), 4.74-4.63 (m, 1H 
(CO)OCH), 3.89 (s, 3H, OCH3), 3.87-3.73 (m, 3H, OCH2CH2O), 3.56 (dt, 1H, J = 9.3, 4.7, 
ArCH), 3.47-3.41 (m, 1H, OCH2CH2O), 2.88-2.80 (m, 1H, CH2CO), 2.66-2.56 (m, 1H, 
CH2CO), 1.93-1.87 (m, 2H, CH2(C)CH2), 1.82-1.80 (m, 2H, CH2(C)CH2); 13C NMR (75 
MHz, CDCl3): δ 173.6 (CO), 150.0 (ArCipso), 148.1 (ArCipso), 136.8 (ArCipso), 128.9 
(ArCipso), 128.6 (2 x ArC), 128.0 (ArC), 127.4 (2 x ArC), 120.5 (ArC), 114.3 (ArC), 111.8 
(ArC), 107.2 (OCO), 77.8 (CH2NO2), 75.8 (COC(O)), 70.9 (OCH2Ph), 65.0 (OCH2CH2O), 
64.3 (OCH2CH2O), 56.1 (OCH3), 48.5 (OCHCH2), 41.4 (CHCH2NO2), 33.1 (CH2(C)CH2), 
29.4 (CH2(C)CH2); HRMS (APPI, pos.): m/z 457.1749 (457.1737 calc. for C24H27NO8 
[M+]), m/z 475.2086 (475.2080 calc. for C24H31N2O8 [M+NH4]+). 
Methyl 3-(2-((2S, 3R)-3-(4-(benzyloxy)-3-methoxyphenyl)-2-hydroxy-4-nitrobutyl)-
1,3-dioxolan-2-yl)propanoate (19): 
 
A solution of the lactone 18 (3.3 g, 7.2 mmol) in methanol (70 mL) was cooled to 
0 °C and potassium carbonate (2.00 g, 14.4 mmol) was added. The mixture was stirred at 
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ambient temperature for 2 h. The mixture was then cooled to 0 °C, neutralized with aq. 
HCl (0.5 M) and the resulting solution was extracted with dichloromethane (2 x 50 mL). 
The combined organic layers were dried (Na2SO4) and concentrated to provide 3.0 g, (85%) 
of the nitroketal 19 as a light brown gum. This material was pure by 1H NMR and was 
directly used further. 
IR (neat): 3499, 2953, 1732, 1549, 1515, 1453, 1436, 1379, 1261, 1233, 1141, 1024 cm-1; 
1H NMR (300 MHz, CDCl3) : δ 7.44-7.29 (m, 5H, ArH), 6.83 (d, 1H, J = 8.2, ArH), 6.70 
(d, 1H, J = 2.1, ArH), 6.65 (dd, 1H, J = 8.2, 2.1, ArH), 5.12 (s, 2H, OCH2Ph), 5.02 (dd, 
1H, J = 12.9, 5.3, CH2NO2), 4.59 (dd, 1H, J = 12.9, 9.5, CH2NO2), 4.08-3.98 (m, 1H, 
ArCH), 3.98-3.90 (m, 4H, OCH2CH2O), 3.86 (s, 3H, ArOCH3), 3.63 (s, 3H, CO2CH3), 3.37 
(dt, 1H, J = 9.3, 5.3, CHOH), 2.25-2.17 (m, 2H, CO2CH2), 2.05-1.95 (m, 1H, CH2(C)CH2), 
1.87-1.77 (m, 1H, CH2(C)CH2), 1.66-1.62 (m, 2H, CH2(C)CH2); 13C NMR (75 MHz, 
CDCl3): δ 173.6 (CO2CH3), 149.9 (ArCipso), 147.9 (ArCipso), 137.0 (ArCipso), 130.3 
(ArCipso), 128.6 (2 x ArC), 127.9 (ArC), 127.3 (2 x ArC), 120.1 (ArC), 114.3 (ArC), 111.8 
(ArC), 110.9 (OCO), 78.4 (CH2NO2), 71.0 (OCH2Ph), 70.0 (CHOH), 65.1 (OCH2CH2O), 
64.6 (OCH2CH2O), 56.1 (ArOCH3), 51.7 (CO2CH3), 50.6 (HO-CCH2), 40.5 (ArCH), 31.8 
(CH2CH2COOCH3), 28.5 (CH2CO2CH3); HRMS (APPI, pos.): m/z 489.2016 (489.1999 
calc. for C25H31NO9[M+]), m/z 507.2317 (507.2343 calc. for C25H35N2O9 [M+NH4+])). 
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(6S,7R)-Methyl 7-(4-(benzyloxy)-3-methoxyphenyl)-6-hydroxy-8-nitro-4- 
oxooctanoate (20): 
 
To a solution of nitroketal 19 (2.9 g, 5.9 mmol) in acetone (55 mL) was added 
iodine (150 mg, 0.6 mmol) and the solution was stirred at ambient temperature for 1 h. The 
acetone was removed under reduced pressure and the residue was diluted with 
dichloromethane (2 x 50 mL). The resulting solution was washed with aqueous Na2S2O3 
(5% w/v, 2 x 10 mL) and brine (10 mL). The organic layer was dried (Na2SO4) and 
concentrated under reduced pressure. This procedure was repeated one more time with the 
same amount of materials to finally provide 2.4 g (92%) of nitroketone 20 as a white, fluffy 
solid. This material was pure by 1H NMR and was directly used in the next step. 
IR (neat): 3441, 2939, 2900, 1732, 1711, 1549, 1519, 1379, 1366, 1262, 1205, 1139, 1105, 
1026 cm-1; 1H NMR (300 MHz, CDCl3) : δ 7.44-7.29 (m, 5H, ArH), 6.83 (d, 1H, J = 8.2, 
ArH), 6.71 (d, 1H, J = 2.1, ArH), 6.65 (dd, 1H, J = 8.2, 2.1, ArH), 5.11 (s, 2H, OCH2Ph), 
5.05 (dd, 1H, J = 12.8, 5.0, CH2NO2), 4.6 (dd, 1H, J = 12.8, 9.7,  CH2NO2), 4.24-4.18 (m, 
1H, Ar-CH), 3.87 (s, 3H, OCH3), 3.65 (s, 3H, CO2CH3), 3.65 (s, 1H, CHOH), 3.50-3.42 
(dt, 1H, J = 9.9, 5.2, CHOH), 2.61-2.55 (m, 4H, CH2COCH2), 2.54-2.45 (m, 2H, 
CH2CO2CH3); 13C NMR (75 MHz, CDCl3): 209.8 (CO), 173.2 (CO2CH3), 150.0 (ArCipso), 
148.1 (ArCipso), 136.9 (ArCipso), 129.8 (ArCipso), 128.6 (2 x ArC), 128.0 (ArC), 127.4 (2 x 
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ArC), 120.1 (ArC), 114.3 (ArC), 111.7 (ArC), 78.4 (CH2NO2), 71.0 (CH2OPh), 69.9 
(CHOH), 56.1 (OCH3), 52.0 (CO2CH3), 49.6 (HOC-CH2CO), 47.1 (ArCH), 37.8 (COCH2), 
27.5 (CH2CO2CH3); HRMS (APPI, pos.): m/z 445.1754 (445.1737 calc. for C23H27NO8 
[M+]), m/z  463.2087 (463.2080 calc. for C23H31N2O8 [M+NH4]+). 
(3R, 4S)-3-(4-(Benzyloxy)-3-methoxyphenyl)-4-hydroxy-6-(3-methoxy-3-oxopropyl)- 
2,3,4,5-tetrahydropyridine-1-oxide (21): 
 
A solution of NH4Cl (252 mg, 4.70 mmol) in water (11.5 mL) was added to a 
solution of the nitroketone 20 (2.1 g, 4.7 mmol) in THF (32 mL). Activated Zn powder 
(3.10 g, 47.1 mmol) was added and the mixture was stirred vigorously at room temperature 
under nitrogen for 3 h. The mixture was filtered (Celite), the filter cake was washed with 
THF, and the combined filtrates were concentrated under reduced pressure. 
Dichloromethane (50 mL) was added to the residue and the resulting mixture was washed 
with water (10 mL), dried (Na2SO4) and concentrated under reduced pressure. The crude 
product was purified by flash column chromatography on silica gel (98/2 
Dichloromethane/MeOH) to provide 1.2 g (63%) of the nitrone 21 as a purple foam. 
IR (neat): 2948, 1735, 1511, 1453, 1435, 1265, 12124, 1196, 1173, 1133, 1070, 1007 cm-
1; 1H NMR (300 MHz, CDCl3): δ 7.45-7.30 (m, 5H, ArH), 6.87-6.85 (m, 2H, ArH), 6.75 
(dd, 1H, J = 8.4, 2.0, ArH), 5.15 (s, 2H, OCH2Ph), 4.29 (br t, 1H, J = 13.6, ArCH), 4.19 
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(br s, 1H, CHOH), 3.92 (dd, 1H, J = 13.6, 5.7, CH2N), 3.88 (s, 3H, OCH3), 3.66 (s, 3H, 
CO2CH3), 3.21 (dd, 1H, J = 13.6, 5.7, CH2N), 2.91-2.66 (m, 6H, CH2C=N, COCH2CH2, 
COCH2), 2.36 (br s, 1H, OH); 13C NMR (75 MHz, CDCl3) : 173.7 (CO), 149.7 (ArCipso), 
147.6 (ArCipso), 145.4 (C=NO), 137.03 (ArCipso), 130.9 (ArCipso), 128.6 (2 x ArC), 127.9 
(ArC), 127.3 (2 x ArC), 119.8 (ArC), 114.0 (ArC), 111.8 (ArC), 71.0 (CH2OPh), 64.9 
(CH2NO), 57.7 (ArCH), 56.0 (OCH3), 51.9 (CO2CH3), 44.0 (CHOH), 38.8 (CH2CO2CH3), 
28.3 (N=CCH2), 27.4 (N=CCH2); HRMS (APPI): m/z 413.1828 (413.1838 calc. for 
C23H27NO6 [M+]), m/z 414.1901 (414.1917 calc. for C23H28NO6 [M+H]+). 
(6R,7S, 8aS)-6-(4-(Benzyloxy)-3-methoxyphenyl)-7-hydroxyhexahydroindolizin- 
3(5H)-one (24): 
 
To a solution of tetramethylammonium triacetoxyborohydride (891 mg, 3.39 
mmol) in acetonitrile (4 mL) was added glacial acetic acid (2.26 mL). The mixture was 
stirred at 0 °C for 5 min and a solution of nitrone 21 (700 mg, 1.69 mmol) in acetonitrile 
(6 mL) was added. The mixture was stirred at 0 °C for 1 h and the pH of the solution was 
adjusted (pH 7 to 8) with aqueous NaOH (5% solution). The resulting mixture was 
extracted with dichloromethane (50 mL) and the combined extracts were dried (Na2SO4) 
and concentrated to give 630 mg (90%) of 22 as a purple foam. This crude material was 
used further. 
230 
 
1H NMR (300 MHz, CDCl3): 7.45-7.29 (m, 5H, ArCH), 6.84 (d, 1H, J = 8.2, ArCH), (m, 
1H, ArCH), 6.70-6.64 (m, 2H, ArCH), 5.13 (s, 2H, OCH2Ph), 3.92 (br s, 1H, ArCH), 3.87 
(s, OCH3), 3.67 (s, OCH3), 3.46 (m, 1H, CHOH), 3.27-3.21 (m, 1H, ArCHCH2), 2.99-2.87 
(m, 1H, ArCHCH2), 2.50-2.41 (m, 2H, COCH2), 2.17-2.04 (m, 1H, NCH), 1.93-1.87 (m, 
1H, OHCHCH2), 1.71-1.62 (m, 1H, OHCHCH2), 1.54-1.50 (m, 2H, NCHCH2); HRMS 
(APPI, pos.): m/z  415.1982 (415.2000 calc. for C23H29NO6 [M]+) m/z 416.2055 (416.2100 
calc. for C23H30NO6 [M+H]+); 
The hydroxylamine 22 (720 mg, 1.73 mmol) was dissolved in a mixture of ethanol 
(15 mL) and saturated aqueous NH4Cl (3.6 mL). Indium powder (378 mg, 3.30 mmol) was 
added and the mixture was heated to reflux for 4 h. The mixture was cooled, filtered 
through a pad of Celite, and the filtrate was concentrated under reduced pressure. 
Dichloromethane (25 mL) was added to the residue and the aqueous layer was separated. 
The organic layer was washed with saturated aqueous NaHCO3 solution (2 × 10 mL), dried 
(Na2SO4) and concentrated to give 630 mg of a yellow gum. This material is a mixture of 
the amino ester 23 and the cyclization product (lactam 24, ~30%) (1H NMR analysis). The 
crude mixture was directly converted to the lactam as follows. 
To a solution of crude aminoester and lactam mixture (280 mg) in THF (7 mL) was 
added diisopropylethylamine (24µL, 0.14 mmol) and the solution was heated to reflux for 
5 h. The THF was removed under reduced pressure, the residue was dissolved in 
dichloromethane (15 mL) and the resulting solution was washed with aqueous HCl (0.5 M, 
10 mL). The organic layer was dried (Na2SO4) and concentrated to provide 200 mg (78%) 
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of lactam 24 as a pale yellow foam. This material was pure by 1H NMR and was directly 
used further. 
IR (neat): 3341, 2961, 2931, 1654, 1512, 1454, 1419, 1259, 1220, 1140, 1019 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 7.43 (d, 1H, J = 7.4, ArH), 7.36 (t, 2H, J = 7.4, ArH), 7.29-
7.22 (m, 1H, J = 7.4, ArH), 6.80 (d, 1H, J = 8.3, ArH), 6.75 (d, 1H, J = 2.1, ArH), 6.66 
(dd, 1H, J = 8.3, 2.1, ArCH), 5.1 (s, 2H, OCH2Ph),  4.11 (br s, 1H, NCH), 4.05 (dd, 1H, J 
= 12.7, 4.8 , NCH2), 3.94-3.88 (m, 1H, ArCH), 3.85 (s, 3H, OCH3), 3.31 (t, 1H, J = 12.7, 
NCH2), 2.73-2.70 (ddd, 1H, J = 12.5, 4.8, 2.0, CHOH), 2.36 (br t, 2H, J = 7.0, COCH2), 
2.30 (br s, 1H, CH2CHOH), 2.24-2.17 (m, 1H, CH2CHOH), 2.16-2.12 (m, 1H, 
CH2CH2C(O)), 1.60-1.54 (m, 1H, CHCH2CH), 1.45 (dt, 1H, J = 11.0, 2.1, NCHCH2); 13C 
NMR (75 MHz, CDCl3): 173.7 (NCO), 149.7 (ArCipso), 147.3 (ArCipso), 137.1 (ArCipso), 
133.0 (ArCipso), 128.6 (2 x ArC), 127.9 (ArC), 127.3 (2 x ArC), 119.6 (ArC), 114.1 (ArC), 
111.7 (ArC), 71.0 (OCH2Ph), 68.8 (CHOH), 56.0 (OCH3), 50.9 (NCH), 45.2 (NCH2), 39.8 
(ArCH), 38.3 (HOCHCH2), 30.6 (NCOCH2), 24.7 (NCHCH2); HRMS (APPI, pos.): m/z 
367.1779 (367.1784 calc. for C22H25NO4 [M+]), m/z 368.1851 (368.1862 calc. for 
(C22H26NO4 [M+H]+). 
(6R, 8aS)-6-(4-(Benzyloxy)-3-methoxyphenyl) hexahydroindolizine-3,7-dione (25): 
 
To a stirred solution of amidoalcohol 24 (200 mg, 0.540 mmol) in dichloromethane 
(4 mL) was added Dess-Martin periodinane (462 mg, 1.08 mmol) and the mixture was 
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stirred at ambient temperature for 3 h. Saturated aqueous NaHCO3 (10 mL) was added, the 
organic layer was separated and the aqueous layer was extracted with dichloromethane (15 
mL). The combined organic layers were washed with brine (10 mL), dried (Na2SO4) and 
concentrated. The residue was purified by flash column chromatography on silica gel 
(Ethyl acetate) to provide 164 mg (83%) of 25 as a white solid. 
IR (neat): 2934, 1680, 1514, 1454, 1419, 1262, 1220, 1142, 1029, 912 cm-1; 1H NMR (300 
MHz,CDCl3): δ 7.45-7.29 (m, 5H, ArH), 6.86 (d, 1H, J = 8.2, ArH), 6.66 (d, 1H, J = 2.1, 
ArH), 6.62 (dd, 1H, J = 8.2, 2.1, ArH), 5.14 (s, 2H, OCH2Ph), 4.6 (dd, 1H, J = 12.5, 6.9, 
ArCCH), 4.03-3.94 (m, 1H, NCH), 3.86 (s, 3H, OCH3), 3.60 (dd, 1H, J = 12.5, 6.9, NCH2), 
3.09 (t, 1H, J = 12.5, NCH2), 2.73 (dd, 1H, J = 13.6, 3.9, COCH2), 2.58-2.51 (m, 2H, 
COCH2, NCOCH2), 2.48-2.33 (m, 2H, NCOCH2, NCOCH2CH2), 1.86-1.74 (m, 1H, 
NCOCH2CH2); 13C NMR (75 MHz, CDCl3):  205.5 (CO), 173.6 (NCO), 149.6 (ArCipso), 
147.8 (ArCipso), 137.1 (ArCipso), 128.6 (2 x ArC), 127.9 (ArC), 127.4 (ArC), 127.3 (2 x 
ArC), 121.1 (ArC), 113.9 (ArC), 112.8 (ArC), 71.0 (OCH2Ph), 57.1 (NCH), 56.1 (OCH3), 
55.3 (ArCCH), 48.6 (CH2N), 45.1 (CH2CO), 29.7 (CH2CH2CO), 24.7 (CH2CO); HRMS 
(ESI, pos.) m/z 365.1639 (365.1627 calc. for C22H23NO4 [M+]), m/z  366.1709 (366.1705 
calc. for C22H24NO4 [M+H]+). 
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(S)-6-(4-(Benzyloxy)-3-methoxyphenyl)-3-oxo-1,2,3,5,8,8a-hexahydroindolizin-7-yl  
trifluoromethanesulfonate (26): 
  
To a suspension of KH (73 mg, 0.54 mmol) in THF (2 mL) was added ketone 25 
(100 mg, 0.27 mmol) at 0 °C. The mixture was stirred at 0 °C for 45 mins and then warmed 
to room temperature for 1 h and N-phenyl-bis(trifluoromethanesulfonimide) (105 mg, 0.29 
mmol) was added in one portion and the mixture was stirred for 1 h at ambient temperature. 
Water (2 mL) was added and the mixture was extracted with EtOAc (5 mL). The combined 
layers were dried (Na2SO4) and concentrated to provide 121 mg (89%) of triflate 26 as a 
yellow foam. This was used further without purification. An analytical sample was 
obtained by flash column chromatography on silica gel (Ethyl acetate). 
IR (neat): 2940, 2843, 1694, 1514, 1413, 1263, 1243, 1206, 1139, 1035, 947 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 7.45-7.30 (m, 5H, ArH), 6.91-6.78 (m, 3H, ArH), 5.16 (s, 2H, 
OCH2Ph), 4.75 (br d, 1H, J = 18.1, NCH2), 3.88 (s, 3H, OCH3), 3.93-3.88 (m, 1H, NCH), 
3.71 (br d, 1H, J = 18.1, NCH2), 2.67-2.39 (m, 5H, COCH2, C=CCH2, COCH2CH2), 1.87-
1.80 (m, 1H, COCH2CH2); 13C NMR (75 MHz, CDCl3):  173.8 (CO), 155.1 (TfOC=C), 
149.5 (ArCipso),  148.7 (ArCipso),  139.6  (ArCipso), 136.7 (ArCipso), 128.6 (2 x ArC), 127.9 
(2 x ArC), 127.3 (2 x ArC),  125.5 (TfOC=C), 120.8 (ArC), 115.2 (q, J = 109.4, CF3), 
113.7 (ArC), 111.9 (ArC), 70.9 (OCH2Ph), 56.1 (OCH3), 53.3 (NCH), 42.9 (NCH2), 35.4 
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(C=CCH2CH), 29.6 (COCH2CH2),  24.2 (COCH2); HRMS (APPI): m/z 497.1106 
(497.1120 calc. for C23H23F3NO6S [M]+). 
2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (27)21: 
 
A mixture of 4-hydroxy-3-methoxyphenyl bromide (500 mg, 2.46 mmol), 
potassium acetate (725 mg, 7.38 mmol) and PdCl2.dppf (140 mg, 0.025 mmol) in dry 
dioxane (10 mL) was stirred at 80 °C for 2 h. Bis(pinacolato)diboron (687 mg, 2.70 mmol) 
in dry dioxane (5 mL) was added and the mixture was stirred at 80 °C for 1 h. The solvent 
was removed under reduced pressure and the residue was suspended in ethyl acetate (15 
mL). The mixture was filtered through a pad of celite and the pad washed with ethyl acetate 
(20 mL). The combined filtrates were washed with saturated aqueous ammonium chloride 
(10 mL), water (10 mL), dried (Na2SO4) and the solvent was removed under reduced 
pressure. The residue was purified by flash column chromatography (95/5 hexanes/Ethyl 
acetate) to provide 403 mg (65%) of 4-hydroxy-3-methoxy phenyl pinacolate 27 as a white 
solid. 
IR (neat): 3486, 3361 (br), 2975, 2938, 1763, 1603, 1590, 1413, 1341, 1309, 1266, 1219, 
1169, 1140, 1121, 1085, 1029, 962 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.37 (dd, 1H, J = 
7.8, 1.3, ArCH), 7.28 (d, 1H, J = 1.3, ArCH), 6.92 (d, 1H, J = 7.8, ArCH), 5.86 (s, 1H, 
OH), 3.92 (s, 3H, OCH3), 1.33 (s, 12H, (CH3)2C-C(CH3)2); 13C NMR (75 MHz, CDCl3): 
148.6 (ArCipso), 146.1 (ArCipso), 129.1 (ArCipso, ArC), 116.2 (ArC), 114.1 (ArC), 83.7 
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(CH3)2C-C(CH3)2), 83.5 (CH3)2C-C(CH3)2), 56.0 (OCH3), 25.1 ((CH3)2C-C(CH3)2), 24.9 
((CH3)2C-C(CH3)2); HRMS (ESI): m/z: 249.1311 (249.1298 calc. for C13H18BO4 [M-H]-); 
 
(S)-6,7-Bis (4-hydroxy-3-methoxyphenyl)-1,2,8,8a-tetrahydroindolizin-3(5H)-one  
(29): 
 
To a mixture of triflate 26 (70 mg, 0.14 mmol), 4-hydroxy-3-methoxy phenyl 
pinacolate ester 27 (42 mg, 0.17 mmol), and PdCl2·(PPh3)2 (20 mg, 0.030 mmol) in THF 
(1 mL) was added a saturated aqueous solution of NaHCO3 (2.8 mL) and the resulting 
mixture was heated to reflux. After 15 min, the resulting solution was cooled to room 
temperature, diluted with cold water (5 mL) and then extracted with ethyl acetate (2 x 10 
mL). The combined extracts were washed with brine (5 mL), dried (Na2SO4) and 
concentrated in vacuo to provide 34 mg (51%) of 28 as a yellow gum. This was used further 
without purification. 
The coupled product 28 (38 mg, 0.080 mmol) was dissolved in methanol (0.5 mL) 
and Pd/C (10%, 8 mg, 8 mmol) was added to the solution. The mixture was stirred under 
an atmosphere of hydrogen (balloon) for 5 h and then filtered through a pad of celite. The 
residue was washed with methanol (5 mL) and the combined filtrates were concentrated in 
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vacuo. The residue was purified by flash column chromatography (98/2 
Dichloromethane/Methanol) to provide 21 mg (68%) of 29 as a yellow gum. 
IR (neat): 3291 (br), 2927, 2853, 1660, 1595, 1515, 1461, 1423, 1372, 1269, 1206, 1166, 
1033 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.77 (d, 1H, J = 7.5, ArH), 6.74 (d, 1H, J = 7.5, 
ArH), 6.62 (dt, 2H, J = 8.2, 1.9, ArH), 6.46 (d, 1H, J = 1.9, ArH), 6.37 (d, 1H, J = 1.9, 
ArH), 5.6 (s, 1H, OH), 5.5 (s,1H, OH), 4.73 (dd, 1H, J = 18.5, 2.7, NCH2), 3.94-3.87 (m, 
1H, NCH), 3.79-3.73 (br d, 1H, J = 18.5, NCH2), 3.61 (s, 3H, OCH3), 3.56 (s, 3H, OCH3), 
2.74 (dd, 1H, J = 16.7, 4.4, COCH2), 2.54-2.38 (m, 4H, COCH2, C=CCH2, COCH2CH2), 
1.86-1.75 (m, 1H, COCH2CH2); 13C NMR (75 MHz, CDCl3): 174.0 (CO), 146.0 (ArCipso), 
145.9 (ArCipso), 144.6 (ArCipso), 144.3 (ArCipso), 133.8 (ArCipso), 131.8 (ArC=CCH2CH), 
131.4 (C=CCH2N), 130.6 (ArCipso), 121.8 (ArC), 121.3 (ArC), 114.0 (ArC), 113.9 (ArC), 
112.4 (ArC), 112.3 (ArC), 55.84 (OCH3), 55.76 (OCH3), 53.4 (NCH), 44.3 (NCH2), 38.8 
(C=CCH2CH), 30.1 (COCH2CH2), 24.9 (COCH2); HRMS (APPI, pos.): m/z 381.1588 
(381.1576 calc. for C22H23NO5 [M+]), m/z 382.1654 (382.1654 calc. for C22H24NO5 
[M+H]+), m/z 404.1399 (404.1474 calc. for (C22H23NNaO5) [M+Na]+)). 
4-((S)-6-(4-(Benzyloxy)-3-methoxyphenyl)-1,2,3,5,8,8a-hexahydroindolizin-7-yl)-2-
methoxyphenol (30): 
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To a suspension of LiAH4 (17 mg, 0.44 mmol) in dry THF (1 mL) at 0 °C was 
slowly added a solution of the lactam 28 (50 mg, 0.10 mmol) in THF (1 mL). After stirring 
for 1 h at 0 °C, the mixture was stirred at ambient temperature for 24 h. It was then cooled 
to 0 °C and water (8 L), 1M NaOH (18 L), water (24 L) were added sequentially with 
vigorous stirring. The precipitated inorganic salts were filtered and the residue washed with 
dichloromethane. The combined filtrates were dried (Na2SO4) and concentrated to provide 
20 mg (40%) of 30 as a pale yellow gum. 
IR (neat): 2933, 1599, 1509, 1461, 1416, 1383, 1263, 1208, 1169, 1141, 1032, 910 cm-1; 
1H NMR (300 MHz, CDCl3): δ 7.38 (d, 2H, J = 7.5, ArCH), 7.36 (t, 2H, J = 7.5, ArCH), 
7.30-7.25 (m, 1H, ArCH), 6.74 (d, 1H, J = 8.1, ArCH), 6.70 (d, 1H, J = 8.3, ArCH), 6.65 
(dd, 1H, J = 8.5, 2.0, ArCH), 6.61 (dd, 1H, J = 8.5, 2.0, ArCH), 6.52 (br d, 1H,  J = 1.3, 
ArCH), 6.41 (br d, 1H, J = 1.6, ArCH), 5.08 (s, 2H, OCH2Ph), 3.91 (br d, 1H, J = 15.5, 
NCH2), 3.59 (s, 3H, OCH3), 3.50 (s, 3H, OCH3), 3.35-3.12 (br m, 1H, NCH), 2.75 (br d, 
1H, J = 15.5, NCH2), 2.47-2.30 (br m, 2H, NCH2CH2), 2.14-1.87 (m, 4H, NCHCH2, 
NCHCH2CH2), 1.66-1.56 (m, 2H, NCHCH2CH2);  13C NMR (75 MHz, CDCl3): 149.0 
(ArCipso), 146.7 (ArCipso), 145.7 (ArCipso), 144.1 (ArCipso), 137.2 (2 x ArCipso), 133.1 (2 x 
ArCipso), 128.5 (2 x ArC), 127.8 (ArC), 127.2 (2 x ArC), 121.2 (ArC), 120.9 (ArC), 113.76 
(ArC), 113.71 (ArC), 113.5 (ArC), 112.5 (ArC), 70.9 (OCH2Ph), 60.5 (NCH), 59.1 
(NCH2), 55.8 (OCH3), 55.7 (OCH3), 54.2 (NCH2CH2), 30.7 (NCH2CH2CH2), 29.7 
(NCHCH2), 21.5 (NCH2CH2). HRMS (APPI): m/z 457.2233 (457.2253 calc. for 
C29H31NO4 [M]+), 458.2304 (458.2331 calc. for C29H32NO4 [M+H]+), m/z 480.2122 
(480.2151 calc. for C29H31NNaO4 [M+Na]+); []23D = +36 (c = 0.5, CH2Cl2). 
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4-((S)-6-(4-(Hydroxy)-3-methoxyphenyl)-1,2,3,5,8,8a-hexahydroindolizin-7-yl)-2-
methoxyphenol ((+)-fistulopsine B, 2): 
         
To a suspension of excess RaNi in ethanol (50% slurry in H2O, 1 mL) was slowly 
added a solution of 30 (0.030 g, 6.56 mmol). The mixture was stirred at ambient 
temperature for 1 h and filtered through a pad of celite. The residue was washed with 
ethanol and the combined filtrates were concentrated in vacuo. The residue obtained was 
purified by preparative TLC (neutral alumina) to provide 10 mg (45%) of (+)-fistulopsine 
B (2) as a white solid. 
 
IR (neat): 3315 (br), 2955, 2935, 1593, 1513, 1462, 1419, 1270 (br), 1208, 1168, 1124, 
1034  cm-1; 1H NMR (500 MHz, CDCl3): δ 6.71 (d, 2H, J = 8.1), 6.62 (dd, 2H, J = 8.1, 
1.7), 6.44 (d, 1H, J = 1.3), 6.41 (d, 1H, J = 1.6), 3.87 (d, 1H, J = 16), 3.56 (s, 3H), 3.53 (s, 
3H), 3.29 (br t, 1H, J = 7.3), 3.08 (d, 1H, J = 17.1), 2.73-2.69 (m, 1H), 2.41-2.39 (m, 2H), 
2.26-2.24 (m, 1H), 2.15-1.95 (m, 1H), 1.96-1.92 (m, 1H), 1.85-1.79 (m, 1H), 1.61-1.55, 
(m, 1H); 13C NMR (125 MHz, CDCl3): 145.9, 145.7, 144.1, 143.9, 134.6, 132.8, 132.9, 
132.5, 121.5, 121.2, 113.8, 113.7, 112.7, 112.5, 60.5, 57.6, 55.74, 55.68, 54.2, 38.5, 30.7, 
21.3; HRMS (APPI): m/z 367.1766 (367.1784 calc. for C22H25NO4 [M+]),  m/z 368.1838 
239 
 
(368.1862 calc. for C22H26NO4 [M+H]+); []23D = +23.9 (c = 0.23, MeOH; lit.12 []25D = 
+18 (c = 0.32, MeOH for the S enantiomer)). 
Comparison of observed NMR data for compound 2 with reported12 data 
         
 
Position 1H NMR (500 MHz, 
CDCl3) 
Observed for 2 
1H NMR (600 MHz, 
CDCl3) 
Reported12 for 2 
5, 4 6.71 (d, 2H, J = 8.1 Hz) 6.71 (d, 1H, J = 8.0 Hz), 
6.70 (d, 1H, J = 8.0 Hz) 
4a, 4b 6.62 (dd, 2H, J = 8.1, 1.7 
Hz) 
6.62 (dd, 2H, J = 8.0, 1.6 
Hz) 
8 6.44 (d, 1H, J = 1.3 Hz) 6.45 (d, 1H, J = 1.6 Hz) 
1 6.41 (d, 1H, J = 1.6 Hz) 6.44 (d, 1H, J = 1.6 Hz) 
9β 3.87 (d, 1H, J = 16.0 Hz) 3.86 (d, 1H, J = 16.0 Hz) 
7-OMe 3.56 (s, 3H) 3.57 (s, 3H) 
2-OMe 3.53 (s, 3H) 3.55 (s, 3H) 
11β 3.29 (br t, 1H, J = 7.3 
Hz) 
3.29 (t, 1H, J = 9.0 Hz) 
9α 3.08 (d, 1H, J = 17.1 Hz) 3.09 (d, 1H, J = 16.0 Hz) 
14β 2.73-2.69 (m, 1H) 2.73 (d, 1H, J = 16.0 Hz) 
13a, 14α 2.41-2.39 (m, 2H) 2.45 (m, 1H), 2.42 (m, 1H) 
11α 2.26-2.24 (m, 1H) 2.28 (q, 1H) 
13α 2.15-1.95 (m, 1H) 2.11 (m, 1H) 
12b 1.96-1.92 (m, 1H) 1.94 (m, 1H) 
12a 1.85-1.79 (m, 1H) 1.86 (m, 1H) 
          13β 1.61-1.55 (m, 1H) 1.57 (m, 1H) 
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Position 13C NMR (75 MHz, 
CDCl3) 
Observed for 2 
 13C NMR (150 MHz, 
CDCl3) 
Reported12 for 2 
7 145.9 146.62 
2 145.7 146.43 
6 144.1 144.53 
3 143.9 144.32 
14a 134.6 134.31 
14b 133.1 132.86 
8a 132.9 132.82 
8b 132.5 132.26 
4b 121.5 121.51 
4a 121.2 121.30 
5 113.8 114.44 
4 113.7 114.33 
8 112.7 113.24 
1 112.5 113.00 
13a 60.5 60.71 
9 57.6 57.57 
7-OMe 55.7 55.79 
2-OMe 55.7 55.74 
11 54.2 54.19 
14α 38.5 38.02 
13 30.7 30.58 
12a 21.3 21.40 
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4.7  Selected 1H NMR and 13C NMR Spectra 
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Chapter 5 - Summary of the thesis 
Conclusions 
5.1 Organocatalytic conjugate addition reactions of aldehydes/ketones   
       to in situ generated α-nitrostyrenes. 
The organocatalytic, enamine mediated conjugate addition of aldehydes 1 to -
nitrostyrenes generated in situ from the corresponding nitroacetates was developed. A 
catalyst survey was carried out to find the optimal catalyst. Among the various catalysts 
examined, (S)-proline (5) gave the best result. The optimized conditions were employed 
in the study of the scope of the reaction with a variety of aldehydes. Overall, moderate 
yields (up to 45%) and enantioselectivities (up to 76%) were obtained. 
 
Scheme 5.1 
The organocatalytic, enamine mediated conjugate addition of cyclic ketones 7 to 
-nitrostyrenes generated in situ from the corresponding nitroacetates (2-4) was also 
examined. In this case, a (S)-proline derived diamine was found to be the optimal 
catalyst. The optimized conditions were employed in the study of the scope of the 
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reaction with a variety of cyclic ketones. The Michael adducts 9 were obtained with 
moderate diastereoselectivities (up to 2.3:1) and moderate to good enantioselectivities (up 
to 92%). 
 
Scheme 5.2 
5.2 Formal Synthesis of (+)-Lasubine II and (-)-Subcosine II via Organocatalytic 
Michael Addition Reactions of a Ketone to in situ Generated α-Nitrostyrene 
The above methodology was used as the key step in a synthesis of enantiomers of 
the naturally occurring quinolizidine alkaloids (+)-lasubine II (18) and (-)-subcosine II 
(19). The organocatalytic Michael addition of 1,4-cyclohexanedione monoethylene ketal 
10 to the -nitrostyrene generated in situ from the nitroacetate 2 gave the 
enantiomerically enriched -nitroketone 11. Oxidative ring expansion of the ketone 11 
and subsequent reduction provided a nitrodiol 13. This is stereoselectively transformed to 
the key, functionalized piperidine intermediate which is readily converted to (+)-2-
epilasubine II 17 which is the precursor for the formal total synthesis of  (+)-lasubine II 
18 and (-)-subcosine II 19 (Scheme 5.3). 
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Scheme 5.3 
5.3 Synthesis of Fistulopsine B: An Application of an Organocatalytic Michael 
Addition Reaction 
In another organocatalysis-based investigation, an enantiomerically enriched -
nitroketone was employed as the key starting material in the first total synthesis of the 
diarylindolizidine alkaloid (+)-fistulopsine B isolated1 in 2016. Organocatalytic Michael 
addition of 1,4-cyclohexanedione monoethylene ketal 10 to -nitrostyrene 20 in the 
presence of the (S)-proline-derived triamine catalyst 21 gave enantiomerically enriched -
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nitroketone 23. Oxidative ring expansion of the nitroketone 22, followed by the 
methanolysis and deprotection provided the nitro ketoester 24. This is stereoselectively 
converted to the functionalized piperidine 25 which was converted to (+)-fistulopsine B 
(27) in 7 steps. 
 
Scheme 5.4 
In summary, an efficient synthesis of functionalized indolizidines and 
quinolizidines was developed from enantiomerically enriched -nitroketone starting 
materials which are readily available from the organocatalytic ketone-nitroalkene 
Michael addition reaction. This methodology was applied in the formal total synthesis of 
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quinolizidine alkaloids (+)-lasubine II (18) and (-)-subcosine II (19) and the first total 
synthesis of recently isolated indolizidine alkaloid (+)-fistulopsine B (27). 
5.4 Future Work 
The -nitroketones 28 obtained from the organocatalytic Michael addition of 
ketones to -nitrostyrenes can be converted to nitrones 29 which could be useful in the 
stereoselective synthesis of 2-aryl octahydroindoles 30 (Scheme 5.5). These 
octahydroindoles may have applications in diversity oriented synthesis2 and medicinal 
chemistry.3 
 
Scheme 5.5 
Conjugate addition reactions of -nitrostryrenes with other carbon nucleophiles 
can also be examined. For example, the palladium4 catalyzed (Heck reaction) C-C 
coupling between aryl halides 31 and -nitrostyrenes could provide diaryl nitroalkenes 
32. Subsequent Barton-Zard pyrrole cyclocondensation of isocyanoacetate with 33 should 
provide functionalized pyrroles such as 34 which have numerous applications in 
medicinal chemistry. If successful, this methodology may have wide application in the 
synthesis of functionalized pyrroles.5 
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Scheme 5.6 
The synthetic approach to fistulopsine B has potential application in the syntheses 
of analogues of indolizidine alkaloids6 by variation in the nitrostyrenes and the aryl-cross 
coupling partners. Organocatalytic Michael addition of 1,4-cyclohexanedione mono 
ethylene ketal 10 to a variety of -nitrostyrenes 35 in presence of triamine catalyst 21 
provides Michael adduct 36 which on several steps could provide ketone 37 followed by 
cross-coupling with different aryl groups and reduction could afford 38. 
 
Scheme 5.7 
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